Cobiz Financial (COBZ) 10-K 13 Feb 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 12, 2015	Jun. 30, 2014
Document And Entity Information
Entity Registrant Name	COBIZ FINANCIAL INC
Entity Central Index Key	1028734
Document Type	10-K
Amendment Flag	FALSE
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Current Fiscal Year End Date	-19
Entity Filer Category	Accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$298,127,321
Entity Common Stock, Shares Outstanding		40,781,741

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets
Cash and due from banks	$54,629	$53,359
Interest-bearing deposits and federal funds sold	36,936	22,669
Total cash and cash equivalents	91,565	76,028
Investment securities available for sale (cost of $448,253 and $526,908, respectively)	459,815	535,133
Investment securities held to maturity (fair value of $13,616 and $12,715, respectively)	13,329	13,266
Other investments	11,477	8,397
Total investments	484,621	556,796
Loans - net of allowance for loan losses of $32,765 and $37,050, respectively	2,372,810	2,047,309
Intangible assets - net of amortization of $6,197 and $5,600, respectively	2,526	2,798
Bank-owned life insurance	48,040	43,768
Premises and equipment - net of depreciation of $37,954 and $35,705, respectively	7,250	6,034
Accrued interest receivable	9,617	8,770
Deferred income taxes, net	20,008	26,506
Other real estate owned - net of valuation allowance of $8,760 and $8,674, respectively	5,819	5,097
Other	19,910	27,585
TOTAL ASSETS	3,062,166	2,800,691
Liabilities
Noninterest-bearing demand	1,073,164	961,705
Interest-bearing demand	531,365	487,037
Money market	661,519	572,175
Savings	15,236	12,803
Certificates of deposit	211,007	245,317
Total deposits	2,492,291	2,279,037
Securities sold under agreements to repurchase	49,976	138,494
Other short-term borrowings	112,469
Accrued interest and other liabilities	26,495	29,909
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	2,753,397	2,519,606
Commitments and contingencies - see note 16
Shareholders' Equity
Preferred stock, $.01 par value; 2,000,000 shares authorized; 57,366 issued and outstanding ($57,366 liquidation value)	1	1
Common, $.01 par value; 100,000,000 shares authorized; 40,770,390 and 40,368,008 issued and outstanding, respectively	401	397
Additional paid-in capital	245,020	240,660
Accumulated earnings (deficit)	59,019	37,297
Accumulated other comprehensive income, net of income tax of $2,655 and $1,673, respectively	4,328	2,730
TOTAL SHAREHOLDERS' EQUITY	308,769	281,085
TOTAL LIABILITIES AND EQUITY	$3,062,166	$2,800,691

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Consolidated Balance Sheets
Investment securities available for sale, cost	$448,253	$526,908
Investment securities held to maturity, fair value	13,616	12,715
Allowance for loan losses	32,765	37,050
Intangible assets, amortization	6,197	5,600
Premises and equipment, depreciation	37,953	35,705
Other real estate owned assets, allowance	8,760	8,674
Preferred, par value	$0.01	$0.01
Preferred, shares authorized	2,000,000	2,000,000
Preferred, shares issued	57,366	57,366
Preferred stock, shares outstanding	57,366	57,366
Preferred, liquidation value	57,366	57,366
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	100,000,000	50,000,000
Common stock, shares issued	40,770,390	40,368,008
Common stock, shares outstanding	40,770,390	40,368,008
Accumulated other comprehensive income, tax	$2,655	$1,673

Consolidated_Statements_Of_Inc

Consolidated Statements Of Income (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
INTEREST INCOME:
Interest and fees on loans	$98,627	$89,071	$86,505
Interest and dividends on investment securities:
Taxable securities	14,810	16,607	19,209
Nontaxable securities	271	38	15
Dividends on securities	507	294	286
Interest on federal funds sold and other	102	117	113
Total interest income	114,317	106,127	106,128
INTEREST EXPENSE:
Interest on deposits	3,866	4,616	6,161
Interest on short-term borrowings and securities sold under agreements to repurchase	441	450	548
Interest on subordinated debentures	4,122	5,360	6,041
Total interest expense	8,429	10,426	12,750
NET INTEREST INCOME BEFORE PROVISION FOR LOAN LOSSES	105,888	95,701	93,378
Provision for loan losses	-4,155	-8,804	-4,733
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	110,043	104,505	98,111
NONINTEREST INCOME:
Service charges	5,598	5,315	4,903
Investment advisory income	5,736	5,077	4,203
Insurance income	11,150	11,199	9,680
Investment banking income	4,166	2,302	3,833
Other income	5,425	7,019	7,940
Total noninterest income	32,075	30,912	30,559
NONINTEREST EXPENSE:
Salaries and employee benefits	69,089	64,540	59,935
Occupancy expenses, premises and equipment	13,369	13,262	13,471
Amortization of intangibles	597	662	724
FDIC and other assessments	1,737	1,690	1,782
Other real estate owned and loan workout costs	1,066	715	2,326
Net other than temporary impairment losses on securities recognized in earnings			297
Net (gain) loss on securities, other assets and other real estate owned	-2,618	683	65
Other	14,724	13,076	12,566
Total noninterest expense	97,964	94,628	91,166
INCOME BEFORE INCOME TAXES	44,154	40,789	37,504
Provision for income taxes	15,147	13,351	13,258
NET INCOME FROM CONTINUING OPERATIONS	29,007	27,438	24,246
DISCONTINUED OPERATIONS
Income from discontinued operations		259	495
Provision for income taxes		86	171
Net income from discontinued operations		173	324
NET INCOME	29,007	27,611	24,570
NET INCOME AVAILABLE TO COMMON SHAREHOLDERS	$28,433	$26,667	$21,755
EARNINGS (LOSS) PER COMMON SHARE:
Basic - from continuing operations	$0.70	$0.66	$0.54
Diluted - from continuing operations	$0.70	$0.66	$0.54
Basic - from discontinued operation	$0	$0	$0.01
Diluted - from discontinued operations	$0	$0	$0.01
Basic	$0.70	$0.66	$0.55
Diluted	$0.70	$0.66	$0.55

Consolidated_Statements_Of_Com

Consolidated Statements Of Comprehensive Income (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements Of Comprehensive Income
Net income	$29,007	$27,611	$24,570
Other comprehensive income items:
Unrealized gain (loss) on available for sale securities	4,491	-8,183	6,333
Reclassification for gain to operations	-1,154	-439	-782
Change in OTTI-related component of unrealized gain			1,039
Unrealized gain (loss) on derivatives	-2,067	3,126	-2,597
Reclassification of loss to operations	1,310	2,095	2,061
Total other comprehensive income items	2,580	-3,401	6,054
Income tax provision:
Unrealized gain (loss) on available for sale securities	1,708	-3,110	2,406
Reclassification to operations	-439	-167	-297
Change in OTTI-related component of unrealized gain			395
Unrealized gain (loss) on derivatives	-785	1,188	-987
Reclassification to operations	498	796	783
Total income tax provision (benefit)	982	-1,293	2,300
Other comprehensive income (loss), net of tax	1,598	-2,108	3,754
Comprehensive income	$30,605	$25,503	$28,324

Consolidated_Statements_Of_Equ

Consolidated Statements Of Equity (USD $)	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Deficit)	Accumulated Comprehensive Income (Loss)	Total
In Thousands, except Share data
BALANCE - beginning of period at Dec. 31, 2011	$1	$368	$222,200	($3,571)	$1,084	$220,082
BALANCE - beginning of period (shares) at Dec. 31, 2011	57,366	37,089,753
Options exercised, value		1	342			343
Options exercised, shares		57,434
Employee stock purchase plan, value		1	408			409
Employee stock purchase plan, shares		65,900
Proceeds from issuance of common stock, net of costs		21	11,809			11,830
Proceeds from issuance of common stock, net of costs, shares		2,100,000
Restricted stock awards, net of forfeitures, shares		476,672
Stock-based compensation expense			1,965			1,965
Tax deficit from stock-based compensation			-340			-340
Dividends paid-common				-2,747		-2,747
Dividends paid/accumulated-preferred stock				-2,815		-2,815
Other comprehensive loss, net of income tax (expense) benefit of $(982), $1,293, and $(2,300), respectively					-3,754	-3,754
Net income				24,570		24,570
BALANCE - end of period at Dec. 31, 2012	1	391	236,384	15,437	4,838	257,051
BALANCE - end of period (shares) at Dec. 31, 2012	57,366	39,789,759
Options exercised, value		2	1,558			1,560
Options exercised, shares		240,683
Employee stock purchase plan, value		1	399			400
Employee stock purchase plan, shares		47,296
Shares withheld in net settlement of restricted stock		3	-300			-297
Shares withheld in net settlement of restricted stock (shares)		-35,256
Restricted stock awards, net of forfeitures, shares		325,526
Stock-based compensation expense			2,742			2,742
Tax deficit from stock-based compensation			-123			-123
Dividends paid-common				-4,807		-4,807
Dividends paid/accumulated-preferred stock				-944		-944
Other comprehensive loss, net of income tax (expense) benefit of $(982), $1,293, and $(2,300), respectively					-2,108	-2,108
Net income				27,611		27,611
BALANCE - end of period at Dec. 31, 2013	1	397	240,660	37,297	2,730	281,085
BALANCE - end of period (shares) at Dec. 31, 2013	57,366	40,368,008
Options exercised, value		4	1,112			1,116
Options exercised, shares		154,091				154,091
Employee stock purchase plan, value		1	453			454
Employee stock purchase plan, shares		43,449
Shares withheld in net settlement of restricted stock		-1	-409	-635		-1,045
Shares withheld in net settlement of restricted stock (shares)		-92,340
Restricted stock awards, net of forfeitures, shares		297,182
Stock-based compensation expense			3,141			3,141
Tax deficit from stock-based compensation			63			63
Dividends paid-common				-6,076		-6,076
Dividends paid/accumulated-preferred stock				-574		-574
Other comprehensive loss, net of income tax (expense) benefit of $(982), $1,293, and $(2,300), respectively					1,598	1,598
Net income				29,007		29,007
BALANCE - end of period at Dec. 31, 2014	$1	$401	$245,020	$59,019	$4,328	$308,769
BALANCE - end of period (shares) at Dec. 31, 2014	57,366	40,770,390

Consolidated_Statements_Of_Equ1

Consolidated Statements Of Equity (Parenthetical) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Consolidated Statements Of Equity
Common Stock, Dividends, Per Share, Cash Paid	$0.15	$0.12	$0.07
Preferred Stock, Dividend Rate, Percentage	1.00%	1.60%	4.90%
Preferred Stock, Liquidation Preference Per Share	$1,000	$1,000	$1,000
Other comprehensive income, tax (expense) benefit	($982)	$1,293	($2,300)

Consolidated_Statements_Of_Cas

Consolidated Statements Of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$29,007	$27,611	$24,570
Adjustments to reconcile net income to net cash provided by operating activities:
Net amortization on investment securities	2,203	3,352	3,649
Depreciation and amortization	3,286	3,670	4,004
Amortization of net loan fees	-2,180	-1,114	-1,001
Provision for loan and credit losses	-4,155	-8,804	-4,768
Stock-based compensation	3,141	2,742	1,965
Federal Home Loan Bank stock dividend	-268	-60	-59
Deferred income taxes	5,519	4,782	752
Increase in cash surrender value of bank-owned life insurance	-1,271	-1,295	-1,286
Supplemental executive retirement plan			181
(Gain) loss on securities, other assets and other real estate owned	-2,618	683	362
Other operating activities, net	-625	-2,080	-2,724
Changes in operating assets and liabilities:
Prepaid FDIC insurance		1,365	1,465
Accrued interest and other liabilities	-3,375	-5,634	998
Accrued interest receivable	-847	-416	-81
Other assets	-546	1,949	3,485
Net cash provided by operating activities	27,271	26,751	31,512
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of other investments	-20,859	-2,992	-3,319
Proceeds from other investments	19,456	4,100	7,470
Purchases of investment securities available for sale	-13,053	-139,628	-188,110
Purchases of investment securities held to maturity		-7,765	-5,254
Proceeds from sale of investment securities available for sale	11,590		9,598
Maturities of investment securities available for sale	83,515	146,540	246,849
Maturities of investment securities held to maturity	34	30	28
Restricted cash		4,540	-5
Acquisition of client relationships	-250		-766
Purchase of bank-owned life insurance	-3,335		-1,420
Proceeds from sale of loans, OREO and repossessed assets	12,392	11,266	12,838
Loan originations and repayments, net	-326,658	-165,813	-298,512
Purchase of premises and equipment	-4,226	-1,956	-1,973
Other investing activities, net	-1,976	24	39
Net cash used in investing activities	-243,370	-151,654	-222,537
CASH FLOWS FROM FINANCING ACTIVITIES:
Net increase in demand, NOW, money market and savings accounts	247,564	164,829	255,488
Net decrease in certificates of deposits	-34,310	-15,052	-44,634
Net increase (decrease) in short-term borrowings	112,469		-20,000
Net increase (decrease) in securities sold under agreements to repurchase	-88,518	10,607	-61
Redemption of subordinated notes payable		-20,984
Proceeds from issuance of common stock, net	1,570	1,960	12,582
Taxes paid in net settlement of restricted stock	-1,045	-297
Dividends paid on common stock	-6,076	-4,820	-2,747
Dividends paid on preferred stock	-574	-1,465	-2,868
Other financing activities, net	556	260	-52
Net cash provided by financing activities	231,636	135,038	197,708
NET INCREASE IN CASH AND CASH EQUIVALENTS	15,537	10,135	6,683
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	76,028	65,893	59,210
CASH AND CASH EQUIVALENTS, END OF PERIOD	$91,565	$76,028	$65,893

Nature_Of_Operations_and_Signi

Nature Of Operations and Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Nature Of Operations and Significant Accounting Policies
Nature Of Operations and Significant Accounting Policies	COBIZ FINANCIAL INC. AND SUBSIDIARIES
	NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
	AT AND FOR THE YEARS ENDED DECEMBER 31, 2014,  2013 AND 2012
	1. Nature of Operations and Significant Accounting Policies
	The accounting and reporting practices of CoBiz Financial Inc. (Parent) and its wholly owned subsidiaries: CoBiz Bank (Bank); CoBiz Insurance, Inc.; CoBiz GMB, Inc.; and CoBiz IM, Inc. (CoBiz IM); all collectively referred to as the “Company” or “CoBiz,” conform to accounting principles generally accepted in the United States of America and prevailing practices within the banking industry.  The operations of the Company are comprised predominantly of the Bank, which operates in its Colorado market areas under the name Colorado Business Bank (CBB) and in its Arizona market areas under the name Arizona Business Bank (ABB).
	Organization - The Bank is a commercial banking institution with nine locations in the Denver metropolitan area; one in Boulder; one near Vail; one in Colorado Springs; one in Fort Collins; and six in the Phoenix metropolitan area.  As a state chartered bank, deposits are insured by the Bank Insurance Fund of the Federal Deposit Insurance Corporation (FDIC) and the Bank is subject to supervision, regulation and examination by the Federal Reserve, Colorado Division of Banking and the FDIC. Pursuant to such regulations, the Bank is subject to special restrictions, supervisory requirements and potential enforcement actions. CoBiz Insurance, Inc. provides commercial and personal property and casualty (P&C) insurance brokerage, as well as risk management consulting services to small and medium-sized businesses and individuals.  On January 1, 2014, CoBiz Insurance – Employee Benefits, Inc. (formerly Financial Designs Ltd.(FDL)), a provider employee benefits consulting, insurance brokerage and related administrative support to employers, was merged into CoBiz Insurance Inc.  CoBiz GMB, Inc. provides investment banking services to middle-market companies through its wholly-owned subsidiary, Green Manning & Bunch, Ltd. (GMB).  CoBiz IM provides wealth planning and investment management to institutions and individuals through its SEC-registered investment advisor subsidiary, CoBiz Investment Management, LLC (CIM).  During the fourth quarter of 2012, the Company exited two business lines:  trust services and FDL’s wealth transfer business.  See Note 2 – Discontinued Operations for additional information.
	Use of Estimates – In preparing its financial statements, the company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ significantly from those estimates.  Material estimates that are particularly susceptible to significant changes in the near-term relate to the determination of the allowance for loan losses; fair value of financial instruments; and recoverability of deferred taxes.
	Reclassifications – Certain reclassifications have been made to prior years’ consolidated financial statements and related notes to conform to current year presentation including: the effects of discontinued operations (Note 2 – Discontinued Operations) and a change to the Company’s segments (Note 19 – Segments).
	The following is a summary of certain of the Company’s significant accounting and reporting policies.
	Basis of Presentation — The consolidated financial statements include entities in which the Parent has a controlling financial interest.  These entities include; the Bank; CoBiz Insurance Inc.; CoBiz GMB, Inc.; and CoBiz IM.  Intercompany balances and transactions are eliminated in consolidation.  The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE).
	The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity.  The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE.  The Company was not the primary beneficiary of a VIE at December 31, 2014 or December 31, 2013.
	Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements.  At December 31, 2014 and 2013, the Company had reserve requirements of $13.4 million and $0, respectively.  The following table shows supplemental disclosures of certain cash and noncash items:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Cash paid during the period for:
	Interest	$	8,295	$	10,409	$	12,823
	Income taxes		11,061		11,197		4,975
	Other noncash activities:
	Loans transferred to held for sale		7,087		8,044		6,201
	Loans transferred to OREO and repossessed assets		2,660		449		421
	Financed sales of OREO and loans held for sale		-		2,000		249
	Deferred gain on sale of wealth transfer business		-		-		285
	Restricted Cash – Restricted cash consists of cash deposits that are contractually restricted as collateral for outstanding letters of credit.  There was no restricted cash at December 31, 2014 and 2013.
	Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent.  Investment security transactions are recorded on a trade date basis.  At December 31, 2014 and 2013, the Company had no trading securities.
	Available for sale securities consist of residential mortgage-backed securities (MBS), bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized.
	Investment securities held to maturity consist of MBS, bonds, notes, debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts.
	Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific identification method.
	Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors.  The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI).  See Note 3 – Investments.
	Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method.  See Note 3 – Investments.
	Loans Held for Investment— Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms.  The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest.
	Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell.  Loans held for sale are primarily nonperforming loans.  Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis.
	Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450).
	Included in impaired loans are troubled debt restructurings.  A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date.  Troubled debt restructurings are evaluated in accordance with ASC Topic 310-10-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms.
	Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs.
	Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance.
	The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available.
	Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the consolidated balance sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded.  See Note 4 – Loans.
	Intangible Assets —Intangible assets, primarily consisting of customer contracts and relationships, are being amortized by the straight-line method over 10 to 15 years.  See Note 6 – Intangible Assets.
	Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs and are recorded at net realizable value.  Changes in the amount that could be realized are recorded in the consolidated statements of income under the caption “Other Income”.
	Premises and Equipment – Premises and equipment are stated at cost less accumulated depreciation and amortization, which is calculated using the straight-line method over the estimated useful lives of generally three to five years.  Leasehold improvements are capitalized and amortized using the straight-line method over the terms of the respective leases or the estimated useful lives of the improvements, whichever is shorter.  The Company reviews the carrying value of property and equipment for indications of impairment in accordance with ASC Topic 360-10-35, Impairment or Disposal of Long-Lived Assets.  See Note 5 – Premises and Equipment.
	Other Assets – Included in other assets are certain investments, where the Company has the ability to exercise significant influence or has ownership between 20% and 50% that are accounted for under the equity method.  The Funds are equity method investments licensed as Small Business Investment Companies that invest primarily in subordinated debt securities.  In certain circumstances, the Funds may also receive warrants or other equity positions as part of their investments.  There were no significant transactions between the Company and the Funds for the years ended December 31, 2014,  2013, and 2012.  The Company recognized income (loss) from the Funds of $(0.1) million, $0.9 million, and $2.2 million for the years ended December 31, 2014,  2013, and 2012, respectively, which is included in “Other Income” in the consolidated statements of income.
	Repossessed Assets – Assets acquired through repossession are held for sale and initially recorded at estimated fair value at the date of repossession.  Subsequent to repossession, valuations are periodically performed by management and the assets are carried at the lower of carrying amount or fair value less costs to sell.  Repossessed assets are reported in the consolidated balance sheets under the caption “Other Assets.”  There were no repossessed assets at December 31, 2014 and 2013.
	Other Real Estate Owned (OREO) – OREO held for sale acquired through foreclosure, physical possession or in settlement of debt is valued at estimated fair value, less estimated costs to sell, at the date of receipt.  Subsequent to foreclosure, OREO is carried at the lower of carrying amount or fair value less costs to sell.  Subsequent declines in value are charged to operations.  Activity in the valuation allowance on OREO for the years ended December 31, 2014,  2013, and 2012 is as follows:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Beginning balance	$	8,674	$	8,055	$	7,668
	Additions		398		2,185		1,872
	Deductions due to sales		-312		-1,566		-1,485
	Ending balance	$	8,760	$	8,674	$	8,055
	Securities Sold Under Agreements to Repurchase – The Company sells certain securities under agreements to repurchase with its customers.  The agreements transacted with its customers are utilized as an overnight investment product.  These agreements are treated as secured borrowings, where the agreements are reflected as a liability of the Company and the securities underlying the agreements are reflected as a Company asset in accordance with ASC Topic 860, Transfers and Servicing.  See Note 8 – Borrowed Funds.
	Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The net cash flows from these hedges are classified in operating activities within the Consolidated Statements of Cash Flows with the hedged items.  The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans.  These instruments are accounted for as fair value hedges in accordance with ASC 815.  The Company also has a derivative program that offers interest-rate caps, floors, swaps and collars to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement.  The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions.  FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments.  See Note 10 – Derivatives.
	Self-Insurance Reserves – The Company self-insures a portion of its employee medical costs.  The Company maintains a liability for incurred-but-not-reported claims based on assumptions as to eligible employees, historical claims experience and lags in claims reporting.
	Investment Advisory Income – Fees earned from providing investment advisory services are based on the market value of assets under management and are collected at the end of each quarter.
	Insurance Income  – Insurance income includes commissions on the sale of life and property and casualty insurance policies and other employee benefit products earned as an agent for unaffiliated insurance underwriters.  Property and casualty income is primarily recognized upon policy origination and renewal dates.  Benefits brokerage income is recognized on a monthly basis as the customer pays their insurance premiums.
	Investment Banking Income – Investment banking income includes nonrefundable retainer fees recognized over the expected term of the engagement and success fees recognized when the transaction is completed and collectability of fees is reasonably assured.
	Income From Discontinued Operations, Net of Income Taxes – Income from discontinued operations net of income taxes for the years ended December 31, 2013 and 2012 includes the results of FDL’s wealth transfer business and trust, which is discussed in Note 2 – Discontinued Operations.
	Income Taxes – A deferred income tax liability or asset is recognized for temporary differences which exist in the recognition of certain income and expense items for financial statement reporting purposes in periods different than for tax reporting purposes.  The provision for income taxes is based on the amount of current and deferred income taxes payable or refundable at the date of the financial statements as measured by the provisions of current tax laws.  A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible.  Management considers the scheduled reversal of deferred tax liabilities, taxes paid in prior carryback years, projected future taxable income and tax planning strategies in its assessment of a valuation allowance.  See Note 11 – Income Taxes.
	Stock-Based Compensation — Pursuant to ASC Topic 718, Compensation – Stock Compensation (ASC 718), the Company recognizes the fair value of stock-based awards to employees as compensation cost over the requisite service period.  See Note 15 – Employee Benefit and Stock Compensation Plans.
	Earnings Per Common Share — Basic and diluted earnings per share is based on the two-class method prescribed in ASC Topic 260, Earnings Per Share (ASC 260).  The weighted-average number of shares outstanding used to compute diluted earnings per share include the number of additional common shares that would be outstanding if the potential dilutive common shares and common share equivalents had been issued at the beginning of the period.  See Note 14 – Earnings per Common Share.
	Segment Information - The Company has disclosed separately the results of operations relating to its segments in Note 19 – Segments.
	Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurements and Disclosures (ASC 820).  ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.  See Note 18 - Fair Value Measurements.
	Recent Accounting Pronouncements — In January 2014, the Financial Accounting Standard Board (FASB) issued Accounting Standard Update (ASU) No. 2014-04, Receivables – Troubled Debt Restructurings by Creditors (Subtopic 310-40) – Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure (ASU 2014-04).  The amendments in ASU 2014-04 are intended to clarify when a creditor should be considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan such that the loan should be derecognized and the real estate recognized.  This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2014.  The Company is currently evaluating the effects of ASU 2014-04 on its financial statements and disclosures, if any.
	In April 2014, the FASB issued ASU No. 2014-08 Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) – Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08).  The amendments in ASU 2014-08 change the criteria for reporting discontinued operations and improve related disclosures.  This ASU also addresses sources of confusion and inconsistent application related to financial reporting of discontinued operations guidance.  ASU 2014-08 will be effective for annual financial statements with fiscal years beginning on or after December 31, 2014 and interim periods thereafter.  The Company is currently evaluating the effects ASU 2014-08 will have on its financial statements and disclosures, if any.
	In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (Topic 606) (ASU 2014-09).  This update to the ASC is the culmination of efforts by the FASB and the International Accounting Standards Board (IASB) to develop a common revenue standard for U.S. GAAP and International Financial Reporting Standards (IFRS).  ASU 2014-09 supersedes Topic 605 – Revenue Recognition and most industry-specific guidance.  The core principal of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  The guidance in ASU 2014-09 describes a 5-step process entities can apply to achieve the core principle of revenue recognition and requires disclosures sufficient to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers and the significant judgments used in determining that information.  The amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period and early application is not allowed.  The Company is currently evaluating the effects of ASU 2014-09 on its financial statements and disclosures, if any.
In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718) –Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Services Period (ASU 2014-12).  The amendments in ASU 2014-12 provide guidance for determining compensation cost under specific circumstances when an employee is eligible to vest in an award regardless of whether the employee is rendering service on the date the performance target is achieved.  ASU 2014-12 becomes effective for annual and interim periods beginning after December 15, 2015 with early adoption permitted.  The Company does not believe the effects of ASU 2014-12 will have an impact on its financial statements and disclosures.
In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40) (ASU 2014-15).  The amendments’ objective of ASU 2014-15 is to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and provide related disclosures.  Currently, GAAP does not provide guidance to evaluate whether there is substantial doubt the organization’s ability to continue as a going concern.  This ASU provides guidance to an organization’s management, with principles and definitions to reduce diversity in the timing and content of disclosures commonly provided by organizations today in the financial statements footnotes.  ASU 2014-15 is effective for periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016.  The Company does not believe the effects of ASU 2014-15 will have an impact on its financial statements and disclosures.
In January 2015, the FASB issued ASU No. 2015-01, Income Statement – Extraordinary and Unusual Items (Subtopic 225-202).  This ASU eliminates the concept of extraordinary items.  Subtopic 225-20, Income Statement – Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions.  An event or transaction is currently presumed to be an ordinary and usual activity of the reporting entity unless evidence clearly supports its classification as an extraordinary item.  The elimination of the concept of extraordinary items is expected to save time and reduce costs for preparers.  ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  A reporting entity may apply the amendments prospectively.  The Company does not believe the effects of ASU 2015-01 will have an impact on its financial statements and disclosures.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2014
Discontinued Operations
Discontinued Operations	2. Discontinued Operations
	During the fourth quarter of 2012, the Company made the decision to close its trust department and sell its wealth transfer business.  Both of these divisions were within the Wealth Management segment.
	On December 31, 2012, the Company completed the sale of certain assets and liabilities, including all rights to the customer lists, of FDL’s wealth transfer business.  The net carrying value of the assets and liabilities of the disposal group was $0.2 million.  Pursuant to the sale agreement, the Company will receive contingent consideration based on a percentage of revenues generated by the acquiring company.  The contingent consideration will be paid annually between the years 2013-2017.  The maximum amount the Company will receive is approximately $0.6 million.  In conjunction with the sale, the Company deferred a gain of $0.3 million, which will be recognized when the contingency is resolved.
	Additionally, during the fourth quarter of 2012, the Company entered into a transition agreement with another local bank to transfer the fiduciary and custodial accounts of its trust department.  As the trust department was closed and not sold, the Company will not receive any compensation for the transfer of its trust customers.  Assets and liabilities relating to the trust department were immaterial.
	The operating results associated with the trust and wealth transfer divisions have been retrospectively presented as discontinued operations beginning January 1, 2011. The table below presents the results of trust and wealth transfer for the years ended December 31, 2014, 2013, and 2012.
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Noninterest income	$	-	$	333	$	6,448
	Noninterest expense		-		74		5,953
	Income before income taxes		-		259		495
	Provision for income taxes		-		86		171
	Net income from discontinued operations	$	-	$	173	$	324

Investments

Investments	12 Months Ended
	Dec. 31, 2014
Investments
Investments	3. Investments
	The amortized cost and estimated fair values of investment securities are summarized as follows:
		December 31, 2014								December 31, 2013
				Gross		Gross						Gross		Gross
		Amortized		unrealized		unrealized		Fair		Amortized		unrealized		unrealized		Fair
	(in thousands)	cost		gains		losses		value		cost		gains		losses		value
	Available for sale securities (AFS):
	Mortgage-backed securities	$	275,855	$	8,052	$	403	$	283,504	$	326,555	$	7,467	$	811	$	333,211
	Trust preferred securities		57,974		2,127		446		59,655		82,768		1,250		1,694		82,324
	Corporate debt securities		99,249		2,186		225		101,210		108,862		3,088		968		110,982
	Municipal securities		15,175		280		9		15,446		8,723		8		115		8,616
	Total AFS	$	448,253	$	12,645	$	1,083	$	459,815	$	526,908	$	11,813	$	3,588	$	535,133
	Held to maturity securities (HTM):
	Mortgage-backed securities	$	140	$	4	$	-	$	144	$	175	$	6	$	-	$	181
	Trust preferred securities		13,189		294		11		13,472		13,091		-		557		12,534
	Total HTM	$	13,329	$	298	$	11	$	13,616	$	13,266	$	6	$	557	$	12,715
	Proceeds from the sale of investments and the gain (loss) recognized on securities sold or called are summarized as follows:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Proceeds	$	11,590	$	-	$	9,598
	Gains		1,242		552		1,651
	Losses		-88		-113		-572
	The amortized cost and estimated fair value of investments in debt securities at December 31, 2014, by contractual maturity are shown below.  Expected maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties.
		Available for sale				Held to maturity
		Amortized		Fair		Amortized		Fair
	(in thousands)	cost		value		cost		value
	Due in one year or less	$	24,240	$	24,458	$	-	$	-
	Due after one year through five years		61,244		62,834		-		-
	Due after five years through ten years		28,378		28,778		-		-
	Due after ten years		58,536		60,241		13,189		13,472
	Mortgage-backed securities		275,855		283,504		140		144
		$	448,253	$	459,815	$	13,329	$	13,616
	Investment securities with a fair value of $171.1 million and $138.8 million were pledged to secure public deposits of $122.3 million and $106.4 million at December 31, 2014 and 2013, respectively.
	Changes in interest rates and market liquidity may cause adverse fluctuations in the market price of securities resulting in temporary unrealized losses.  In reviewing the realizable value of its securities in a loss position, the Company considered the following factors: (1) the length of time and extent to which the market had been less than cost; (2) the financial condition and near-term prospects of the issuer: (3) investment downgrades by rating agencies; and (4) whether it is more likely than not that the Company will have to sell the security before a recovery in value.  When it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the security, and the fair value of the investment security is less than its amortized cost, an other-than-temporary impairment is recognized in earnings.
	For debt securities that are considered other-than temporarily impaired and that the Company does not intend to sell and will not be required to sell prior to recovery of the amortized cost basis, an OTTI is recognized.  OTTI is separated into the amount that is credit related (credit loss component) and the amount due to all other factors.  The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows.  The amount due to all other factors is recognized in other comprehensive income.
	There were 24 and 44 securities in the tables below at December 31, 2014 and 2013, respectively, in an unrealized loss position.
		December 31, 2014
		Less than 12 months				12 months or greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	(in thousands)	value		loss		value		loss		value		loss
	AFS
	Mortgage-backed securities	$	9,699	$	12	$	26,470	$	391	$	36,169	$	403
	Trust preferred securities		17,175		48		6,145		398		23,320		446
	Corporate debt securities		5,856		117		4,924		108		10,780		225
	Municipal securities		773		9		-		-		773		9
	Total AFS	$	33,503	$	186	$	37,539	$	897	$	71,042	$	1,083
	HTM
	Trust preferred securities	$	845	$	11	$	-	$	-	$	845	$	11
	Total HTM	$	845	$	11	$	-	$	-	$	845	$	11
		December 31, 2013
		Less than 12 months				12 months or greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	(in thousands)	value		loss		value		loss		value		loss
	AFS
	Mortgage-backed securities	$	52,509	$	811	$	-	$	-	$	52,509	$	811
	Trust preferred securities		49,934		1,599		1,903		95		51,837		1,694
	Corporate debt securities		20,609		938		4,970		30		25,579		968
	Municipal securities		7,787		115		-		-		7,787		115
	Total AFS	$	130,839	$	3,463	$	6,873	$	125	$	137,712	$	3,588
	HTM
	Trust preferred securities	$	12,534	$	557	$	-	$	-	$	12,534	$	557
	Total HTM	$	12,534	$	557	$	-	$	-	$	12,534	$	557
	There was no OTTI recognized in earnings during the years ended December 31, 2014 and 2013, and $0.3 million in 2012.
	Other investments at December 31, 2014 and 2013, consist of the following:
	December 31,
(in thousands)	2014		2013
Bank stocks — at cost	$	9,305	$	6,225
Investment in statutory trusts — equity method		2,172		2,172
	$	11,477	$	8,397
Bank stocks consist primarily of stock in the FHLB which is part of the Federal Home Loan Bank System (FHLB System).  The purpose of the FHLB investment relates to maintenance of a borrowing base with the FHLB.  FHLB stock holdings are largely dependent upon the Company’s liquidity position.  To the extent the need for wholesale funding increases or decreases, the Company may purchase additional or sell excess FHLB stock, respectively.  The Company evaluates impairment in this investment based on the ultimate recoverability of the par value and at December 31, 2014 and 2013, did not consider the investment to be other-than-temporarily impaired.

Loans

Loans	12 Months Ended
	Dec. 31, 2014
Loans
Loans	4. Loans
	The following disclosure reports the Company’s loan portfolio segments and classes.  Segments are groupings of similar loans at a level which the Company has adopted systematic methods of documentation for determining its allowance for loan and credit losses. Classes are a disaggregation of the portfolio segments.  In the first quarter of 2014, the Company combined its land acquisition and development and real estate construction loan segments into a single segment called Construction and land.  Prior period balances were adjusted to conform to the current presentation.  The Company’s loan portfolio segments are:
		·		Commercial loans – Commercial loans consist of loans to small and medium-sized businesses in a wide variety of industries.  The Bank’s areas of emphasis in commercial lending include, but are not limited to, loans to wholesalers, manufacturers, construction and business services companies.  Commercial loans are generally collateralized by inventory, accounts receivable, equipment, real estate and other commercial assets, and may be supported by other credit enhancements such as personal guarantees.  Risk arises primarily due to a difference between expected and actual cash flows of the borrowers.  However, the recoverability of the Company’s investment in these loans is also dependent on other factors primarily dictated by the type of collateral securing these loans.  The fair value of the collateral securing these loans may fluctuate as market conditions change.  In the case of loans secured by accounts receivable, the recovery of the Company’s investment is dependent upon the borrowers’ ability to collect amounts due from its customers.
		·		Real estate - mortgage loans – Real estate mortgage loans include various types of loans for which the Company holds real property as collateral.  Commercial real estate lending activity is typically restricted to owner-occupied properties or to investor properties that are owned by customers with a current banking relationship.  The primary risks of real estate mortgage loans include the borrower’s inability to pay, material decreases in the value of the real estate that is being held as collateral and significant increases in interest rates, which may make the real estate mortgage loan unprofitable.  Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy.
		·		Construction and land – The Company originates loans to finance construction projects including one- to four-family residences, multifamily residences, commercial office, senior housing, and industrial projects.  Residential construction loans are due upon the sale of the completed project and are generally collateralized by first liens on the real estate and have floating interest rates.  Construction loans are considered to have higher risks due to construction completion and timing risk, and the ultimate repayment being sensitive to interest rate changes, governmental regulation of real property and the availability of long-term financing. Additionally, economic conditions may impact the Company’s ability to recover its investment in construction loans.  Adverse economic conditions may negatively impact the real estate market which could affect the borrowers’ ability to complete and sell the project.  Additionally, the fair value of the underlying collateral may fluctuate as market conditions change.  The Company also originates loans for the acquisition and future development of land for residential building projects, as well as finished lots prepared to enter the construction phase.  The primary risks include the borrower’s inability to pay and the inability of the Company to recover its investment due to a decline in the fair value of the underlying collateral.
		·		Consumer loans – The Company provides a broad range of consumer loans to customers, including personal lines of credit, home equity loans, jumbo mortgage loans and automobile loans.  Repayment of these loans is dependent on the borrowers’ ability to pay and the fair value of the underlying collateral.
		·		Other loans – Other loans include lending products, such as taxable and tax-exempt leasing, not defined as commercial, real estate, acquisition and development, construction, or consumer loans.
	The loan portfolio segments at December 31, 2014 and 2013 were as follows:
			December 31,
	(in thousands)		2014			2013
	Commercial		$	977,628		$	825,530
	Real estate - mortgage			990,594			901,721
	Construction & land			182,869			128,670
	Consumer			207,921			181,067
	Other			47,904			49,394
	Loans held for investment			2,406,916			2,086,382
	Allowance for loan losses			-32,765			-37,050
	Unearned net loan fees			-1,341			-2,023
	Total net loans		$	2,372,810		$	2,047,309
	The Company purchased 9 loans during the year ended December 31, 2014 totaling $58.3 million primarily comprised of $46.6 million in Commercial loans and $11.7 million in Real estate-mortgage,  none of which were of deteriorated credit quality.  For the year ended December 31, 2013, the Company purchased 90 loans totaling $30.6 million primarily comprised of $13.0 million in Other loans and $4.7 million in Commercial loans, $3.3 million in Real estate-mortgage and $9.6 million in Construction and land, none of which were of deteriorated credit quality.
	At December 31, 2014 and 2013, overdraft demand deposits totaling $0.9 million and $0.4 million, respectively, were reclassified from deposits to loans.
	The Company maintains a loan review program independent of the lending function that is designed to reduce and control risk in lending. It includes the continuous monitoring of lending activities with respect to underwriting and processing new loans, preventing insider abuse and timely follow-up and corrective action for loans showing signs of deterioration in quality.  The Company also has a systematic process to evaluate individual loans and pools of loans within our loan portfolio. The Company maintains a loan grading system whereby each loan is assigned a grade between 1 and 8, with 1 representing the highest quality credit, 7 representing a nonaccrual loan where collection or liquidation in full is highly questionable and improbable, and 8 representing a loss that has been or will be charged-off.  Grades are assigned based upon the degree of risk associated with repayment of a loan in the normal course of business pursuant to the original terms.  Loans that are graded 5 or lower are categorized as non-classified credits while loans graded 6 and higher are categorized as classified credits.  Loan grade changes are evaluated on a monthly basis.  Loans above a certain dollar amount that are adversely graded are reported to the Special Assets group manager and the Chief Credit Officer along with current financial information, a collateral analysis and an action plan.
	The loan portfolio showing total non-classified and classified balances by loan class at December 31, 2014 and 2013 is summarized below:
			At December 31, 2014
	(in thousands)		Non-classified			Classified			Total
	Commercial
	Manufacturing		$	121,617		$	4,501		$	126,118
	Finance and insurance			80,948			99			81,047
	Health care			91,631			180			91,811
	Real estate services			110,031			2,357			112,388
	Construction			53,513			2,982			56,495
	Wholesale and retail trade			68,811			3,484			72,295
	Other			435,337			2,137			437,474
				961,888			15,740			977,628
	Real estate - mortgage
	Residential & commercial owner-occupied			409,659			12,749			422,408
	Residential & commercial investor			563,657			4,349			568,006
	Other			180			-			180
				973,496			17,098			990,594
	Construction & land			181,641			1,228			182,869
	Consumer			205,131			2,790			207,921
	Other			47,820			84			47,904
	Total loans held for investment		$	2,369,976		$	36,940		$	2,406,916
	Unearned net loan fees									-1,341
	Net loans held for investment								$	2,405,575
			At December 31, 2013
	(in thousands)		Non-classified			Classified			Total
	Commercial
	Manufacturing		$	101,114		$	4,582		$	105,696
	Finance and insurance			76,589			517			77,106
	Health care			99,526			639			100,165
	Real estate services			98,691			1,591			100,282
	Construction			51,616			1,695			53,311
	Wholesale and retail trade			69,167			1,937			71,104
	Other			313,862			4,004			317,866
				810,565			14,965			825,530
	Real estate - mortgage
	Residential & commercial owner-occupied			436,479			16,500			452,979
	Residential & commercial investor			441,186			7,556			448,742
				877,665			24,056			901,721
	Construction & land			122,637			6,033			128,670
	Consumer			179,645			1,422			181,067
	Other			49,394			-			49,394
	Total loans held for investment		$	2,039,906		$	46,476		$	2,086,382
Unearned net loan fees									-2,023
Net loans held for investment								$	2,084,359
Transactions in the allowance for loan losses by segment for the years ended December 31, 2014 and 2013 are summarized below:
		For the year ended
		December 31,
(in thousands)		2014			2013
Allowance for loan losses, beginning of period
Commercial		$	14,103		$	13,448
Real estate - mortgage			14,919			17,832
Construction & land			3,346			9,893
Consumer			2,471			3,061
Other			479			451
Unallocated			1,732			2,181
Total			37,050			46,866
Provision
Commercial		$	2,094		$	233
Real estate - mortgage			-2,839			-957
Construction & land			-2,499			-7,150
Consumer			257			-513
Other			9			32
Unallocated			-1,177			-449
Total			-4,155			-8,804
Charge-offs
Commercial		$	-1,956		$	-613
Real estate - mortgage			-52			-3,055
Construction & land			-50			-796
Consumer			-453			-122
Other			-6			-5
Total			-2,517			-4,591
Recoveries
Commercial		$	373		$	1,035
Real estate - mortgage			435			1,099
Construction & land			1,519			1,399
Consumer			54			45
Other			6			1
Total			2,387			3,579
Allowance for loan losses, end of period
Commercial		$	14,614		$	14,103
Real estate - mortgage			12,463			14,919
Construction & land			2,316			3,346
Consumer			2,329			2,471
Other			488			479
Unallocated			555			1,732
Total		$	32,765		$	37,050
The Company estimates the ALL in accordance with ASC 310 for purposes of evaluating loan impairment on a loan-by-loan basis and ASC 450 for purposes of collectively evaluating loan impairment by grouping loans with common risk characteristics (i.e. risk classification, past-due status, type of loan, and collateral).  The ALL is comprised of the following components:
	·		Specific Reserves – The Company continuously evaluates its reserve for loan losses to maintain an adequate level to absorb loan losses incurred in the loan portfolio. Reserves on loans identified as impaired, including troubled debt restructurings, are based on discounted expected cash flows using the loan’s initial effective interest rate, the observable market value of the loan or the fair value of the collateral for certain collateral-dependent loans. The fair value of the collateral is determined in accordance with ASC 820. Loans are considered to be impaired in accordance with the provisions of ASC 310, when it is probable that all amounts due in accordance with the contractual terms will not be collected. Factors contributing to the determination of specific reserves include the financial condition of the borrower, changes in the value of pledged collateral and general economic conditions.  Troubled debt restructurings meet the definition of an impaired loan under ASC 310 and therefore, troubled debt restructurings are subject to impairment evaluation on a loan-by-loan basis.
For collateral dependent loans that have been specifically identified as impaired, the Company measures fair value based on third-party appraisals, adjusted for estimated costs to sell the property.  Upon impairment, the Company will obtain a new appraisal if one had not been previously obtained in the last 12 months.  For credits over $2.0 million, the Company engages an additional third-party appraiser to review the appraisal.  For credits under $2.0 million, the Company’s internal appraisal department reviews the appraisal.  All appraisals are reviewed for reasonableness based on recent sales transactions that may have occurred subsequent to or right at the time of the appraisal.  Based on this analysis the appraised value may be adjusted downward if there is evidence that the appraised value may not be indicative of fair value.  Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process.
Values are reviewed and monitored internally and fair value is re-assessed at least quarterly or more frequently when events or circumstances occur that indicate a change in fair value.  It has been the Company’s experience that appraisals quickly become outdated due to the volatile real estate environment.  As such, fair value based on property appraisals may be adjusted to reflect estimated declines in the fair value of properties since the time the last appraisal was performed.
	·		General Reserves – General reserves are considered part of the allocated portion of the allowance. The Company uses a comprehensive loan grading process for our loan portfolios. Based on this process, a loss factor is assigned to each pool of graded loans.  A combination of loss experience and external loss data is used in determining the appropriate loss factor.  This estimate represents the probable incurred losses within the portfolio. In evaluating the adequacy of the ALL, management considers historical losses (Migration), as well as other factors including changes in:
	·		Lending policies and procedures
	·		National and local economic and business conditions and developments
	·		Nature and volume of portfolio
	·		Trends of the volume and severity of past-due and classified loans
	·		Trends in the volume of nonaccrual loans, troubled debt restructurings, and other loan modifications
	·		Credit concentrations
Troubled debt restructurings have a direct impact on the allowance to the extent a loss has been recognized in relation to the loan modified.  This is consistent with the Company’s consideration of Migration in determining general reserves.
The aforementioned factors enable management to recognize environmental conditions contributing to incurred losses in the portfolio, which have not yet manifested in Migration.  Management believes Migration history adequately captures a great percentage of probable incurred losses within the portfolio.
In addition to the allocated reserve for graded loans, a portion of the allowance is determined by segmenting the portfolio into product groupings with similar risk characteristics.  Part of the segmentation involves assigning increased reserve factors to those lending activities deemed higher-risk such as leverage-financings, unsecured loans, certain loans lacking personal guarantees, and multifamily loans.
	·		Unallocated Reserves – The unallocated reserve, which is judgmentally determined, is maintained to recognize the imprecision in estimating and measuring loss when evaluating reserves for individual loans or pools of loans.  The unallocated reserve consists of a missed grade component that is intended to capture the inherent risk that certain loans may be assigned an incorrect loan grade.
In assessing the reasonableness of management’s assumptions, consideration is given to select peer ratios, industry standards and directional consistency of the ALL.  Ratio analysis highlights divergent trends in the relationship of the ALL to nonaccrual loans, to total loans and to historical charge-offs.  Although these comparisons can be helpful as a supplement to assess reasonableness of management assumptions, they are not, by themselves, sufficient basis for determining the adequacy of the ALL.  While management utilizes its best judgment and information available, the ultimate adequacy of the allowance is dependent upon a variety of factors beyond the Company’s control, including the performance of our loan portfolio, the economy, changes in interest rates and the view of the regulatory authorities toward loan classifications.
The following tables summarize loans held for investment and the allowance for loan and credit losses on the basis of the impairment method:
		At December 31, 2014											At December 31, 2013
		Individually											Individually
		evaluated for						Collectively evaluated for					evaluated for				Collectively evaluated for
		impairment						impairment					impairment				impairment
		Loans			Allowance			Loans			Allowance		Loans		Allowance		Loans		Allowance
		held for			loan for			held for			loan for		held for		loan for		held for		loan for
(in thousands)		investment			losses			investment			losses		investment		losses		investment		losses
Commercial		$	20,415		$	3,441		$	957,284		$	11,173	$	17,454	$	2,140	$	806,999	$	11,963
Real estate - mortgage			17,803			281			971,916			12,182		25,501		2,371		875,363		12,548
Construction & land			4,004			280			177,860			2,036		10,454		932		117,498		2,414
Consumer			2,506			139			205,449			2,190		807		174		180,249		2,297
Other			84			6			48,254			482		-		-		50,034		479
Unallocated			-			-			-			555		-		-		-		1,732
Total		$	44,812		$	4,147		$	2,360,763		$	28,618	$	54,216	$	5,617	$	2,030,143	$	31,433
Information on impaired loans at December 31, 2014 and 2013 is reported in the following tables:
		At December 31, 2014
								Recorded			Recorded
					Recorded			investment			investment
		Unpaid			investment			with a			with no
		principal			in impaired			related			related		Related
(in thousands)		balance			loans (1)			allowance			allowance		allowance
Commercial
Manufacturing		$	5,169		$	4,887		$	4,833		$	54	$	431
Finance and insurance			99			99			99			-		53
Healthcare			140			140			140			-		9
Real estate services			8,469			8,469			8,469			-		782
Construction			2,050			2,050			1,961			89		296
Wholesale and retail trade			3,713			3,091			2,741			350		1,611
Other			1,989			1,679			1,670			9		259
			21,629			20,415			19,913			502		3,441
Real estate - mortgage
Residential & commercial owner-occupied			3,063			3,050			1,183			1,867		117
Residential & commercial investor			6,210			6,210			4,885			1,325		164
			9,273			9,260			6,068			3,192		281
Construction & land			4,038			4,004			3,325			679		280
Consumer			2,506			2,506			494			2,012		139
Other			84			84			84			-		6
Total		$	37,530		$	36,269		$	29,884		$	6,385	$	4,147
		At December 31, 2013
								Recorded			Recorded
					Recorded			investment			investment
		Unpaid			investment			with a			with no
		principal			in impaired			related			related		Related
(in thousands)		balance			loans (1)			allowance			allowance		allowance
Commercial
Manufacturing		$	4,887		$	4,859		$	4,797		$	62	$	479
Finance and insurance			517			517			517			-		106
Healthcare			236			236			236			-		23
Real estate services			7,473			7,473			7,473			-		505
Construction			1,708			1,708			1,613			95		222
Wholesale and retail trade			294			248			97			151		59
Other			2,418			2,413			2,215			198		746
			17,533			17,454			16,948			506		2,140
Real estate - mortgage
Residential & commercial owner-occupied			6,468			5,967			2,524			3,443		709
Residential & commercial investor			11,058			10,518			8,357			2,161		1,662
			17,526			16,485			10,881			5,604		2,371
Construction & land			10,279			8,877			4,557			4,320		932
Consumer			807			807			807			-		174
Total		$	46,145		$	43,623		$	33,193		$	10,430	$	5,617
	-1		Recorded investment in impaired loans in this table does not agree to loans individually evaluated for impairment disclosed in the previous table due to certain loans being excluded pursuant to ASC 310-40-50-2.
		For the year ended December 31,
		2014						2013					2012
		Average						Average					Average
		recorded						recorded					recorded
		investment			Interest			investment			Interest		investment		Interest
		in impaired			income			in impaired			income		in impaired		income
(in thousands)		loans			recognized			loans			recognized		loans		recognized
Commercial
Manufacturing		$	4,244		$	299		$	5,027		$	331	$	4,732	$	309
Finance and insurance			307			13			671			30		817		42
Healthcare			205			13			263			14		25		2
Real estate services			6,416			281			8,256			326		7,097		252
Construction			1,604			158			2,625			251		2,380		107
Wholesale and retail trade			1,303			184			370			17		631		15
Other			2,504			165			1,886			134		2,608		89
			16,583			1,113			19,098			1,103		18,290		816
Real estate - mortgage
Residential & commercial owner-occupied			4,102			176			8,915			162		9,914		44
Residential & commercial investor			7,062			247			12,638			275		10,384		559
			11,164			423			21,553			437		20,298		603
Construction & land			5,957			166			9,042			499		16,047		395
Consumer			1,362			93			1,184			61		972		3
Other			51			1			-			-		-		-
Total		$	35,117		$	1,796		$	50,877		$	2,100	$	55,607	$	1,817
Interest income recognized on impaired loans noted in the table above, primarily represents interest earned on troubled debt restructurings that meet the definition of an impaired loan pursuant to ASC 310-10-35-16 and are subject to disclosure requirement under ASC 310-10-50-15.  Interest income recognized on impaired loans using the cash-basis method of accounting during the years ended December 31, 2014, 2013, and 2012 was immaterial.
Interest income that would have been recorded had nonaccrual loans performed in accordance with their original contract terms during 2014,  2013, and 2012 was $0.3 million, $0.6 million, and $0.7 million, respectively.
The table below summarizes transactions as it relates to troubled debt restructurings for the year ended December 31, 2014:
(in thousands)		Performing			Nonperforming			Total
Beginning balance at December 31, 2013		$	29,683		$	12,010		$	41,693
New restructurings			12,183			876			13,059
Change in accrual status			-3,222			3,222			-
Paydowns			-11,369			-12,328			-23,697
Charge-offs			-			-865			-865
Beginning balance at December 31, 2014		$	27,275		$	2,915		$	30,190
The below table provides information regarding troubled debt restructurings that occurred during years ended December 31, 2014,  2013, and 2012.  Pre-modification outstanding recorded investment reflects the Company’s recorded investment immediately before the modification.  Post-modification outstanding recorded investment represents the Company’s recorded investment at the end of the reporting period.  The tables below do not include loans restructured and paid-off during the periods presented.
		For the year ended December 31, 2014									For the year ended December 31, 2013
					Pre-modification			Post-modification					Pre-modification		Post-modification
					outstanding			outstanding					outstanding		outstanding
		Number of			recorded			recorded			Number of		recorded		recorded
($ in thousands)		contracts			investment			investment			contracts		investment		investment
Commercial
Manufacturing			3		$	1,611		$	1,318			4	$	791	$	723
Real estate services			4			1,171			1,024			1		30		55
Construction			5			2,784			1,478			4		198		153
Wholesale and retail trade			3			1,297			886			4		1,413		146
Other			5			795			568			10		2,276		2,054
			20			7,658			5,274			23		4,708		3,131
Real estate - mortgage
Residential & commercial owner-occupied			1			29			28			4		3,221		2,580
Construction & land			1			121			95			1		2,615		2,615
Consumer			1			93			89			-		-		-
Other			1			91			84			2		87		84
Total			24		$	7,992		$	5,570			30	$	10,631	$	8,410
		For the year ended December 31, 2012
					Pre-modification			Post-modification
					outstanding			outstanding
		Number of			recorded			recorded
($ in thousands)		contracts			investment			investment
Commercial
Manufacturing			9		$	6,708		$	5,423
Finance and insurance			4			1,047			796
Health care			1			296			288
Real estate services			1			367			345
Construction			12			4,734			4,040
Other			11			2,074			1,963
			38			15,226			12,855
Real estate - mortgage
Residential & commercial owner-occupied			4			3,538			2,653
Residential & commercial investor			1			3,305			3,305
			5			6,843			5,958
Construction & land			10			8,331			7,469
Consumer			6			1,504			1,466
Total			59		$	31,904		$	27,748
Troubled debt restructurings during the year ended December 31, 2014, 2013, and 2012 resulted primarily from the extension of repayment terms and interest rate reductions.  The Company recognized charge-offs of $0.4 million in conjunction with current period troubled debt restructurings during the year ended December 31, 2014 and 2013.
Loans modified as troubled debt restructurings within the previous twelve months having a payment default during the years ended December 31, 2014 and 2013, are included below.
		At December 31,
		2014					2013
		Number of		Recorded			Number of		Recorded
Troubled debt restructurings that subsequently defaulted ($ in thousands)		contracts		investment			contracts		investment
Commercial
Construction		-		$	-		1		$	19
		-			-		1			19
Real estate - mortgage
Residential & commercial owner-occupied		-			-		1			737
Other		1			84		-			-
Total		1		$	84		2		$	756
At December 31, 2014 and 2013 there were $2.4 million and $1.9 million in outstanding commitments on restructured loans, respectively.
The Company’s recorded investment on nonaccrual loans by class at December 31, 2014 and 2013 is reported in the following table:
		At December 31,
(in thousands)		2014			2013
Commercial
Manufacturing		$	66		$	79
Finance and insurance			50			63
Real estate services			212			-
Construction			312			201
Wholesale and retail trade			2,491			206
Other			186			781
Total commercial			3,317			1,330
Real estate - mortgage
Residential & commercial owner-occupied			2,091			5,020
Residential & commercial investor			1,325			5,484
Total real estate - mortgage			3,416			10,504
Construction & land			135			1,986
Consumer			2,126			101
Total nonaccrual loans		$	8,994		$	13,921
The following tables summarize the aging of the Company’s loan portfolio at December 31, 2014 and 2013:
		At December 31, 2014
																	Recorded
																	investment
																	in loans
		30 - 59			60 - 89												90 days or more
		Days past			Days past			90+ Days			Total past						past due and
(in thousands)		due			due			past due			due		Current		Total loans		accruing
Commercial
Manufacturing		$	45		$	9		$	-		$	54	$	126,064	$	126,118	$	-
Finance and insurance			-			-			-			-		81,047		81,047		-
Health care			193			-			-			193		91,618		91,811		-
Real estate services			-			-			-			-		112,388		112,388		-
Construction			-			-			122			122		56,373		56,495		-
Wholesale and retail trade			247			-			2,095			2,342		69,953		72,295		161
Other			-			-			9			9		437,465		437,474		-
			485			9			2,226			2,720		974,908		977,628		161
Real estate - mortgage
Residential & commercial owner-occupied			-			-			473			473		421,935		422,408		-
Residential & commercial investor			235			-			-			235		567,771		568,006		-
Other			-			-			-			-		180		180		-
			235			-			473			708		989,886		990,594		-
Construction & land			-			-			104			104		182,765		182,869		-
Consumer			176			253			1,954			2,383		205,538		207,921		-
Other			-			-			-			-		47,904		47,904		-
Total loans held for investment		$	896		$	262		$	4,757		$	5,915	$	2,401,001	$	2,406,916	$	161
Unearned net loan fees																-1,341
Net loans held for investment															$	2,405,575
		At December 31, 2013
																	Recorded
																	investment
																	in loans
		30 - 59			60 - 89												90 days or more
		Days past			Days past			90+ Days			Total past						past due and
(in thousands)		due			due			past due			due		Current		Total loans		accruing
Commercial
Manufacturing		$	-		$	-		$	-		$	-	$	105,696	$	105,696	$	-
Finance and insurance			-			-			-			-		77,106		77,106		-
Health care			259			-			-			259		99,906		100,165		-
Real estate services			24			-			-			24		100,258		100,282		-
Construction			-			-			19			19		53,292		53,311		19
Wholesale and retail trade			-			-			100			100		71,004		71,104		-
Other			727			324			-			1,051		316,815		317,866		-
			1,010			324			119			1,453		824,077		825,530		19
Real estate - mortgage
Residential & commercial owner-occupied			-			-			913			913		452,066		452,979		-
Residential & commercial investor			-			-			-			-		448,742		448,742		-
Other			-			-			-			-		-		-		-
			-			-			913			913		900,808		901,721		-
Construction & land			816			-			1,951			2,767		125,903		128,670		-
Consumer			-			2			-			2		181,065		181,067		-
Other			-			-			-			-		49,394		49,394		-
Total loans held for investment		$	1,826		$	326		$	2,983		$	5,135	$	2,081,247	$	2,086,382	$	19
Unearned net loan fees																-2,023
Net loans held for investment															$	2,084,359
In the ordinary course of business, the Company makes various direct and indirect loans to officers and directors of the Company.  Activity with respect to officer and director loans is as follows for the years ended December 31, 2014 and 2013.
(in thousands)		2014			2013
Balance - beginning of year		$	29,766		$	8,343
New loan and advances			19,390			27,667
Principal paydowns and payoffs			-23,634			-6,244
Balance - end of year		$	25,522		$	29,766

Premises_And_Equipment

Premises And Equipment	12 Months Ended
	Dec. 31, 2014
Premises And Equipment
Premises And Equipment	5.  Premises and Equipment
	The major classes of premises and equipment at December 31, 2014 and 2013, are summarized as follows:
	(in thousands)	2014		2013
	Land	$	230	$	230
	Buildings		230		230
	Leasehold improvements		10,931		10,342
	Furniture, fixtures, and equipment		33,812		30,937
	Premises and equipment, gross		45,203		41,739
	Accumulated depreciation		-37,953		-35,705
	Premises and equipment, net	$	7,250	$	6,034
	The Company recorded depreciation expense related to premises and equipment of $2.7 million, $3.0 million, and $3.2 million during the years ended December 31, 2014, 2013, and 2012, respectively.

Intangible_Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2014
Intangible Assets
Intangible Assets	6.  Intangible Assets
	At December 31, 2014 and 2013, the Company’s intangible assets and related accumulated amortization consisted of the following:
		Customer
		contracts, lists
	(in thousands)	and relationships
	At December 31, 2012	$	3,573
	Disposals and other adjustments		-113
	Amortization		-662
	At December 31, 2013		2,798
	Acquired relationships		325
	Amortization		-597
	At December 31, 2014	$	2,526
	During the year ended December 31, 2014, the Company acquired an insurance book of business for a total of $0.2 million initial cash consideration that has an estimated useful life of 10 years.  Pursuant to the requirements of ASC Topic 805 Business Combinations, the Company recorded an additional $0.1 million in 2014 related to the acquisition in recognition of the fair value of contingent consideration which may be paid under an earnout arrangement in 2015.
	The Company recorded amortization expense of $0.6 million, $0.7 million and $0.7 million for the years ended December 31, 2014, 2013, and 2012, respectively.  Amortization expense on intangible assets for each of the five succeeding years is in the following table.
	(in thousands)
	2015	$	600
	2016		600
	2017		600
	2018		206
	2019		201
	Total	$	2,207

Deposits

Deposits	12 Months Ended
	Dec. 31, 2014
Deposits
Deposits	7.  Deposits
	In the ordinary course of business, the Company takes various deposits from employees, officers, and directors of the Company.  Related party deposits totaled $99.5 million and $84.9 million at December 31, 2014 and 2013, respectively.
	The composition of the certificates of deposit portfolio at December 31, 2014 and 2013, is as follows:
		At December 31,
	(in thousands)	2014		2013
	Less than $100	$	27,202	$	30,972
	$100 and more		183,805		214,345
		$	211,007	$	245,317
	Related interest expense for the years ended December 31, 2014, 2013, and 2012, is as follows:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Less than $100	$	125	$	158	$	220
	$100 and more		892		1,154		1,625
		$	1,017	$	1,312	$	1,845
	Maturities of certificates of deposit of $100,000 and more at December 31, 2014, are as follows:
	(in thousands)	Amount
	Remaining maturity:
	Three months or less	$	75,863
	Over three months through six months		44,993
	Over six months through 12 months		48,985
	Over 12 months		13,964
	Total	$	183,805
	The aggregate amount of certificates of deposit in denominations that meet or exceed the $250,000 FDIC insurance limit was $70.8 million and $73.5 million at December 31, 2014 and 2013, respectively.

Borrowed_Funds

Borrowed Funds	12 Months Ended
	Dec. 31, 2014
Borrowed Funds
Borrowed Funds	8.  Borrowed Funds
	Securities sold under agreements to repurchase at December 31, 2014 and 2013 are summarized as follows:
		At December 31,
	(in thousands)	2014		2013
	Securities sold under agreements to repurchase (principally mortgage-backed securities with an estimated fair value of $54,652 and $162,781 in 2014 and 2013, respectively	$	49,976	$	138,494
	The Company enters into sales of securities under agreements to repurchase.  The amounts received under these agreements represent short-term borrowings and are reflected as a liability in the consolidated balance sheets.  The securities underlying these agreements are included in investment securities in the consolidated balance sheets.  Securities sold under agreements to repurchase averaged $83.5 million and $154.5 million during 2014 and 2013, respectively.  The maximum amounts outstanding at any month-end during 2014 and 2013 were $115.3 million and $178.7 million, respectively.  At December 31, 2014 and 2013, the weighted‑average interest rate was 0.08% and 0.22%, respectively.  All securities sold under agreements to repurchase had a maturity date of less than three months.
	During the second quarter of 2014, the Company entered into a revolving Line of Credit (LOC) agreement with an aggregate principal sum of up to $20.0 million bearing interest at 1-month LIBOR plus 225 basis points (2.25%).  The Company pays a quarterly commitment fee of 0.25% per annum on the unused portion of the line of credit.  The line matures on May 15, 2015 at which time any outstanding amounts are due and payable.  Proceeds from the line will be used for general corporate purposes and backup liquidity.  Although the credit facility is unsecured, the Company has agreed not to sell, pledge or transfer any part of its right, title or interest in CoBiz Bank.  At December 31, 2014, there was no amount outstanding on the revolving line.
	The Company has a line of credit with the FHLB with a rolling one year term that matures every July with automatic renewals unless canceled.  There was $112.5 million outstanding on the FHLB line of credit at December 31, 2014.  There was nothing outstanding on the FHLB line of credit at December 31, 2013.  The average FHLB line of credit balance was $104.2 million and $33.2 million during 2014 and 2013, respectively.  The line of credit is collateralized by either qualifying loans or investment securities not otherwise pledged as collateral.  At December 31, 2014, the FHLB line of credit was collateralized by loans of $804.7 million with a lending value of $521.4 million.  At December 31, 2013, the FHLB line of credit was collateralized by loans of $800.4 million with a lending value of $473.9 million.
	The Company has approved federal fund purchase lines with seven banks with an aggregate credit line of $175.0 million.  No amounts were outstanding on the federal funds purchase lines at the end of either 2014 or 2013.  The average balance of federal funds purchased was $9.3 million and $10.2 million during 2014 and 2013, respectively.

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2014
Long-Term Debt
Long-Term Debt	9.  Long-Term Debt
	Outstanding subordinated debentures and notes payable at December 31, 2014 and 2013, is summarized as follows:
		At December 31,
	(in thousands)	2014		2013		Interest rate	Maturity date	Earliest call date
	Junior subordinated debentures:
	CoBiz Statutory Trust I	$	20,619	$	20,619	3-month LIBOR + 2.95%	September 17, 2033	March 17, 2015
	CoBiz Capital Trust II		30,928		30,928	3-month LIBOR + 2.60%	July 23, 2034	January 23, 2015
	CoBiz Capital Trust III		20,619		20,619	3-month LIBOR + 1.45%	September 30, 2035	March 30, 2015
	Total junior subordinated debentures	$	72,166	$	72,166
	Effective for interest payments beginning in February 2010, the Company fixed the interest rate on its junior subordinated debentures through a series of interest rate swaps.  For further discussion of the interest rate swaps and the corresponding terms, see Note 10 - Derivatives.
	In September 2003, the Company created a wholly owned trust, CoBiz Statutory Trust I, formed under the laws of the State of Connecticut (the Statutory Trust). The Statutory Trust issued $20.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Statutory Trust for $0.6 million. The Statutory Trust invested the proceeds thereof in $20.6 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three‑month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on March 17, June 17, September 17 and December 17. The junior subordinated debentures will mature and the capital securities must be redeemed on September 17, 2033, which may be shortened to any quarterly distribution date, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals) and notice is given at least 30 and not more than 60 days prior to the redemption date.
	In May 2004, the Company created a wholly owned trust, CoBiz Capital Trust II, formed under the laws of the State of Delaware (the Capital Trust II). The Capital Trust II issued $30.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Capital Trust II for $0.9 million. The Capital Trust II invested the proceeds thereof in $30.9 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three-month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on January 23, April 23, July 23 and October 23. The junior subordinated debentures will mature and the capital securities must be redeemed no later than July 23, 2034, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals).
	In August 2005, the Company created a wholly owned trust, CoBiz Capital Trust III, formed under the laws of the State of Delaware (the Capital Trust III). The Capital Trust III issued $20.0 million of trust preferred securities bearing an interest rate based on a spread above three-month LIBOR. Simultaneously with the issuance, the Company purchased a minority interest in the Capital Trust III for $0.6 million. The Capital Trust III invested the proceeds thereof in $20.6 million of junior subordinated debentures of CoBiz that also bear an interest rate based on a spread above three‑month LIBOR. The securities and junior subordinated debentures provide cumulative distributions at a floating rate that is reset each quarter on March 30, June 30, September 30 and December 30. The junior subordinated debentures will mature and the capital securities must be redeemed no later than September 30, 2035, if certain conditions are met (including the Company having received prior approval from the Federal Reserve and any other required regulatory approvals).
	The Company records the distributions of the junior subordinated debentures in interest expense on the consolidated statements of income. All of the outstanding junior subordinated debentures may be prepaid if certain events occur, including a change in tax status or regulatory capital treatment of trust preferred securities. In each case, redemption will be made at par, plus the accrued and unpaid distributions thereon through the redemption date.
	Although the accounts of the Statutory Trust, Capital Trust II and Capital Trust III are not included in the Company’s consolidated financial statements, $70.0 million in trust preferred securities issued by the trusts are included in Tier 1 capital for regulatory capital purposes as allowed by the Federal Reserve Board at December 31, 2014.  Under current capital rules, the aggregate amount of trust preferred securities and certain other capital elements are limited to 25% of Tier 1 capital elements.  The amount of trust preferred securities and certain other elements in excess of the limit can be included in Tier 2 capital, subject to certain restrictions.  Rules adopted by the Federal Reserve Board during 2013 pursuant to the implementation of Basel III regulatory capital reforms allow for the continued inclusion of trust preferred securities in regulatory capital, subject to the aforementioned limitations, by financial institution holding companies with less than $15 billion in total consolidated assets.

Derivatives

Derivatives	12 Months Ended
	Dec. 31, 2014
Derivatives
Derivatives	10. Derivatives
	ASC 815 contains the authoritative guidance on accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and hedging activities.   As required by ASC 815, the Company records all derivatives on the consolidated balance sheets at fair value.
	The Company is exposed to certain risks arising from both its business operations and economic conditions.  The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments.  Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and unknown cash amounts, the value of which are determined by interest rates.  The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to certain variable-rate loan assets and variable-rate borrowings.  The Company also enters into derivative financial instruments to protect against adverse changes in fair value on fixed-rate loans.
	The Company’s objective in using derivatives is to minimize the impact of interest rate fluctuations on the Company’s net interest income. To accomplish this objective, the Company uses interest-rate swaps as part of its cash flow hedging strategy. The Company also offers an interest-rate hedge program that includes derivative products such as swaps, caps, floors and collars to assist its customers in managing their interest-rate risk profile. In order to eliminate the interest-rate risk associated with offering these products, the Company enters into derivative contracts with third parties to offset the customer contracts.  These customer accommodation interest rate swap contracts are not designated as hedging instruments.
	The Company has also expanded its product offering by adding international banking products, which exposes the Company to foreign exchange risk.  The Company utilizes foreign exchange forward contracts to manage the risk associated with fluctuation in foreign exchange rates.
	The Company has agreements with its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations.  Also, the Company has agreements with certain of its derivative counterparties that contain a provision where if the Bank fails to maintain its status as a well or adequately capitalized institution, then the counterparty could terminate the derivative positions and the Company would be required to settle its obligations under the agreements.
	At December 31, 2014, the fair value of derivatives in a net liability position, including accrued interest but excluding any adjustment for nonperformance risk, related to these agreements was $10.0 million. The Company has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $15.9 million against its obligations under these agreements.  At December 31, 2014, the Company was not in default with any of its debt or capitalization covenants.
	The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the consolidated balance sheets.
			Asset derivatives								Liability derivatives
					Fair value at December 31,								Fair value at December 31,
			Balance sheet								Balance sheet
	(in thousands)		classification		2014			2013			classification		2014			2013
	Derivatives designated as hedging instruments under ASC 815:
	Cash flow hedge		Other assets		$	437		$	184		Accrued interest and other liabilities		$	5,017		$	4,007
	Fair value hedge		Other assets			297			1,735		Accrued interest and other liabilities			988			-
	Derivatives not designated as hedging instruments under ASC 815:
	Interest rate swap		Other assets		$	4,103		$	6,422		Accrued interest and other liabilities		$	4,284		$	6,409
	Foreign exchange forward contracts		Other assets			54			-		Accrued interest and other liabilities			17			10
	The tables below include information required by ASU No. 2011-11 Disclosures about Offsetting Assets and Liabilities, about financial instruments that are eligible for offset.
			At December 31, 2014
									Net amounts
									included in
			Gross						other assets'
			amounts of			Gross			in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		assets			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges		$	734		$	-		$	734		$	-487		$	-		$	247
	Derivatives not designated as hedges			4,157			-			4,157			-220			-			3,937
	Total		$	4,891		$	-		$	4,891		$	-707		$	-		$	4,184
			At December 31, 2014
			Gross						Net amounts
			amounts of			Gross			included in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		liabilities			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges(1)		$	-6,005		$	-		$	-6,005		$	487		$	5,518		$	-
	Derivatives not designated as hedges(1)			-4,301			-			-4,301			220			3,891			-190
	Securities sold under agreements to repurchase(2)			-49,976			-			-49,976			-			49,976			-
	Total		$	-60,282		$	-		$	-60,282		$	707		$	59,385		$	-190
			At December 31, 2013
									Net amounts
									included in
			Gross						other assets'
			amounts of			Gross			in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		assets			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges		$	1,919		$	-286		$	1,633		$	-		$	-		$	1,633
	Derivatives not designated as hedges			6,422			-366			6,056			-			-			6,056
	Total		$	8,341		$	-652		$	7,689		$	-		$	-		$	7,689
			At December 31, 2013
			Gross						Net amounts
			amounts of			Gross			included in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		liabilities			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges(1)		$	-4,007		$	286		$	-3,721		$	-		$	3,721		$	-
	Derivatives not designated as hedges(1)			-6,419			366			-6,053			-			6,053			-
	Securities sold under agreements to repurchase(2)			-138,494			-			-138,494			-			138,494			-
	Total		$	-148,920		$	652		$	-148,268		$	-		$	148,268		$	-
		-1		Included in accrued interest and other liabilities
		-2		Separately stated in Consolidated Balance Sheets
	Cash Flow Hedges of Interest Rate Risk — For hedges of the Company’s variable-rate loan assets, interest-rate swaps designated as cash flow hedges involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount.  At December 31, 2014, the Company had five interest rate swaps with a notional value of $75.0 million that effectively fixed the interest rate on a portion of its 1-Month LIBOR loan portfolio.  The weighted average fixed rate under these swaps was 1.41%.  The swaps have remaining maturities ranging from three to four years.
	For hedges of the Company’s variable-rate borrowings, interest-rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments.  The Company has executed a series of interest-rate swap transactions in order to fix the effective interest rate for payments due on its junior subordinated debentures with the objective of reducing the Company’s exposure to adverse changes in cash flows relating to payments on its LIBOR-based floating rate debt.  Select critical terms of the cash flow hedges are as follows:
	(in thousands)		Notional			Fixed rate		Termination date
	Hedged item - Junior subordinated debentures issued by:
	CoBiz Statutory Trust I		$	20,000		6.04	%	March 17, 2015
CoBiz Capital Trust II		$	30,000		5.99	%	April 23, 2020
CoBiz Capital Trust III		$	20,000		5.02	%	March 30, 2024
In October 2014, the Company entered into a new interest-rate swap agreement on CoBiz Statutory Trust I that is effective upon the termination of the existing swap on March 17, 2015.  The swap is effective on March 17, 2015 and will fix the interest-rate on $20.0 million of variable-rate borrowings at 4.99% through March 17, 2022.
Based on the Company’s ongoing assessments (including at inception of the hedging relationship), it is probable that there will be sufficient variable interest payments through the maturity date of the swaps.  The Company also monitors the risk of counterparty default on an ongoing basis.  The Company uses the “Hypothetical Derivative” method described in Statement 133 Implementation Issue No. G7, Cash Flow Hedges: Measuring the Ineffectiveness for a Cash Flow Hedge under Paragraph 30(b) When the Shortcut Method Is Not Applied, for both prospective and retrospective assessments of hedge effectiveness on a quarterly basis.  The Company also uses this methodology to measure hedge ineffectiveness each period.  The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in AOCI and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company’s derivatives did not have any hedge ineffectiveness recognized in earnings during the years ended December 31, 2014, 2013 and 2012.
Amounts reported in AOCI related to derivatives will be reclassified to interest income as interest payments are received/paid on the Company’s variable-rate assets.  Payments received/paid on variable-rate liabilities will be reclassified to interest expense. During the next 12 months, the Company estimates that $0.8 million and $1.9 million will be reclassified as an increase to interest income and interest expense, respectively.
The following table reports the beginning and ending balances of AOCI relating to derivatives designated as hedging transactions and the associated periodic change, net of reclassifications to earnings and the effect of income taxes for the periods shown.
		Cash flow hedge component of AOCI
(in thousands)		2014			2013			2012
Beginning of year balance		$	-2,370		$	-5,607		$	-5,275
Net change			-470			3,237			-332
End of year balance		$	-2,840		$	-2,370		$	-5,607
Fair Value Hedges of Fixed-Rate Assets – The Company is exposed to changes in the fair value of certain of its fixed-rate assets due to changes in benchmark interest rates based on LIBOR.  The Company uses interest rate swaps to manage its exposure to changes in fair value on certain fixed-rate loans.  Interest rate swaps designated as fair value hedges involve the receipt of variable-rate payments from a counterparty in exchange for the Company’s fixed-rate payments over the life of the agreements without the exchange of the underlying notional amount.  Certain interest-rate swaps met the criteria to qualify for the shortcut method of accounting.  Under the shortcut method of accounting no ineffectiveness is assumed.  For interest-rate swaps not accounted for under the shortcut method, the Company performs ongoing retrospective and prospective effectiveness assessments (including at inception) using a regression analysis to compare periodic changes in fair value of the swaps to periodic changes in fair value of the fixed-rate loans attributable to changes in the benchmark interest rate.  At December 31, 2014, the Company had interest rate swaps with a notional amount of $31.6 million used to hedge the change in the fair value of five commercial loans.  For derivatives that are designated and qualify as fair value hedges that are not accounted for under the shortcut method, the gain or loss on the derivative as well as the gain or loss on the hedged item attributable to the hedged risk are recognized in earnings.  The net amount recognized in noninterest expense during the years ended December 31, 2014 and 2013 representing hedge ineffectiveness, was $0.2 million and $0.1 million, respectively.  Hedge ineffectiveness was immaterial for the year ended December 31, 2012.
Non-designated Hedges — Derivatives not designated as hedges are not speculative and primarily result from a service the Company provides to its customers.  The Company executes interest-rate swaps with commercial banking customers to facilitate their respective risk management strategies.  Those interest-rate swaps are simultaneously hedged by offsetting interest-rate swaps that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions.  As the interest-rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings.   At December 31, 2014, the Company had 108 interest-rate swaps with an aggregate notional amount of $263.8 million related to this program.  Gains and losses arising from changes in the fair value of these swaps are included in “Other income.” During the years ending December 31, 2014 and 2013, the Company recorded $0.2 million in losses and $0.4 million in gains, respectively. Gains recorded for the year ended December 31, 2012 were immaterial.
The Company’s product offerings also include international banking products that create foreign currency exchange-rate risk exposure.  At December 31, 2014, the Company’s foreign currency holdings included British pounds, Euros, Japanese Yen, Mexican Pesos, and Australian and Canadian dollars.  In order to economically reduce the risk associated with the fluctuation of foreign exchange rates, the Company utilizes short-term foreign exchange forward contracts to lock in exchange rates so the gain or loss on the forward contracts approximately offsets the transaction gain or loss.  These contracts are not designated as hedging instruments.  Ineffectiveness in the economic hedging relationship may occur as the foreign currency holdings are revalued based upon changes in the currency’s spot rate, while the forward contracts are revalued using the currency’s forward rates.  Forward contracts in gain positions are recorded at fair value in ‘other’ assets, while contracts in loss positions are recorded in ‘other’ liabilities in the consolidated balance sheets.  Net changes in the fair value of the forward contracts are recognized through earnings, disclosed as ‘other’ noninterest income in the consolidated statement of operations.  At December 31, 2014, the Company had entered into forward contracts with a notional amount of $7.3 million that mature in the first quarter of 2015.  Net gains recognized during the year ended December 31, 2014 on foreign exchange forward contracts were immaterial.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes
Income Taxes	11. Income Taxes
	The components of consolidated income tax expense (benefit) for the years ended December 31, 2014, 2013, and 2012 are as follows:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Current tax provision (benefit):
	Federal tax	$	9,737	$	7,497	$	11,290
	State tax		-109		1,072		1,216
	Total current tax provision		9,628		8,569		12,506
	Deferred tax provision (benefit):
	Federal tax		3,357		3,974		178
	State tax		513		654		-21
	Net operating loss carryforward		1,649		154		595
	Total deferred tax provision		5,519		4,782		752
	Provision for income taxes	$	15,147	$	13,351	$	13,258
	Provision related to discontinued operations	$	-	$	86	$	171
	The primary component of deferred tax expense during 2014, 2013 and 2012 was attributable to timing differences in the allowance for loan and credit losses.  At December 31, 2014, the Company had a $21.0 million net operating loss carryforward for Colorado that originated in 2010 and 2009 and will expire on various dates between 2025 and 2027.  The state of Colorado does not allow net loss carrybacks, but allows net loss carryforwards of up to 15 years.
	A deferred tax asset or liability is recognized for the tax consequences of temporary differences in the recognition of revenue and expense, and unrealized gains and losses, for financial and tax reporting purposes. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some or all of the deferred tax assets may not be realized.
	The Company conducted an analysis to assess the need of a valuation allowance at December 31, 2014 and 2013.  As part of this assessment, all available evidence, including both positive and negative, was considered to determine whether based on the weight of such evidence, a valuation allowance for deferred tax assets was needed.  In accordance with ASC Topic 740-10, Income Taxes (ASC 740), a valuation allowance is deemed to be needed when, based on the weight of the available evidence, it is more likely than not (a likelihood of more than 50%) that some portion or all of a deferred tax asset will not be realized.  The future realization of the tax benefit depends on the existence of sufficient taxable income within the carryback and carryforward periods.
	At December 31, 2014 and 2013, the Company was in a positive three-year cumulative income position, had availability in its carryback years to absorb potential deferred income tax asset reversals and had financial forecasts of pre-tax income that were sufficient to absorb the deferred income tax assets.  Accordingly, the Company determined that a valuation allowance was not warranted at December 31, 2014 and 2013.
	The net change in deferred taxes related to investment securities available for sale and cash flow hedges is included in other comprehensive income. The temporary differences, tax effected, which give rise to the Company’s net deferred tax assets at December 31, 2014 and 2013 are as follows:
		At December 31,
	(in thousands)	2014		2013
	Deferred tax assets:
	Allowance for loan and credit losses	$	12,451	$	14,054
	Intangible assets		1,872		2,151
	Other real estate owned		3,329		3,296
	Deferred loan fees		472		415
	Other accrued liabilities		1,325		2,324
	Stock-based compensation		1,428		1,930
	Interest on nonaccrual loans		577		412
	Employee bonus		2,472		2,175
	State operating loss carryforward		633		1,758
	Other		136		1,657
	Total deferred tax assets	$	24,695	$	30,172
	Deferred tax liabilities:
	Deferred initial direct loan costs	$	-1,538	$	-1,183
	Prepaid assets		-431		-697
	FHLB stock dividends		-63		-113
	Investment securities and derivatives		-2,655		-1,673
	Total deferred tax liabilities	$	-4,687	$	-3,666
	Net deferred tax assets	$	20,008	$	26,506
	A reconciliation of income tax expense at the statutory rate to the Company’s actual income tax expense for the years ended December 31, 2014, 2013, and 2012 is shown below:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Computed at the statutory rate (35%)	$	15,454	$	14,276	$	13,126
	Increase (decrease) resulting from:
	State income taxes - net of federal income tax effect		1,336		1,373		1,177
	Tax exempt income		-2,838		-1,976		-1,475
	Other - net		1,195		-322		430
	Actual tax provision (benefit)	$	15,147	$	13,351	$	13,258
	ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. At December 31, 2014 and 2013, the Company did not have any unrecognized benefits.
	Penalties and interest are classified as income tax expense when incurred. Interest and penalties accrued during the year ended December 31, 2014 and 2013 were immaterial.
	The Company files income tax returns in the U.S. federal jurisdiction and in several state jurisdictions.
	The Company received an Internal Revenue Service (IRS) determination letter dated January 4, 2013 stating the Congressional Joint Committee on Taxation completed its examination resulting in no exceptions to the conclusions reached for the Company’s 2009 and 2010 tax returns.  The following are the major tax jurisdictions in which the Company and its affiliates operate and the earliest tax year subject to examination:
	Jurisdiction	Tax year
	United States	2011
	Colorado	2010
	Arizona	2010

Shareholders_Equity

Shareholders' Equity	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity
Shareholders' Equity	12. Shareholders’ Equity
	Common Stock – At December 31, 2014 and 2013, the Company has reserved the following shares of its authorized but unissued common stock for possible future issuance in connection with the following:
		At December 31,
		2014		2013
	Exercise of outstanding stock options	819,755		1,292,077
	Exercise of outstanding stock warrants	895,968		895,968
	Future granting of option and stock awards	2,508,115		1,096,680
	Future stock purchases through ESPP	273,188		116,637
		4,497,026		3,401,362
	Preferred Stock, Series C — On September 7, 2011, the Company amended its Articles of Incorporation to establish the Senior Non-Cumulative Perpetual Preferred Stock, Series C (Series C Preferred Stock) and fix the powers, preferences and relative, participating, optional and other special rights, and the qualifications, limitations and restrictions, of the shares of Series C Preferred Stock.
	On September 8, 2011, the Company entered into and consummated the transactions contemplated by a Securities Purchase Agreement (Purchase Agreement) with the U.S. Secretary of the Treasury (Treasury) under the Small Business Lending Fund (SBLF), a $30 billion fund established under the Small Business Jobs Act of 2010 that was designed to encourage lending to small businesses by providing capital to qualified community banks with assets of less than $10 billion. Pursuant to the Purchase Agreement, the Company issued and sold to the Treasury, for an aggregate purchase price of $57.4 million, 57,366 shares of the Company’s Series C Preferred Stock, par value $0.01 per share, having a liquidation value of $1,000 per share.
	The Series C Preferred Stock is non-voting, except in limited circumstances that could impact the SBLF investment, such as (i) authorization of senior stock, (ii) charter amendments adversely affecting the Series C Preferred Stock and (iii) extraordinary transactions such as mergers, asset sales, share exchanges and the like (unless the Series C Preferred Stock remains outstanding and the rights and preferences thereof are not impaired by such transaction).
	The Series C Preferred Stock is not convertible to common stock or any other securities. Distributions upon any liquidation of the Company must be paid on the Series C Preferred Stock up to the aggregate liquidation value, plus accrued dividends, before any other shareholder distributions can be made.
	The Series C Preferred Stock may be redeemed (repurchased) by the Company at any time, at a redemption price of $1,000 per share plus accrued but unpaid dividends to the date of redemption, subject to the approval of the Company’s federal banking regulator. The Series C Preferred Stock may be redeemed in whole or in part, subject to a minimum redemption of at least 25% of the original SBLF investment (i.e., about $14.3 million).
	Warrant — The Company issued a warrant on December 19, 2008 as part of the Company’s participation in the TARP Capital Purchase program.  The warrant has a 10-year term and allows for the purchase of 895,968 shares of the Company’s common stock at an exercise price of $10.79 per share.
	Dividends — The Company’s ability to pay dividends to its shareholders is generally dependent upon the payment of dividends by the Bank to the Parent.  The Bank cannot pay dividends to the extent it would be deemed undercapitalized by the FDIC after making such dividend.  At December 31, 2014, the Bank was not otherwise restricted in its ability to pay a dividend to the Parent as its earnings in the current and prior two years, net of dividends paid during those years, was positive.
	Dividends on the Company’s capital stock (common and preferred stock) are prohibited under the terms of the junior subordinated debenture agreements (see Note 9 – Long-term debt) if the Company is in continuous default on its payment obligations to the capital trusts, has elected to defer interest payments on the debentures or extends the interest payment period.  At December 31, 2014, the Company was not in default on any of the junior subordinated debt issuances.
	Dividends declared per common share for the years ended December 31, 2014, 2013, and 2012 were $0.15,  $0.12 and $0.07, respectively.  Dividends on the Series C Preferred Stock for the years ended December 31, 2014, 2013, and 2012 were $0.6 million, $0.9 million, and $2.9 million, respectively.
	Dividends for the Series C Preferred Stock began accruing at five percent (5.0%) on September 8, 2011, when issued, and are payable the first day of each January, April, July and October. The 5.0% rate was effective for the first calendar quarter (or partial period thereof) the Series C was outstanding. During the second through ninth calendar quarters under the SBLF Program, the dividend rate fluctuated between one percent (1%) and five percent (5%) with a reduced dividend rate applying to the lesser of the amount of change in the Bank’s level of Qualified Small Business Lending (QSBL) compared to the initial baseline or $57.4 million. More specifically, if the Bank’s QSBL two quarters prior to the quarter under measurement has increased as compared to the baseline, then the dividend rate payable on the Series C Preferred Stock would change as follows:
	Relative increase in QSBL to Baseline	Dividend Rate
	Less than 2.5%	5.0	%
	Between 2.5% and 5.0%	4.0	%
	Between 5.0% and 7.5%	3.0	%
	Between 7.5% and 10.0%	2.0	%
	10.0% or more	1.0	%
	QSBL is defined as certain loans of up to $10.0 million to businesses with up to $50.0 million in annual revenues. QSBL includes: (i) commercial and industrial loans; (ii) owner-occupied nonfarm, nonresidential real estate loans; (iii) loans to finance agricultural production and other loans to farmers; and, (iv) loans secured by farmland.  The SBLF requires that quarterly supplemental reports be submitted to Treasury, based in part on information already provided by the Bank in its quarterly Call Report.  Changes in QSBL compared to baseline QSBL based on the supplemental reports will determine the applicable dividend rate.
	From the tenth calendar quarter through 4.5 years after closing of the SBLF Program transaction, the dividend rate on the Series C Preferred Stock will be fixed at or between one percent (1%) and nine percent (9%) based on the level of QSBL at that time, as compared to the baseline.  Based on QSBL through December 31, 2012, growth in QSBL exceeded the 10.0% required under the program to achieve the lowest dividend rate of 1% (effective April 1, 2013).  The Company was able to maintain the QSBL growth through the reporting period ending December 31, 2013, and has fixed the dividend rate at 1% through December 31, 2015.  If the Series C Preferred Stock remains outstanding after 2015, the dividend rate will increase to 9% beginning in 2016.
	If the Company has not declared and paid an aggregate of five dividend payments, whether or not consecutive, the holder of the Series C Preferred Stock will have the right to appoint a representative as an “observer” on the Company’s Board of Directors.  If the Company has not declared and paid an aggregate of six dividend payments, whether or not consecutive, the holder of the Series C Preferred Stock will have the right, but not the obligation, to elect two directors to the Company’s Board of Directors.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss) Reclassifications	12 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) Reclassifications
Comprehensive Income (Loss)	13. Accumulated Other Comprehensive Income (Loss) Reclassifications
	The following table provides information on reclassifications out of accumulated comprehensive income:
		Year ended December 31,
	AOCI component	2014		2013		2012		Affected line item in the Consolidated Statement of Income
	Unrealized (gain) loss on AFS securities	$	1,154	$	439	$	782	Net gain (loss) on securities, other assets and OREO
	Tax (expense) benefit		-439		-167		-297	Provision (benefit) for income taxes
			715		272		485
	Cash flow hedges on loans		905		90		-	Interest and fees on loans
	Cash flow hedges on debt		-2,215		-2,185		-2,061	Interest expense on subordinated debentures
	Unrealized (gain) loss on derivatives		-1,310		-2,095		-2,061
	Tax (expense) benefit		498		796		783	Provision (benefit) for income taxes
			-812		-1,299		-1,278
	Total reclassifications out of AOCI	$	-97	$	-1,027	$	-793

Earnings_per_Common_Share

Earnings per Common Share	12 Months Ended
	Dec. 31, 2014
Earnings per Common Share
Earnings per Common Share	14.  Earnings per Common Share
	Earnings per common share is calculated based on the two-class method prescribed in ASC 260, Earnings per Share.  The two-class method is an allocation of undistributed earnings to common stock and securities that participate in dividends with common stock.  The Company’s restricted stock awards are considered participating securities as the unvested awards have non-forfeitable rights to dividends, paid or unpaid, on unvested awards.  The impact of participating securities is included in the common shareholder basic earnings per share for all periods presented as the Company had positive earnings in those periods.
	Income available to common shareholders together with weighted average shares outstanding used in the calculation of basic and diluted earnings per common share are as follows:
			Year ended December 31,
	(in thousands, except share amounts)		2014		2013		2012
	Net income from continuing operations		$	29,007	$	27,438	$	24,246
	Net income from discontinued operations			-		173		324
	Net income			29,007		27,611		24,570
	Preferred stock dividends			-574		-944		-2,815
	Net income available to common shareholders			28,433		26,667		21,755
	Dividends and undistributed earnings allocated to participating securities			-434		-457		-335
	Earnings allocated to common shares (1)		$	27,999	$	26,210	$	21,420
	Weighted average common shares - issued			40,616,022		40,193,315		39,170,218
	Average unvested restricted share awards			-609,276		-724,821		-613,710
	Weighted average common shares outstanding - basic			40,006,746		39,468,494		38,556,508
	Effect of dilutive stock options and awards outstanding			205,847		160,862		45,878
	Weighted average common shares outstanding - diluted			40,212,593		39,629,356		38,602,386
	Weighted average antidilutive common shares outstanding (2)			676,248		1,530,263		2,785,855
	Earnings per common share are as follows:
	Basic - from continuing operations		$	0.70	$	0.66	$	0.54
	Diluted - from continuing operations		$	0.70	$	0.66	$	0.54
	Basic - from discontinued operations		$	0.00	$	0.00	$	0.01
	Diluted - from discontinued operations		$	0.00	$	0.00	$	0.01
	Basic		$	0.70	$	0.66	$	0.55
	Diluted		$	0.70	$	0.66	$	0.55
		-1		Earnings allocated to common shareholders for basic EPS under the two-class method may differ from earnings allocated for diluted EPS when use of the treasury method results in greater dilution than the two-class method.
		-2		Antidilutive shares excluded from the diluted earnings per share computation.

Employee_Benefit_And_Stock_Com

Employee Benefit And Stock Compensation Plans	12 Months Ended
	Dec. 31, 2014
Employee Benefit And Stock Compensation Plans
Employee Benefit And Stock Compensation Plans
	15. Employee Benefit and Stock Compensation Plans
	Stock Options and Awards — The Company has adopted an equity plan to reward and provide long-term incentives for directors and key employees of the Company. The term of all options issued may not exceed 10 years. The Company issues new shares upon exercise of a stock option award.
	The 2005 Equity Incentive Plan (the 2005 Plan) originally authorized the issuance 1,250,000 shares of common stock.  The 2005 Plan was amended at the May 15, 2008 Annual Shareholder Meeting to increase the authorized shares available under the plan to 2,750,000 shares of common stock and shares available for restricted stock awards was increased by 250,000 shares to 500,000 shares. The 2005 Plan was further amended at the May 20, 2010 Annual Shareholder Meeting to increase the authorized shares available under the plan to 3,750,000 shares of common stock and shares available for restricted stock awards was increased by 1,500,000 shares to 2,000,000 shares. The 2005 Plan was most recently amended at the May 15, 2014 Annual Shareholder Meeting to increase the authorized shares available to 5,250,000 and remove the restriction on the number of restricted stock awards.  Under the 2005 Plan, the Compensation Committee of the Company has the authority to determine the identity of the key employees, consultants and directors who shall be granted options; the option price, which shall not be less than 85% of the fair market value of the common stock on the date of grant; and the manner and times at which the options shall be exercisable. Shares available for grant under the 2005 Plan at December 31, 2014, totaled 2,508,115.
	During 2014,  2013 and 2012, the Company recognized compensation expense from continuing operations, net of estimated forfeitures, of $3.1 million, $2.7 million and $1.9 million, respectively, for stock-based compensation awards for which the requisite service was rendered during the year.  The Company recognized an income tax benefit of $1.2 million, $1.0 million and $0.7 million on the compensation expense for 2014,  2013 and 2012, respectively.
	ASC 718 requires the Company to select a valuation technique that meets the measurement criteria set forth in the standard. Valuation techniques that meet the criteria for estimating the fair values of employee stock options include a lattice model and a closed-form model (for example, the Black-Scholes formula). The Company uses the Black-Scholes option pricing model (Black-Scholes) to estimate the fair value of stock options.  Restricted stock award fair values are based on the closing price of the Company stock on the award date.
	The fair value of each option grant is estimated on the date of grant using the Black-Scholes. The risk-free rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The expected term of options granted is based on the options’ vesting schedule and the Company’s historical exercise patterns for different employee groups and represents the period of time that options granted are expected to be outstanding. Expected volatilities are based on the historical volatility of the Company’s stock and vesting period of the option to be issued. The dividend yield is determined by annualizing the dividend rate as a percentage of the Company’s stock price. The following weighted-average assumptions were used for grants issued during the years ended December 31, 2014, 2013, and 2012:
		2014						2013						2012
				Range						Range						Range
		Weighted						Weighted						Weighted
		average		Low		High		average		Low		High		average		Low		High
	Risk-free interest rate	1.38	%	0.79	%	1.82	%	0.96	%	0.41	%	1.80	%	0.62	%	0.34	%	0.95	%
	Expected dividend yield	1.27	%	1.05	%	1.49	%	1.42	%	1.23	%	1.67	%	1.12	%	0.65	%	1.32	%
	Expected volatility	40.34	%	29.38	%	52.50	%	49.80	%	39.49	%	65.77	%	61.70	%	45.52	%	71.27	%
	Expected life (years)	3.9						4.1						4.0
	The following tables summarize changes in shares under option and restricted stock award arrangement for the year ended December 31, 2014:
		2014
				Weighted average
	Stock Option Awards	Shares		exercise price
	Outstanding - beginning of year	1,292,077		$	11.82
	Granted	92,917			11.35
	Exercised	-154,091			7.25
	Forfeited	-411,148			17.73
	Outstanding - end of year	819,755		$	9.66
	Exercisable - end of year	649,264		$	9.59
	There were 811,714 options vested or expected to vest with a weighted average price of $9.65 at December 31, 2014. The weighted-average remaining terms for options outstanding, vested or expected to vest and options exercisable at the end of the period were 2.8,  2.8 and 2.0 years, respectively. The aggregate intrinsic value for options outstanding, vested or expected to vest and options exercisable at December 31, 2014 was $3.1 million, $3.1 million and $2.6 million, respectively. The weighted average grant date fair value of options granted during the years ended December 31, 2014, 2013, and 2012 was $3.06,  $3.10 and $2.75, respectively. The total intrinsic value of options exercised during the years ended December 31, 2014, 2013 and 2012 was $0.7 million and $0.7 million and $0.1, respectively.
		2014
				Weighted average
				grant date
	Restricted Stock Awards	Shares		fair value
	Unvested - beginning of year	681,578		$	7.04
	Granted	319,466			11.33
	Vested	-343,162			7.24
	Forfeited	-22,284			8.22
	Unvested - end of year	635,598		$	9.05
	Total fair value of vested shares (in thousands)			$	3,874
	The weighted average grant date fair value of restricted stock awards granted during the years ended December 31, 2014, 2013 and 2012 was $11.33,  $8.44 and $5.64, respectively.  The fair value of restricted stock amounts vested during the years ended December 31, 2014, 2013 and 2012 was $3.9 million, $2.7 million and $0.5 million, respectively.
	At December 31, 2014, there was $4.0 million of total unrecognized compensation cost related to unvested share-based compensation arrangements granted under the Plans. The cost is expected to be recognized over a weighted-average period of 1.8 years.
	The following table summarizes the Company’s outstanding stock options:
		Options outstanding							Options exercisable
				Weighted			Weighted				Weighted
				average			average				average
		Number		exercise			remaining		Number		exercise
	Range of exercise price	outstanding		price			life (years)		exercisable		price
	$4.49  -  $6.62	176,433		$	6.22		2.0		168,601		$	6.21
	$6.68  -  $7.54	178,935			7.35		2.7		171,602			7.38
	$7.57  -  $11.00	166,261			9.43		5.4		64,685			9.39
	$11.03  -  $12.39	229,476			12.08		2.3		175,726			12.17
	$13.73  -  $20.75	68,650			16.95		0.3		68,650			16.95
		819,755		$	9.66		2.8		649,264		$	9.59
	Employee Stock Purchase Plan (ESPP) — The ESPP was established in January 2000 and is administered by the Compensation Committee of the Company.  At the 2014 Annual Meeting, shareholders of the Company approved an amendment to the ESPP, increasing the number of shares of common stock available for awards under the plan by 200,000.  Employees may elect to have a percentage of their payroll deducted and applied to the purchase of Common Stock at a discount. In addition, the Company may make a matching contribution up to 50% of an employee’s deduction toward the purchase of additional Common Stock. No matching contribution was made for the years presented in the table below.
		For the year ended December 31,
		2014		2013		2012
	Available ESPP shares - beginning of year	116,637		163,933		229,833
	Plan amendment increasing available shares	200,000		-		-
	Purchases	-43,449		-47,296		-65,900
	Available ESPP shares - end of year	273,188		116,637		163,933
	Employee 401(k) Plan — The Company has a defined contribution plan covering substantially all its employees. Employees may contribute up to the maximum allowed by the internal revenue service.  The Company may also make discretionary contributions within the limits of the 401(k) Plan and internal revenue service limitations.  The Company matched 4.5% of eligible compensation for the years ended December 31, 2014 and 2013, and 3.0% for 2012.  Employer contributions charged to expense for the years ended December 31, 2014, 2013, and 2012 were $1.5 million, $1.6 million and $1.1 million, respectively, and are included in the consolidated statements of income under the caption “Salaries and employee benefits.”
	Supplemental Executive Retirement Plan — The Company had a Supplemental Executive Retirement Plan (SERP) that covered certain executive officers.  In 2012, the Company’s Compensation Committee conducted a review of the SERP as part of its ongoing assessment of overall compensation and determined that the SERP was no longer aligned with the Company’s compensation objectives.  On March 22, 2012, when all participants were fully vested, the Company terminated the SERP.  At December 31, 2013, the Company had accrued $2.4 million for the expected benefits under the SERP which is included in the consolidated balance sheets under the caption “Accrued interest and other liabilities.”  The SERP balances were fully distributed to the participants in 2014.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies
Commitments And Contingencies	16. Commitments and Contingencies
	Lease Commitments — The Company has various operating lease agreements for office space. Generally leases are subject to rent escalation provisions in subsequent years and have renewal options at the end of the initial lease terms.  The Company entered into a sublet agreement in 2014 for one leased location and at December 31, 2014, the future minimum sublease payment to be received is $1.5 million.  Leasehold improvements are amortized over the useful life of the improvements or the lease term if shorter.  Rent expense (excluding ancillary charges for common area expense, maintenance, etc.) for the years ended December 31, 2014, 2013, and 2012, was $5.1 million, $5.0 million and $5.3 million, respectively.
	In 1998, certain officers and directors acquired the building in which the corporate office is located and certain banking operations are performed. At December 31, 2014, one director of the Company has a remaining interest in the building. One other bank location is leased from an entity controlled by the same director.  Rent payments under the related party leases for the years ended December 31, 2014, 2013, and 2012, were $2.1 million, $2.2 million and $1.9 million, respectively, and the Company was current on these lease obligations at all times.  Future contractual obligations of $2.9 million will be paid to entities controlled by the director and are included in the below schedule of future minimum lease payments under all non-cancelable operating leases.
	Year ending December 31,
	(in thousands)	Amount
	2015	$	5,547
	2016		4,435
	2017		3,631
	2018		3,259
	2019		1,771
	Thereafter		1,896
	Total	$	20,539
	Financial Instruments With Off-Balance Sheet Risk — In the normal course of business the Company has entered into financial instruments which are not reflected in the accompanying consolidated financial statements:
		At December 31,
	(in thousands)	2014		2013
	Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers	$	793,208	$	659,592
	Commitments to originate consumer loans - personal lines of credit and equity lines	$	32,072	$	31,174
	Overdraft protection plans	$	15,322	$	15,359
	Letters of credit	$	37,851	$	46,130
	Unfunded commitments for unconsolidated investments	$	7,356	$	6,607
	Company guarantees	$	2,160	$	1,756
	Commitments to Originate — The Company makes contractual commitments to extend credit and provide standby letters of credit which are binding agreements to lend money to its customers at predetermined interest rates for a specific period of time. These commitments are not held for sale. The credit risk involved in issuing these financial instruments is essentially the same as that involved in granting on-balance sheet financial instruments. As such, the Company’s exposure to credit loss in the event of nonperformance by the counterparty to the financial instrument is represented by the contractual amounts of those instruments. However, the Company applies the same credit policies, standards, and ongoing reassessments in making commitments and conditional obligations as it does for loans. In addition, the amount and type of collateral obtained, if deemed necessary upon extension of a loan commitment or standby letter of credit, is essentially the same as the collateral requirements provided for loans. Additional risk associated with providing these commitments arises when they are drawn upon, such as the demands on liquidity the Company would experience if a significant portion were drawn down at the same time. However, this is considered unlikely, as many commitments expire without being drawn upon and therefore do not necessarily represent future cash requirements.
	Overdraft Protection Plans — The Company provides personal credit lines on customer accounts to advance funds to cover overdrafts.
	Letters of Credit — The Company provides standby and commercial letters of credit during the normal course of business. Standby letters of credit guarantee performance of a customer to a third party while commercial letters of credit guarantee payments on behalf of our customers.
	Unfunded Commitments for Unconsolidated Investments — The Company has committed to purchase up to $12.5 million in limited partnership interests of three entities, of which $7.4 million is unfunded at December 31, 2014. Certain shareholders and directors also have interests in some of these entities.
	Company Guarantees — The Company guarantees, to the issuing merchant banks, the credit card debt transactions for certain customers.  The Company also provides guarantees to the FHLB for certain forgivable loans used to support affordable housing in our market areas.
	Federal Reserve Bank Stock — The fair value of the Federal Reserve Bank stock approximates its carrying value, which is based on the redemption provisions of the Federal Reserve Bank.  At December 31, 2014, the Company held 78,573 shares of Federal Reserve Bank stock with a fair value of $3.9 million (par value of $50).  This investment represents 50% of the subscription amount due to the Federal Reserve Bank to become a member bank and the stock cannot be sold, traded, or pledged as collateral for loans.  Although the probability is remote, the remaining 50% or $3.9 million due to the Federal Reserve Bank may be callable at their discretion.
	Employment Contracts — Certain officers of the Company have entered into employment agreements providing for salaries and fringe benefits. In addition, severance is provided in the event of termination for other than cause, and under certain changes in control, a payment is required.
	Indemnification Agreements — The Company is subject to certain indemnification obligations in conjunction with agreements signed with officers and directors of the Company.  The Indemnification Agreements require the Company to indemnify against judgments, fines, penalties and amounts paid in settlements incurred in connection with civil or criminal action or proceedings, as it relates to their services to the Company.  To the extent the Company maintains an insurance policy or policies providing directors’ and officers’ liability insurance, the Indemnitee will be covered to the maximum extent of the coverage available for any director or officer of the Company.  However, certain indemnification payments may not be covered under the Company’s directors’ and officers’ insurance coverage.  The rights of the Indemnitee under the Indemnification Agreement are in addition to any rights the Indemnitee may have under the Company’s articles of incorporation or bylaws.  While the likelihood is remote, performance under these indemnifications could materially affect net income in a particular quarter or annual period.
	Other Matters — The Company is involved in various lawsuits which have arisen in the normal course of business. It is management’s opinion, based upon advice of legal counsel, that the ultimate outcome of these lawsuits will not have a material impact upon the financial condition, cash flow or results of operations of the Company.

Regulatory_Matters

Regulatory Matters	12 Months Ended
	Dec. 31, 2014
Regulatory Matters
Regulatory Matters	17. Regulatory Matters
	The Company and the Bank are subject to various regulatory capital requirements administered by the federal banking agencies.  Failure to meet minimum capital requirements can trigger certain mandatory – and possibly additional discretionary – actions by regulators that, if undertaken, could have a direct material effect on the Company’s financial condition and results of operations.  Under capital adequacy guidelines and the regulatory framework for prompt corrective action, the Company and the Bank must meet specific capital guidelines that involve quantitative measures of the Company and the Bank’s assets, liabilities and certain off-balance-sheet items as calculated under regulatory accounting practices.  The Company and the Bank’s capital amounts and classification are also subject to qualitative judgments by the regulators regarding components, risk weightings and other factors.
	Quantitative measures established by regulation to ensure capital adequacy require the Company and the Bank to maintain minimum amounts and ratios (set forth in the following table) of Tier 1 and Total Capital (as defined in the regulations) to risk-weighted assets and of Tier 1 capital to average assets.  At December 31, 2014 and 2013, management believes the Company and Bank meet all capital adequacy requirements to which they are subject.
	At December 31, 2014, the most recent notification from the Federal Reserve categorized the Bank as well-capitalized under the regulatory framework for prompt corrective action.  To be categorized as well-capitalized the Bank must maintain minimum total risk-based, Tier 1 risk-based, and Tier 1 leverage ratios as set forth in the following table.  There are no conditions or events that management believes have changed the Bank’s categories.
	The following table shows the Company and Bank’s actual capital amounts and ratios and regulatory thresholds at December 31, 2014 and 2013
	At December 31, 2014
	(in thousands)		Company			Bank
	Shareholders' equity		$	308,769		$	323,266
	Disallowed intangible assets			-2,526			-
	Unrealized gain on available for sale securities			-7,168			-7,168
	Unrealized loss on cash flow hedges			2,840			-230
	Subordinated debentures			70,000			-
	Other deductions			-8			-
	Tier 1 regulatory capital		$	371,907		$	315,868
	Allowance for loan losses		$	32,250		$	31,878
	Total risk-based regulatory capital		$	404,157		$	347,746
			Company									Bank
	At December 31, 2014		Risk-based						Leverage			Risk-based						Leverage
	(in thousands)		Tier 1			Total capital			Tier 1			Tier 1			Total capital			Tier 1
	Regulatory capital		$	371,907		$	404,157		$	371,907		$	315,868		$	347,746		$	315,868
	Well-capitalized requirement			154,767			257,946			149,380			152,987			254,978			147,834
	Regulatory capital - excess		$	217,140		$	146,211		$	222,527		$	162,881		$	92,768		$	168,034
	Capital ratios			14.4	%		15.7	%		12.4	%		12.4	%		13.6	%		10.7	%
	Minimum capital requirement			4.0	%		8.0	%		4.0	%		4.0	%		8.0	%		4.0	%
	Well-capitalized requirement (1)			6.0	%		10.0	%		5.0	%		6.0	%		10.0	%		5.0	%
	At December 31, 2013
	(in thousands)		Company			Bank
	Shareholders' equity		$	281,085		$	294,157
	Disallowed intangible assets			-2,798			-
	Unrealized gain on available for sale securities			-5,100			-5,100
	Unrealized loss on cash flow hedges			2,370			46
	Subordinated debentures			70,000			-
	Other deductions			-8			-
	Tier 1 regulatory capital		$	345,549		$	289,103
	Allowance for loan losses		$	29,888		$	29,511
	Total risk-based regulatory capital		$	375,437		$	318,614
			Company									Bank
	At December 31, 2013		Risk-based						Leverage			Risk-based						Leverage
	(in thousands)		Tier 1			Total capital			Tier 1			Tier 1			Total capital			Tier 1
	Regulatory capital		$	345,549		$	375,437		$	345,549		$	289,103		$	318,614		$	289,103
	Well-capitalized requirement			142,997			238,329			139,043			141,232			235,387			137,537
	Regulatory capital - excess		$	202,552		$	137,108		$	206,506		$	147,871		$	83,227		$	151,566
	Capital ratios			14.5	%		15.7	%		12.4	%		12.3	%		13.5	%		10.5	%
	Minimum capital requirement			4.0	%		8.0	%		4.0	%		4.0	%		8.0	%		4.0	%
	Well-capitalized requirement (1)			6.0	%		10.0	%		5.0	%		6.0	%		10.0	%		5.0	%
		-1		The ratios for the well-capitalized requirement are only applicable to the Bank.  However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Fair_Value_Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2014
Fair Value Measurements
Fair Value Measurements	18. Fair Value Measurements
	ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement.  Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing an asset or liability.  As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
		·		Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date.
		·		Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals.
		·		Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity.
	In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.  The Company evaluates fair value measurement inputs on an ongoing basis in order to determine if there is a change of sufficient significance to warrant a transfer between levels.  For example, changes in market activity or the addition of new unobservable inputs could, in the Company’s judgment, cause a transfer to either a higher or lower level.
	A description of the valuation methodologies used for financial instruments measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below.
	Available for Sale Securities – At December 31, 2014, the Company holds, as part of its investment portfolio, available for sale securities reported at fair value consisting of MBS, municipal securities, corporate debt securities, and TPS.  The fair value of the majority of MBS and municipal securities are determined using widely accepted valuation techniques including matrix pricing and broker-quote based applications.  Inputs include benchmark yields, reported trades, issuer spreads, prepayment speeds and other relevant items.  As a result, the Company has determined that these valuations fall within Level 2 of the fair value hierarchy.  The Company also holds TPS that are recorded at fair value based on unadjusted quoted market prices for identical securities in an active market.  The majority of the TPS are actively traded in the market and as a result, the Company has determined that the valuation of these securities falls within Level 1 of the fair value hierarchy.  The Company also holds certain TPS and corporate debt securities for which unadjusted market prices are not available or the market is not active and is therefore classified as Level 2.  For these securities, broker-dealer quotes, valuations based on similar but not identical securities or the most recent market trade (which may not be current), are used.  The Company has also classified three TPS as Level 3 due to their illiquid nature and lack of trading activity.  In 2014, a single-issuer TPS of $0.7 million was transferred from Level 2 to Level 3 due to a lack of trading activity.  Unrealized gains on TPS Level 3 transfers and total net unrealized gains recognized in AOCI at December 31, 2014 and 2013 were immaterial.
	Derivative Financial Instruments – The Company uses interest-rate swaps as part of its cash flow strategy to manage its interest-rate risk.  The valuation of these instruments is determined using widely accepted valuation techniques as discussed further below.  The fair values of interest-rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts).  The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves.
	Pursuant to guidance in ASC 820, credit valuation adjustments are incorporated into the valuation to appropriately reflect both the Company’s own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.  In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings and thresholds. The Company has made an accounting policy election to measure the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.
	The Company uses Level 2 and Level 3 inputs to determine the valuation of its derivatives portfolio.  The valuation of derivative instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs (Level 2 inputs), including interest rate curves and implied volatilities. The estimates of fair value are made using a standardized methodology that nets the discounted expected future cash receipts and cash payments (based on observable market inputs). Level 3 inputs include the credit valuation adjustments which use estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties.  At December 31, 2014 and 2013, the Company assessed the impact of the Level 3 inputs on the overall derivative valuations in terms of the significance of the credit valuation adjustments in basis points and as a percentage of the overall derivative portfolio valuation and the overall notional value.  The Company’s assessment determined that credit valuation adjustments were not significant to the overall valuation of the portfolio.  In addition, the significance of the credit value adjustments and overall derivative portfolio to the Company’s financial statements was considered.  As a result of the insignificance of the credit value adjustments to the derivative portfolio valuations and the Company’s financial statements, the Company classified the derivative valuations in their entirety in Level 2.
	The Company uses foreign exchange forward contracts to mitigate exchange-rate risk arising from the Company’s foreign currency holdings to support its international banking product offering.  Fair value measurements of these assets or liabilities are priced based on spot and forward foreign currency rates and the credit worthiness of the contract counterparty.  These contracts are classified in Level 2.
	Impaired Loans – Certain collateral-dependent impaired loans are reported at the fair value of the underlying collateral.  Impairment is measured based on the fair value of the collateral, which is typically derived from appraisals that take into consideration prices in observed transactions involving similar assets and similar locations.  Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process. Appraised values are reviewed and monitored internally and fair value is assessed at least quarterly or more frequently when circumstances occur that indicate a change in fair value has occurred.  The Company classified these impaired loans as Level 3.
	The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis at December 31, 2014 and 2013, aggregated by the level in the fair value hierarchy within which those measurements fall.
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
			Balance at		identical assets			inputs		inputs
	(in thousands)		December 31, 2014		(Level 1)			(Level 2)		(Level 3)
	Assets
	Available for sale securities:
	Mortgage-backed securities		$	283,504	$	-		$	283,504	$	-
	Trust preferred securities			59,655		21,737			31,164		6,754
	Corporate debt securities			101,210		-			101,210		-
	Municipal securities			15,446		-			15,446		-
	Total available for sale securities		$	459,815	$	21,737		$	431,324	$	6,754
	Derivatives:
	Cash flow hedge		$	437	$	-		$	437	$	-
	Fair value hedge			297		-			297		-
	Non-designated hedges			4,103		-			4,103		-
	Foreign exchange forward contracts			54		-			54		-
	Total derivative assets		$	4,891	$	-		$	4,891	$	-
	Liabilities
	Derivatives:
	Cash flow hedge		$	5,017	$	-		$	5,017	$	-
	Fair value hedge			988		-			988		-
	Non-designated hedges			4,284		-			4,284		-
	Foreign exchange forward contracts			17		-			17		-
	Total derivative liabilities		$	10,306	$	-		$	10,306	$	-
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
			Balance at		identical assets			inputs		inputs
	(in thousands)		December 31, 2013		(Level 1)			(Level 2)		(Level 3)
	Assets
	Available for sale securities:
	Mortgage-backed securities		$	333,211	$	-		$	333,211	$	-
	Trust preferred securities			82,324		46,252			30,036		6,036
	Corporate debt securities			110,982		-			110,982		-
	Municipal securities			8,616		-			8,616		-
	Total available for sale securities		$	535,133	$	46,252		$	482,845	$	6,036
	Derivatives:
	Cash flow hedge		$	184	$	-		$	184	$	-
	Fair value hedge			1,735		-			1,735		-
	Non-designated hedges			6,422		-			6,422		-
	Total derivative assets		$	8,341	$	-		$	8,341	$	-
	Liabilities
	Derivatives:
	Cash flow hedge		$	4,007	$	-		$	4,007	$	-
	Fair value hedge			6,409		-			6,409		-
	Non-designated hedges			10		-			10		-
	Total derivative liabilities		$	10,426	$	-		$	10,426	$	-
	A reconciliation of the beginning and ending balances of assets measured at fair value, on a recurring basis, using Level 3 inputs follows:
			For the year ended December 31,
(in thousands)		2014		2013
Beginning balance		$	6,036	$	980
Transfers and purchases			706		5,119
Net accretion			58		13
Unrealized loss included in comprehensive income			-46		-76
Ending balance		$	6,754	$	6,036
Fair value is used on a nonrecurring basis to evaluate certain financial assets and financial liabilities in specific circumstances.  The following table presents the Company’s assets measured at fair value on a nonrecurring basis at the dates specified in the following table, aggregated by the level in the fair value hierarchy within which those measurements fall.
				Fair value measurements using:
				Quoted prices in			Significant other		Significant
				active markets for			observable		unobservable
				identical assets			inputs		inputs
(in thousands)		Total		(Level 1)			(Level 2)		(Level 3)
Impaired loans, net of specific reserve:
At December 31, 2014		$	15,734	$	-		$	-	$	15,734
At December 31, 2013		$	22,187	$	-		$	-	$	22,187
During the years ended December 31, 2014 and 2013, the Company recorded a $0.4 million and $0.1 million provision for loan losses for impaired loans, respectively.  Net charge-offs of $0.1 million and $1.0 million on impaired loans were recorded for the years ended December 31, 2014 and 2013, respectively.
Fair value is also used on a nonrecurring basis for nonfinancial assets and nonfinancial liabilities such as foreclosed assets, other real estate owned, intangible assets, nonfinancial assets and liabilities evaluated in a goodwill impairment analysis and other nonfinancial assets measured at fair value for purposes of assessing impairment.  A description of the valuation methodologies used for nonfinancial assets measured at fair value, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below.
Other Real Estate Owned (OREO) – OREO represents real property taken by the Company either through foreclosure or through a deed in lieu thereof from the borrower.  The fair value of OREO is based on property appraisals adjusted at management’s discretion to reflect a further decline in the fair value of properties since the time the appraisal analysis was performed.  It has been the Company’s experience that appraisals quickly become outdated due to the volatile real-estate environment.  Therefore, the inputs used to determine the fair value of OREO fall within Level 3. The Company may include within OREO other repossessed assets received as partial satisfaction of a loan.  Other repossessed assets are not material and do not typically have readily determinable market values and are considered Level 3 inputs.
The following tables present the Company’s nonfinancial assets measured at fair value on a nonrecurring basis at December 31, 2014 and 2013, aggregated by the level in the fair value hierarchy within which those measurements fall.
				Fair value measurements using:
				Quoted prices in			Significant other		Significant
				active markets for			observable		unobservable
				identical assets			inputs		inputs		Year to date
(in thousands)		Total		(Level 1)			(Level 2)		(Level 3)		gain (loss)
OREO:
At December 31, 2014		$	6,132	$	-		$	-	$	6,132	$	1,459
At December 31, 2013		$	5,371	$	-		$	-	$	5,371	$	-708
In accordance with ASC 310, the fair value of OREO recorded as an asset is reduced by estimated selling costs.  The following table is a reconciliation of the fair value measurement of OREO disclosed pursuant to ASC 820 to the amount recorded on the condensed consolidated balance sheet:
		At December 31,
(in thousands)		2014		2013
OREO recorded at fair value		$	6,132	$	5,371
Estimated selling costs			-313		-274
OREO		$	5,819	$	5,097
Valuation adjustments on OREO and additional gains or losses at the time OREO is sold are recognized in current earnings under the caption “Net loss on securities, other assets and other real estate owned.”  Below is a summary of OREO transactions for the years ended December 31, 2014 and 2013
(in thousands)		2014		2013
Beginning OREO balance		$	5,097	$	10,577
Additions			4,992		449
Sales			-5,305		-5,221
Net loss on sale and valuation adjustments			1,035		-708
Ending OREO balance		$	5,819	$	5,097
The following table provides information describing the valuation processes used to determine recurring and nonrecurring fair value measurements categorized within Level 3 of the fair value hierarchy.
		Fair Value						Weighted
Category		(in thousands)		Valuation Technique		Unobservable Input		Average	Range
Trust preferred securities		$	6,754	Market approach		Discount to carrying value using broker quotes or observable prices on similar securities		14%	0% to 18%
Impaired loans
Commercial		$	1,150	Market approach		Management discount for asset type		41%	77% to 6%
Real estate - mortgage			9,486	Income approach		Capitalization and/or discount rate		9%	9% to 10%
Real estate - mortgage			2,407	Sales comparison	(1)	Sales comparison adjustments		4%	-9% to 14%
Construction & land			679	Sales comparison	(1)	Sales comparison adjustments		3%	-24% to 5%
Consumer			2,012	Sales comparison	(1)	Sales comparison adjustments		7%	5% to 14%
Total		$	15,734
OREO
Commercial		$	455	Property appraisals		Management discount for property type and recent market volatility		19%	0% to 30%
Land acquisition & development			5,677	Property appraisals		Management discount for property type and recent market volatility		19%	17% to 50%
Total		$	6,132
	-1		The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals.  The majority of the appraisals utilize a single valuation approach or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving identical or comparable properties are used to determine fair value.  Appraisals may include an ‘as is’ sales comparison approach and an ‘upon completion’ valuation approach.  Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data.  Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values.  Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal.  Positive adjustments disclosed in this table represent increases to the sales comparison and negative adjustment represent decreases.
The following table includes the estimated fair value of the Company’s financial instruments. The methodologies for estimating the fair value of financial assets and financial liabilities measured at fair value on a recurring and nonrecurring basis are discussed above.  The methodologies for estimating the fair value for other financial assets and financial liabilities are discussed below.  The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret market data in order to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts at December 31, 2014 and 2013.
		December 31, 2014					December 31, 2013
		Carrying		Estimated			Carrying		Estimated
(in thousands)		value		fair value			value		fair value
Financial assets:
Cash and cash equivalents		$	91,565	$	91,565		$	76,028	$	76,028
Investment securities available for sale			459,815		459,815			535,133		535,133
Investment securities held to maturity			13,329		13,616			13,266		12,715
Other investments			11,477		11,477			8,397		8,397
Loans — net			2,372,810		2,371,756			2,047,309		2,045,447
Accrued interest receivable			9,617		9,617			8,770		8,770
Derivatives			4,891		4,891			8,341		8,341
Financial liabilities:
Deposits		$	2,492,291	$	2,492,340		$	2,279,037	$	2,279,996
Securities sold under agreements to repurchase			49,976		49,991			138,494		138,312
Short-term borrowings			112,469		112,469			-		-
Accrued interest payable			813		813			679		679
Junior subordinated debentures			72,166		72,166			72,166		72,166
Derivatives			10,306		10,306			10,426		10,426
The fair value estimation methodologies utilized by the Company for financial instruments and the classification level within the fair value hierarchy that those instruments fall are summarized as follows:
Cash and Cash Equivalents — The carrying amount of cash and cash equivalents is a reasonable estimate of fair value which is classified as Level 2.
Restricted Cash — The carrying amount of restricted cash is a reasonable estimate of fair value which is classified as Level 2.
Other Investments — Included in this category are the Company’s investment in the FHLB and other equity method investments.  Due to restrictions on transferability, it is not practical to estimate fair value on the FHLB investment which is reported at carrying value.  The fair value of other equity method investments approximates fair value and is classified as Level 2.
Loans — The fair value of loans is estimated by discounting future contractual cash flows using estimated market rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.  In computing the estimate of fair value for all loans, the estimated cash flows and/or carrying value have been reduced by specific and general reserves for loan losses. The fair value of loans is classified as Level 3 within the fair value hierarchy.
Accrued Interest Receivable/Payable — The fair value of accrued interest receivable/payable approximates the carrying amount due to the short-term nature of these amounts and is classified in the same level hierarchy as the underlying assets/liabilities.
Deposits — The fair value of certificates of deposit is estimated by discounting the expected life using an index of the U.S. Treasury curve. Non-maturity deposits are reflected at their carrying value for purposes of estimating fair value. The fair value of all deposits is classified as Level 2.
Securities Sold Under Agreements to Repurchase — Estimated fair value is based on discounting cash flows and is classified as Level 2.
Short-Term Borrowings — The estimated fair value of short-term borrowings approximates their carrying value, due to their short-term nature and is classified as Level 2.
Junior Subordinated Debentures — The estimated fair value of junior subordinated debentures approximates their carrying value, due to the variable interest rate paid on the debentures and is classified as Level 2.
Commitments to Extend Credit and Standby Letters of Credit — The Company’s off-balance sheet commitments are funded at current market rates at the date they are drawn upon. It is management’s opinion that the fair value of these commitments would approximate their carrying value, if drawn upon, and are classified as Level 3.
The fair value estimates presented herein are based on pertinent information available to management at December 31, 2014 and 2013. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since that date and, therefore, current estimates of fair value may differ significantly from the amounts presented herein.

Segments

Segments	12 Months Ended
	Dec. 31, 2014
Segments
Segments	19. Segments
	During 2014 the Company made organizational changes affecting the manner in which the chief operating decision maker reviews the Company.  Reportable segments under ASC Topic 280 – Segment Reporting were re-evaluated and as a result, the Company has aggregated the segments previously reported as Investment Banking, Wealth Management and Insurance into a new segment titled Fee-Based Lines.  The changes to our reporting segments are consistent with the way the Chief Executive Officer, who is the chief operating decision maker, evaluates the performance of operations, develops strategy and allocates capital resources.  None of the segments previously reported (Investment Banking, Wealth Management and Insurance) meet the quantitative thresholds under ASC 280 for separate reporting.  No changes were made to Commercial Banking or Corporate Support and Other.  All prior period disclosures have been adjusted to conform to the new presentation.
	The Commercial Banking segment consists of the operations of CoBiz Bank, a full-service business banking institution.  Services provided include Commercial, Real Estate, and Private banking as well as treasury management, interest-rate hedging, and depository products.
	The Fee-Based Lines segment consists of businesses offering products and services that are financial in nature and for which revenues are based on a percentage of an underlying basis such as deal value, managed assets or paid premiums.  Activities in this segment include investment banking services through GMB, investment advisory through CIM and insurance brokerage through CoBiz Insurance Inc.  GMB provides middle-market companies with merger and acquisition advisory services, institutional private placements of debt and equity, and other strategic financial advisory services.  CoBiz Insurance, Inc. offers property and casualty (P&C) and employee benefit group insurance (EB) broker agency to small- to mid-sized employers, commercial enterprises and individual lines to their owners.  CIM provides investment management advisory services to affluent individuals, families and businesses.
	As discussed in Note 2, the Company exited the trust and wealth transfer business lines at December 31, 2012, that are disclosed as discontinued operations in the Fee-Based Lines.
	The Corporate Support and Other segment consist of activities that are not directly attributable to the other reportable segments and include centralized bank operations and the activities of the Parent.
	The financial information for each business segment reflects that information which is specifically identifiable or which is allocated based on an internal allocation method.  Results of operations and selected financial information by operating segment are as follows:
		For the year ended December 31, 2014
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	113,888	$	6	$	423	$	114,317
	Total interest expense		4,394		41		3,994		8,429
	Provision for loan losses		-3,346		-		-809		-4,155
	Noninterest income		9,940		21,052		1,083		32,075
	Noninterest expense		35,602		18,968		43,394		97,964
	Management fees and allocations		23,988		1,115		-25,103		-
	Provision (benefit) for income taxes		30,926		819		-16,598		15,147
	Net income (loss)	$	32,264	$	115	$	-3,372	$	29,007
	Depreciation and amortization		2,316		949		21		3,286
	Identifiable assets at December 31, 2014	$	3,025,107	$	14,979	$	22,080	$	3,062,166
		For the year ended December 31, 2013
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	105,719	$	11	$	397	$	106,127
	Total interest expense		5,195		61		5,170		10,426
	Provision for loan losses		-7,330		-		-1,474		-8,804
	Noninterest income		11,907		18,578		427		30,912
	Noninterest expense		35,265		18,224		41,139		94,628
	Management fees and allocations		22,313		959		-23,272		-
	Provision (benefit) for income taxes		30,049		211		-16,909		13,351
	Net income (loss) from continuing operations		32,134		-866		-3,830		27,438
	Income from discontinued operations, net of tax		-		173		-		173
	Net income (loss)	$	32,134	$	-693	$	-3,830	$	27,611
	Depreciation and amortization		2,564		1,074		32		3,670
	Identifiable assets at December 31, 2013	$	2,764,609	$	15,403	$	20,679	$	2,800,691
		For the year ended December 31, 2012
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	105,757	$	10	$	361	$	106,128
	Total interest expense		6,886		41		5,823		12,750
	Provision for loan losses		-3,546		-		-1,187		-4,733
	Noninterest income		12,646		17,716		197		30,559
	Noninterest expense		32,964		18,508		39,694		91,166
	Management fees and allocations		20,605		1,179		-21,784		-
	Provision (benefit) for income taxes		30,284		-331		-16,695		13,258
	Net income (loss) from continuing operations		31,210		-1,671		-5,293		24,246
	Income from discontinued operations, net of tax		-		324		-		324
	Net income (loss)	$	31,210	$	-1,347	$	-5,293	$	24,570
	Depreciation and amortization		2,649		1,321		34		4,004
	Identifiable assets at December 31, 2012	$	2,611,788	$	18,517	$	23,336	$	2,653,641

Condensed_Financial_Statements

Condensed Financial Statements Of Parent Company	12 Months Ended
	Dec. 31, 2014
Condensed Financial Statements Of Parent Company
Condensed Financial Statements Of Parent Company	20. Condensed Financial Statements of Parent Company
	Condensed financial statements pertaining only to CoBiz Financial Inc. are presented below.  Investments in subsidiaries are stated using the equity method of accounting.
	Condensed Balance Sheets	At December 31,
	(in thousands)	2014		2013
	Assets:
	Cash on deposit at subsidiary bank	$	24,495	$	24,742
	Investment in bank subsidiary		323,266		294,157
	Investment in non-bank subsidiaries		29,878		27,846
	Accounts receivable from bank subsidiary		498		172
	Accounts receivable from non-bank subsidiaries		1,218		8,893
	Other		17,291		16,539
	Total assets	$	396,646	$	372,349
	Liabilities and shareholders' equity:
	Liabilities:
	Accounts payable to bank subsidiary	$	6,718	$	8,237
	Accounts payable to non-bank subsidiaries		7,337		5,817
	Junior subordinated debentures		72,166		72,166
	Other liabilities		1,656		5,044
	Total liabilities		87,877		91,264
	Shareholders' equity		308,769		281,085
	Total liabilities and shareholders' equity	$	396,646	$	372,349
	Condensed Statements of Income	For the years ended December 31,
	(in thousands)	2014		2013		2012
	Income:
	Management fees	$	4,397	$	4,457	$	3,861
	Dividends from bank subsidiary		8,116		8,000		-
	Dividends from non-bank subsidiaries		1,898		6,123		3,704
	Interest income		181		243		272
	Other income		1,102		445		342
	Total income		15,694		19,268		8,179
	Expenses:
	Salaries and employee benefits		4,408		4,255		4,715
	Interest expense		4,122		5,360		6,041
	Other expense		2,203		2,441		2,344
	Total expenses		10,733		12,056		13,100
	Loss before income taxes		4,961		7,212		-4,921
	Benefit for income taxes		-1,402		-2,748		-3,333
	Net loss before equity in undistributed
	earnings of subsidiaries		6,363		9,960		-1,588
	Equity in undistributed earnings of subsidiaries		22,644		17,651		26,158
	Net income	$	29,007	$	27,611	$	24,570
	Condensed Statements of Cash Flows	For the years ended December 31,
	(in thousands)	2014		2013		2012
	Cash flows from operating activities:
	Net income	$	29,007	$	27,611	$	24,570
	Equity in undistributed earnings of subsidiaries		-22,644		-17,651		-26,158
	Stock-based compensation		584		487		335
	Change in other assets and liabilities		2,205		8,195		1,340
	Net cash provided by operating activities		9,152		18,642		87
	Cash flows from investing activities:
	Net advances (to) from subsidiaries		-3,372		-878		548
	Other		-31		-18		-25
	Net cash provided by (used in) investing activities		-3,403		-896		523
	Cash flows from financing activities:
	Proceeds from issuance of common stock, net		1,570		1,960		12,582
	Taxes paid in net settlement of restricted stock		-1,045		-297		-
	Redemption of subordinated notes payable		-		-20,984		-
	Dividends paid on common stock		-6,076		-4,820		-2,747
	Dividends paid on preferred stock		-574		-1,465		-2,868
	Other		129		5		-
	Net cash provided by (used in) financing activities		-5,996		-25,601		6,967
	Net increase (decrease) in cash and cash equivalents		-247		-7,855		7,577
	Cash and cash equivalents - beginning of year		24,742		32,597		25,020
	Cash and cash equivalents - end of year	$	24,495	$	24,742	$	32,597

Supplemental_Financial_Data

Supplemental Financial Data	12 Months Ended
	Dec. 31, 2014
Supplemental Financial Data
Supplemental Financial Data	21.  Supplemental Financial Data
	Other income and Other expense as shown in the consolidated statements of income is detailed in the following schedules to the extent the components exceed one percent of the aggregate of total interest income and other income.
	Other noninterest income	Year ended December 31,
	(in thousands)	2014		2013		2012
	Loan Fees	$	1,751	$	1,950	$	1,325
	Other customer service fees		2,170		1,620		1,415
	Bank-owned life insurance earnings		1,594		1,295		1,286
	Private equity investment income		-56		897		2,240
	Interest rate swap fees		-106		1,201		1,490
	Other income		72		56		184
	Total	$	5,425	$	7,019	$	7,940
	Other noninterest expense	Year ended December 31,
	(in thousands)	2014		2013		2012
	Marketing and business development	$	3,090	$	2,810	$	2,425
	Service contracts		4,027		3,569		2,295
	Professional fees		2,475		2,337		1,991
	Office supplies and delivery		1,550		1,541		1,559
	Charitable donations		714		993		826
	Other expense		2,868		1,826		3,470
	Total	$	14,724	$	13,076	$	12,566

Selected_Quarterly_Financial_D

Selected Quarterly Financial Data	12 Months Ended
	Dec. 31, 2014
Selected Quarterly Financial Data
Selected Quarterly Financial Data	22. Selected Quarterly Financial Data (Unaudited)
	The table below sets forth unaudited financial information for each quarter of the last two years.  During the fourth quarter of 2012, the Company exited its trust and wealth transfer business lines reported in the table below as discontinued operations.  See Note 2 – Discontinued Operations for additional detail.  Earnings per common share as noted below have not been separated between continuing and discontinued operations, as disclosed in Note 14 – Earnings per Common Share.
			2014								2013
	(in thousands)		Q4		Q3		Q2		Q1		Q4		Q3		Q2		Q1
	Interest income		$	29,611	$	29,205	$	28,510	$	26,991	$	26,954	$	26,961	$	26,160	$	26,052
	Interest expense			2,043		2,143		2,157		2,086		2,178		2,586		2,795		2,867
	Net interest income			27,568		27,062		26,353		24,905		24,776		24,375		23,365		23,185
	Income before income taxes			10,522		12,206		13,099		8,327		10,984		9,874		11,261		8,670
	Net income from continuing operations			6,982		7,891		8,617		5,517		7,275		7,025		7,262		5,876
	Income from discontinued operations, net of tax			-		-		-		-		-		-		-		173
	Net income			6,982		7,891		8,617		5,517		7,275		7,025		7,262		6,049
	Basic earnings per share(1)		$	0.17	$	0.19	$	0.21	$	0.13	$	0.18	$	0.17	$	0.18	$	0.14
	Diluted earnings per share(1)		$	0.17	$	0.19	$	0.21	$	0.13	$	0.18	$	0.17	$	0.18	$	0.14
		-1		Due to rounding, the sum of the quarterly earnings per share amounts may not equal earnings per share for the year as disclosed elsewhere in this report.

Nature_Of_Operations_and_Signi1

Nature Of Operations and Significant Accounting Policies (Policy)	12 Months Ended
	Dec. 31, 2014
Nature Of Operations and Significant Accounting Policies
Use Of Estimates	Use of Estimates – In preparing its financial statements, the company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ significantly from those estimates.  Material estimates that are particularly susceptible to significant changes in the near-term relate to the determination of the allowance for loan losses; fair value of financial instruments; and recoverability of deferred taxes.
Reclassifications	Reclassifications – Certain reclassifications have been made to prior years’ consolidated financial statements and related notes to conform to current year presentation including: the effects of discontinued operations (Note 2 – Discontinued Operations) and a change to the Company’s segments (Note 19 – Segments).
Basis Of Presentation	Basis of Presentation — The consolidated financial statements include entities in which the Parent has a controlling financial interest.  These entities include; the Bank; CoBiz Insurance Inc.; CoBiz GMB, Inc.; and CoBiz IM.  Intercompany balances and transactions are eliminated in consolidation.  The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE).
	The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity.  The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE.  The Company was not the primary beneficiary of a VIE at December 31, 2014 or December 31, 2013.
Cash And Cash Equivalents	Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements.  At December 31, 2014 and 2013, the Company had reserve requirements of $13.4 million and $0, respectively.  The following table shows supplemental disclosures of certain cash and noncash items:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Cash paid during the period for:
	Interest	$	8,295	$	10,409	$	12,823
	Income taxes		11,061		11,197		4,975
	Other noncash activities:
	Loans transferred to held for sale		7,087		8,044		6,201
	Loans transferred to OREO and repossessed assets		2,660		449		421
	Financed sales of OREO and loans held for sale		-		2,000		249
	Deferred gain on sale of wealth transfer business		-		-		285
	Restricted Cash – Restricted cash consists of cash deposits that are contractually restricted as collateral for outstanding letters of credit.  There was no restricted cash at December 31, 2014 and 2013.
Investments	Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent.  Investment security transactions are recorded on a trade date basis.  At December 31, 2014 and 2013, the Company had no trading securities.
	Available for sale securities consist of residential mortgage-backed securities (MBS), bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized.
	Investment securities held to maturity consist of MBS, bonds, notes, debentures for which the Company has the positive intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts.
	Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific identification method.
	Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors.  The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI).  See Note 3 – Investments.
Bank Stocks	Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method.  See Note 3 – Investments.
Loans Held For Investment	Loans Held for Investment— Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balance adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms.  The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest.
Loans Held For Sale	Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell.  Loans held for sale are primarily nonperforming loans.  Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis.
Impaired Loans	Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450).
	Included in impaired loans are troubled debt restructurings.  A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date.  Troubled debt restructurings are evaluated in accordance with ASC Topic 310-10-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms.
Loan Origination Fees And Costs	Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs.
Allowance For Loan Losses	Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance.
	The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available.
Allowance For Credit Losses	Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the consolidated balance sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded.  See Note 4 – Loans.
Intangible Assets	Intangible Assets —Intangible assets, primarily consisting of customer contracts and relationships, are being amortized by the straight-line method over 10 to 15 years.  See Note 6 – Intangible Assets.
Bank-Owned Life Insurance (BOLI)	Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs and are recorded at net realizable value.  Changes in the amount that could be realized are recorded in the consolidated statements of income under the caption “Other Income”.
Premises and Equipment	Premises and Equipment – Premises and equipment are stated at cost less accumulated depreciation and amortization, which is calculated using the straight-line method over the estimated useful lives of generally three to five years.  Leasehold improvements are capitalized and amortized using the straight-line method over the terms of the respective leases or the estimated useful lives of the improvements, whichever is shorter.  The Company reviews the carrying value of property and equipment for indications of impairment in accordance with ASC Topic 360-10-35, Impairment or Disposal of Long-Lived Assets.  See Note 5 – Premises and Equipment.
Other Assets	Other Assets – Included in other assets are certain investments, where the Company has the ability to exercise significant influence or has ownership between 20% and 50% that are accounted for under the equity method.  The Funds are equity method investments licensed as Small Business Investment Companies that invest primarily in subordinated debt securities.  In certain circumstances, the Funds may also receive warrants or other equity positions as part of their investments.  There were no significant transactions between the Company and the Funds for the years ended December 31, 2014,  2013, and 2012.  The Company recognized income (loss) from the Funds of $(0.1) million, $0.9 million, and $2.2 million for the years ended December 31, 2014,  2013, and 2012, respectively, which is included in “Other Income” in the consolidated statements of income.
Repossessed Assets	Repossessed Assets – Assets acquired through repossession are held for sale and initially recorded at estimated fair value at the date of repossession.  Subsequent to repossession, valuations are periodically performed by management and the assets are carried at the lower of carrying amount or fair value less costs to sell.  Repossessed assets are reported in the consolidated balance sheets under the caption “Other Assets.”  There were no repossessed assets at December 31, 2014 and 2013.
Other Real Estate Owned	Other Real Estate Owned (OREO) – OREO held for sale acquired through foreclosure, physical possession or in settlement of debt is valued at estimated fair value, less estimated costs to sell, at the date of receipt.  Subsequent to foreclosure, OREO is carried at the lower of carrying amount or fair value less costs to sell.  Subsequent declines in value are charged to operations.  Activity in the valuation allowance on OREO for the years ended December 31, 2014,  2013, and 2012 is as follows:
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Beginning balance	$	8,674	$	8,055	$	7,668
	Additions		398		2,185		1,872
	Deductions due to sales		-312		-1,566		-1,485
	Ending balance	$	8,760	$	8,674	$	8,055
Securities Sold Under Agreements to Repurchase	Securities Sold Under Agreements to Repurchase – The Company sells certain securities under agreements to repurchase with its customers.  The agreements transacted with its customers are utilized as an overnight investment product.  These agreements are treated as secured borrowings, where the agreements are reflected as a liability of the Company and the securities underlying the agreements are reflected as a Company asset in accordance with ASC Topic 860, Transfers and Servicing.  See Note 8 – Borrowed Funds.
Derivative Instruments	Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The net cash flows from these hedges are classified in operating activities within the Consolidated Statements of Cash Flows with the hedged items.  The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans.  These instruments are accounted for as fair value hedges in accordance with ASC 815.  The Company also has a derivative program that offers interest-rate caps, floors, swaps and collars to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement.  The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions.  FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments.  See Note 10 – Derivatives.
Self-Insurance Reserves	Self-Insurance Reserves – The Company self-insures a portion of its employee medical costs.  The Company maintains a liability for incurred-but-not-reported claims based on assumptions as to eligible employees, historical claims experience and lags in claims reporting.
Investment Advisory Income	Investment Advisory Income – Fees earned from providing investment advisory services are based on the market value of assets under management and are collected at the end of each quarter.
Insurance Income	Insurance Income  – Insurance income includes commissions on the sale of life and property and casualty insurance policies and other employee benefit products earned as an agent for unaffiliated insurance underwriters.  Property and casualty income is primarily recognized upon policy origination and renewal dates.  Benefits brokerage income is recognized on a monthly basis as the customer pays their insurance premiums.
Investment Banking Income	Investment Banking Income – Investment banking income includes nonrefundable retainer fees recognized over the expected term of the engagement and success fees recognized when the transaction is completed and collectability of fees is reasonably assured.
Income From Discontinued Operations, Net of Income Taxes	Income From Discontinued Operations, Net of Income Taxes – Income from discontinued operations net of income taxes for the years ended December 31, 2013 and 2012 includes the results of FDL’s wealth transfer business and trust, which is discussed in Note 2 – Discontinued Operations.
Income Taxes	Income Taxes – A deferred income tax liability or asset is recognized for temporary differences which exist in the recognition of certain income and expense items for financial statement reporting purposes in periods different than for tax reporting purposes.  The provision for income taxes is based on the amount of current and deferred income taxes payable or refundable at the date of the financial statements as measured by the provisions of current tax laws.  A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  The ultimate realization of deferred tax assets depends on the generation of future taxable income during the period in which related temporary differences become deductible.  Management considers the scheduled reversal of deferred tax liabilities, taxes paid in prior carryback years, projected future taxable income and tax planning strategies in its assessment of a valuation allowance.  See Note 11 – Income Taxes.
Stock-Based Compensation	Stock-Based Compensation — Pursuant to ASC Topic 718, Compensation – Stock Compensation (ASC 718), the Company recognizes the fair value of stock-based awards to employees as compensation cost over the requisite service period.  See Note 15 – Employee Benefit and Stock Compensation Plans.
Earnings Per Common Share	Earnings Per Common Share — Basic and diluted earnings per share is based on the two-class method prescribed in ASC Topic 260, Earnings Per Share (ASC 260).  The weighted-average number of shares outstanding used to compute diluted earnings per share include the number of additional common shares that would be outstanding if the potential dilutive common shares and common share equivalents had been issued at the beginning of the period.  See Note 14 – Earnings per Common Share.
Segment Information	Segment Information - The Company has disclosed separately the results of operations relating to its segments in Note 19 – Segments.
Fair Value Measurements	Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurements and Disclosures (ASC 820).  ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.  See Note 18 - Fair Value Measurements.
Recent Accounting Pronouncements	Recent Accounting Pronouncements — In January 2014, the Financial Accounting Standard Board (FASB) issued Accounting Standard Update (ASU) No. 2014-04, Receivables – Troubled Debt Restructurings by Creditors (Subtopic 310-40) – Reclassification of Residential Real Estate Collateralized Consumer Mortgage Loans upon Foreclosure (ASU 2014-04).  The amendments in ASU 2014-04 are intended to clarify when a creditor should be considered to have received physical possession of residential real estate property collateralizing a consumer mortgage loan such that the loan should be derecognized and the real estate recognized.  This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2014.  The Company is currently evaluating the effects of ASU 2014-04 on its financial statements and disclosures, if any.
	In April 2014, the FASB issued ASU No. 2014-08 Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) – Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (ASU 2014-08).  The amendments in ASU 2014-08 change the criteria for reporting discontinued operations and improve related disclosures.  This ASU also addresses sources of confusion and inconsistent application related to financial reporting of discontinued operations guidance.  ASU 2014-08 will be effective for annual financial statements with fiscal years beginning on or after December 31, 2014 and interim periods thereafter.  The Company is currently evaluating the effects ASU 2014-08 will have on its financial statements and disclosures, if any.
	In May 2014, the FASB issued ASU No. 2014-09 Revenue from Contracts with Customers (Topic 606) (ASU 2014-09).  This update to the ASC is the culmination of efforts by the FASB and the International Accounting Standards Board (IASB) to develop a common revenue standard for U.S. GAAP and International Financial Reporting Standards (IFRS).  ASU 2014-09 supersedes Topic 605 – Revenue Recognition and most industry-specific guidance.  The core principal of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.  The guidance in ASU 2014-09 describes a 5-step process entities can apply to achieve the core principle of revenue recognition and requires disclosures sufficient to enable users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers and the significant judgments used in determining that information.  The amendments in ASU 2014-09 are effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period and early application is not allowed.  The Company is currently evaluating the effects of ASU 2014-09 on its financial statements and disclosures, if any.
	In June 2014, the FASB issued ASU No. 2014-12, Compensation – Stock Compensation (Topic 718) –Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Services Period (ASU 2014-12).  The amendments in ASU 2014-12 provide guidance for determining compensation cost under specific circumstances when an employee is eligible to vest in an award regardless of whether the employee is rendering service on the date the performance target is achieved.  ASU 2014-12 becomes effective for annual and interim periods beginning after December 15, 2015 with early adoption permitted.  The Company does not believe the effects of ASU 2014-12 will have an impact on its financial statements and disclosures.
	In August 2014, the FASB issued ASU No. 2014-15, Presentation of Financial Statements – Going Concern (Subtopic 205-40) (ASU 2014-15).  The amendments’ objective of ASU 2014-15 is to define management’s responsibility to evaluate whether there is substantial doubt about an organization’s ability to continue as a going concern and provide related disclosures.  Currently, GAAP does not provide guidance to evaluate whether there is substantial doubt the organization’s ability to continue as a going concern.  This ASU provides guidance to an organization’s management, with principles and definitions to reduce diversity in the timing and content of disclosures commonly provided by organizations today in the financial statements footnotes.  ASU 2014-15 is effective for periods ending after December 15, 2016 and interim periods within annual periods beginning after December 15, 2016.  The Company does not believe the effects of ASU 2014-15 will have an impact on its financial statements and disclosures.
	In January 2015, the FASB issued ASU No. 2015-01, Income Statement – Extraordinary and Unusual Items (Subtopic 225-202).  This ASU eliminates the concept of extraordinary items.  Subtopic 225-20, Income Statement – Extraordinary and Unusual Items, required that an entity separately classify, present, and disclose extraordinary events and transactions.  An event or transaction is currently presumed to be an ordinary and usual activity of the reporting entity unless evidence clearly supports its classification as an extraordinary item.  The elimination of the concept of extraordinary items is expected to save time and reduce costs for preparers.  ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  A reporting entity may apply the amendments prospectively.  The Company does not believe the effects of ASU 2015-01 will have an impact on its financial statements and disclosures.

Nature_Of_Operations_and_Signi2

Nature Of Operations and Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Nature Of Operations and Significant Accounting Policies
Schedule of Cash Flow, Supplemental Disclosures
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Cash paid during the period for:
	Interest	$	8,295	$	10,409	$	12,823
	Income taxes		11,061		11,197		4,975
	Other noncash activities:
	Loans transferred to held for sale		7,087		8,044		6,201
	Loans transferred to OREO and repossessed assets		2,660		449		421
	Financed sales of OREO and loans held for sale		-		2,000		249
	Deferred gain on sale of wealth transfer business		-		-		285
Schedule of change in valuation allowance for other real estate owned (OREO)
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Beginning balance	$	8,674	$	8,055	$	7,668
	Additions		398		2,185		1,872
	Deductions due to sales		-312		-1,566		-1,485
	Ending balance	$	8,760	$	8,674	$	8,055

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2014
Discontinued Operations
Schedule Of Discontinued Operations
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Noninterest income	$	-	$	333	$	6,448
	Noninterest expense		-		74		5,953
	Income before income taxes		-		259		495
	Provision for income taxes		-		86		171
	Net income from discontinued operations	$	-	$	173	$	324

Investments_Tables

Investments (Tables)	12 Months Ended
	Dec. 31, 2014
Investments
Summary of amortized cost and estimated fair values of investment securities
		December 31, 2014								December 31, 2013
				Gross		Gross						Gross		Gross
		Amortized		unrealized		unrealized		Fair		Amortized		unrealized		unrealized		Fair
	(in thousands)	cost		gains		losses		value		cost		gains		losses		value
	Available for sale securities (AFS):
	Mortgage-backed securities	$	275,855	$	8,052	$	403	$	283,504	$	326,555	$	7,467	$	811	$	333,211
	Trust preferred securities		57,974		2,127		446		59,655		82,768		1,250		1,694		82,324
	Corporate debt securities		99,249		2,186		225		101,210		108,862		3,088		968		110,982
	Municipal securities		15,175		280		9		15,446		8,723		8		115		8,616
	Total AFS	$	448,253	$	12,645	$	1,083	$	459,815	$	526,908	$	11,813	$	3,588	$	535,133
	Held to maturity securities (HTM):
	Mortgage-backed securities	$	140	$	4	$	-	$	144	$	175	$	6	$	-	$	181
	Trust preferred securities		13,189		294		11		13,472		13,091		-		557		12,534
	Total HTM	$	13,329	$	298	$	11	$	13,616	$	13,266	$	6	$	557	$	12,715
Schedule Of Proceeds and Gains (Losses) From Securities Sold Or Called
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Proceeds	$	11,590	$	-	$	9,598
	Gains		1,242		552		1,651
	Losses		-88		-113		-572
Investments Classified By Contractual Maturity Date
		Available for sale				Held to maturity
		Amortized		Fair		Amortized		Fair
	(in thousands)	cost		value		cost		value
	Due in one year or less	$	24,240	$	24,458	$	-	$	-
	Due after one year through five years		61,244		62,834		-		-
	Due after five years through ten years		28,378		28,778		-		-
	Due after ten years		58,536		60,241		13,189		13,472
	Mortgage-backed securities		275,855		283,504		140		144
		$	448,253	$	459,815	$	13,329	$	13,616
Schedule of Securites in an Unrealized Loss Position
		December 31, 2014
		Less than 12 months				12 months or greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	(in thousands)	value		loss		value		loss		value		loss
	AFS
	Mortgage-backed securities	$	9,699	$	12	$	26,470	$	391	$	36,169	$	403
	Trust preferred securities		17,175		48		6,145		398		23,320		446
	Corporate debt securities		5,856		117		4,924		108		10,780		225
	Municipal securities		773		9		-		-		773		9
	Total AFS	$	33,503	$	186	$	37,539	$	897	$	71,042	$	1,083
	HTM
	Trust preferred securities	$	845	$	11	$	-	$	-	$	845	$	11
	Total HTM	$	845	$	11	$	-	$	-	$	845	$	11
		December 31, 2013
		Less than 12 months				12 months or greater				Total
		Fair		Unrealized		Fair		Unrealized		Fair		Unrealized
	(in thousands)	value		loss		value		loss		value		loss
	AFS
	Mortgage-backed securities	$	52,509	$	811	$	-	$	-	$	52,509	$	811
	Trust preferred securities		49,934		1,599		1,903		95		51,837		1,694
	Corporate debt securities		20,609		938		4,970		30		25,579		968
	Municipal securities		7,787		115		-		-		7,787		115
	Total AFS	$	130,839	$	3,463	$	6,873	$	125	$	137,712	$	3,588
	HTM
	Trust preferred securities	$	12,534	$	557	$	-	$	-	$	12,534	$	557
	Total HTM	$	12,534	$	557	$	-	$	-	$	12,534	$	557
Schedule Of Other Investments
		December 31,
	(in thousands)	2014		2013
	Bank stocks — at cost	$	9,305	$	6,225
	Investment in statutory trusts — equity method		2,172		2,172
		$	11,477	$	8,397

Loans_Tables

Loans (Tables)	12 Months Ended
	Dec. 31, 2014
Loans
Schedule Of Loan Portfolio Segments
			December 31,
	(in thousands)		2014			2013
	Commercial		$	977,628		$	825,530
	Real estate - mortgage			990,594			901,721
	Construction & land			182,869			128,670
	Consumer			207,921			181,067
	Other			47,904			49,394
	Loans held for investment			2,406,916			2,086,382
	Allowance for loan losses			-32,765			-37,050
	Unearned net loan fees			-1,341			-2,023
	Total net loans		$	2,372,810		$	2,047,309
Schedule Of Major Portfolio Segment And Non Classified And Classified Loan Class
			At December 31, 2014
	(in thousands)		Non-classified			Classified			Total
	Commercial
	Manufacturing		$	121,617		$	4,501		$	126,118
	Finance and insurance			80,948			99			81,047
	Health care			91,631			180			91,811
	Real estate services			110,031			2,357			112,388
	Construction			53,513			2,982			56,495
	Wholesale and retail trade			68,811			3,484			72,295
	Other			435,337			2,137			437,474
				961,888			15,740			977,628
	Real estate - mortgage
	Residential & commercial owner-occupied			409,659			12,749			422,408
	Residential & commercial investor			563,657			4,349			568,006
	Other			180			-			180
				973,496			17,098			990,594
	Construction & land			181,641			1,228			182,869
	Consumer			205,131			2,790			207,921
	Other			47,820			84			47,904
	Total loans held for investment		$	2,369,976		$	36,940		$	2,406,916
	Unearned net loan fees									-1,341
	Net loans held for investment								$	2,405,575
			At December 31, 2013
	(in thousands)		Non-classified			Classified			Total
	Commercial
	Manufacturing		$	101,114		$	4,582		$	105,696
	Finance and insurance			76,589			517			77,106
	Health care			99,526			639			100,165
	Real estate services			98,691			1,591			100,282
	Construction			51,616			1,695			53,311
	Wholesale and retail trade			69,167			1,937			71,104
	Other			313,862			4,004			317,866
				810,565			14,965			825,530
	Real estate - mortgage
	Residential & commercial owner-occupied			436,479			16,500			452,979
	Residential & commercial investor			441,186			7,556			448,742
				877,665			24,056			901,721
	Construction & land			122,637			6,033			128,670
	Consumer			179,645			1,422			181,067
	Other			49,394			-			49,394
	Total loans held for investment		$	2,039,906		$	46,476		$	2,086,382
	Unearned net loan fees									-2,023
	Net loans held for investment								$	2,084,359
Schedule Of Allowance For Loan Losses
			For the year ended
			December 31,
	(in thousands)		2014			2013
	Allowance for loan losses, beginning of period
	Commercial		$	14,103		$	13,448
	Real estate - mortgage			14,919			17,832
	Construction & land			3,346			9,893
	Consumer			2,471			3,061
	Other			479			451
	Unallocated			1,732			2,181
	Total			37,050			46,866
	Provision
	Commercial		$	2,094		$	233
	Real estate - mortgage			-2,839			-957
	Construction & land			-2,499			-7,150
	Consumer			257			-513
	Other			9			32
	Unallocated			-1,177			-449
	Total			-4,155			-8,804
	Charge-offs
	Commercial		$	-1,956		$	-613
	Real estate - mortgage			-52			-3,055
	Construction & land			-50			-796
	Consumer			-453			-122
	Other			-6			-5
	Total			-2,517			-4,591
	Recoveries
	Commercial		$	373		$	1,035
	Real estate - mortgage			435			1,099
	Construction & land			1,519			1,399
	Consumer			54			45
	Other			6			1
	Total			2,387			3,579
	Allowance for loan losses, end of period
	Commercial		$	14,614		$	14,103
	Real estate - mortgage			12,463			14,919
	Construction & land			2,316			3,346
	Consumer			2,329			2,471
	Other			488			479
	Unallocated			555			1,732
	Total		$	32,765		$	37,050
Schedule Of Allowance For Loan Losses On The Basis Of Impairment Method
			At December 31, 2014											At December 31, 2013
			Individually											Individually
			evaluated for						Collectively evaluated for					evaluated for				Collectively evaluated for
			impairment						impairment					impairment				impairment
			Loans			Allowance			Loans			Allowance		Loans		Allowance		Loans		Allowance
			held for			loan for			held for			loan for		held for		loan for		held for		loan for
	(in thousands)		investment			losses			investment			losses		investment		losses		investment		losses
	Commercial		$	20,415		$	3,441		$	957,284		$	11,173	$	17,454	$	2,140	$	806,999	$	11,963
	Real estate - mortgage			17,803			281			971,916			12,182		25,501		2,371		875,363		12,548
	Construction & land			4,004			280			177,860			2,036		10,454		932		117,498		2,414
	Consumer			2,506			139			205,449			2,190		807		174		180,249		2,297
	Other			84			6			48,254			482		-		-		50,034		479
	Unallocated			-			-			-			555		-		-		-		1,732
	Total		$	44,812		$	4,147		$	2,360,763		$	28,618	$	54,216	$	5,617	$	2,030,143	$	31,433
Schedule Of Impaired Loans
			At December 31, 2014
									Recorded			Recorded
						Recorded			investment			investment
			Unpaid			investment			with a			with no
			principal			in impaired			related			related		Related
	(in thousands)		balance			loans (1)			allowance			allowance		allowance
	Commercial
	Manufacturing		$	5,169		$	4,887		$	4,833		$	54	$	431
	Finance and insurance			99			99			99			-		53
	Healthcare			140			140			140			-		9
	Real estate services			8,469			8,469			8,469			-		782
	Construction			2,050			2,050			1,961			89		296
	Wholesale and retail trade			3,713			3,091			2,741			350		1,611
	Other			1,989			1,679			1,670			9		259
				21,629			20,415			19,913			502		3,441
	Real estate - mortgage
	Residential & commercial owner-occupied			3,063			3,050			1,183			1,867		117
	Residential & commercial investor			6,210			6,210			4,885			1,325		164
				9,273			9,260			6,068			3,192		281
	Construction & land			4,038			4,004			3,325			679		280
	Consumer			2,506			2,506			494			2,012		139
	Other			84			84			84			-		6
	Total		$	37,530		$	36,269		$	29,884		$	6,385	$	4,147
			At December 31, 2013
									Recorded			Recorded
						Recorded			investment			investment
			Unpaid			investment			with a			with no
			principal			in impaired			related			related		Related
	(in thousands)		balance			loans (1)			allowance			allowance		allowance
	Commercial
	Manufacturing		$	4,887		$	4,859		$	4,797		$	62	$	479
	Finance and insurance			517			517			517			-		106
	Healthcare			236			236			236			-		23
	Real estate services			7,473			7,473			7,473			-		505
	Construction			1,708			1,708			1,613			95		222
	Wholesale and retail trade			294			248			97			151		59
	Other			2,418			2,413			2,215			198		746
				17,533			17,454			16,948			506		2,140
	Real estate - mortgage
	Residential & commercial owner-occupied			6,468			5,967			2,524			3,443		709
	Residential & commercial investor			11,058			10,518			8,357			2,161		1,662
				17,526			16,485			10,881			5,604		2,371
	Construction & land			10,279			8,877			4,557			4,320		932
	Consumer			807			807			807			-		174
	Total		$	46,145		$	43,623		$	33,193		$	10,430	$	5,617
		-1		Recorded investment in impaired loans in this table does not agree to loans individually evaluated for impairment disclosed in the previous table due to certain loans being excluded pursuant to ASC 310-40-50-2.
			For the year ended December 31,
			2014						2013					2012
			Average						Average					Average
			recorded						recorded					recorded
			investment			Interest			investment			Interest		investment		Interest
			in impaired			income			in impaired			income		in impaired		income
	(in thousands)		loans			recognized			loans			recognized		loans		recognized
	Commercial
	Manufacturing		$	4,244		$	299		$	5,027		$	331	$	4,732	$	309
	Finance and insurance			307			13			671			30		817		42
	Healthcare			205			13			263			14		25		2
	Real estate services			6,416			281			8,256			326		7,097		252
	Construction			1,604			158			2,625			251		2,380		107
	Wholesale and retail trade			1,303			184			370			17		631		15
	Other			2,504			165			1,886			134		2,608		89
				16,583			1,113			19,098			1,103		18,290		816
	Real estate - mortgage
Residential & commercial owner-occupied			4,102			176			8,915			162		9,914		44
Residential & commercial investor			7,062			247			12,638			275		10,384		559
			11,164			423			21,553			437		20,298		603
Construction & land			5,957			166			9,042			499		16,047		395
Consumer			1,362			93			1,184			61		972		3
Other			51			1			-			-		-		-
Total		$	35,117		$	1,796		$	50,877		$	2,100	$	55,607	$	1,817
Schedule Of Transactions Related To Troubled Debt Restructurings
	(in thousands)		Performing			Nonperforming			Total
	Beginning balance at December 31, 2013		$	29,683		$	12,010		$	41,693
	New restructurings			12,183			876			13,059
	Change in accrual status			-3,222			3,222			-
	Paydowns			-11,369			-12,328			-23,697
	Charge-offs			-			-865			-865
	Beginning balance at December 31, 2014		$	27,275		$	2,915		$	30,190
Schedule Of Troubled Debt Restructurings
			For the year ended December 31, 2014									For the year ended December 31, 2013
						Pre-modification			Post-modification					Pre-modification		Post-modification
						outstanding			outstanding					outstanding		outstanding
			Number of			recorded			recorded			Number of		recorded		recorded
	($ in thousands)		contracts			investment			investment			contracts		investment		investment
	Commercial
	Manufacturing			3		$	1,611		$	1,318			4	$	791	$	723
	Real estate services			4			1,171			1,024			1		30		55
	Construction			5			2,784			1,478			4		198		153
	Wholesale and retail trade			3			1,297			886			4		1,413		146
	Other			5			795			568			10		2,276		2,054
				20			7,658			5,274			23		4,708		3,131
	Real estate - mortgage
	Residential & commercial owner-occupied			1			29			28			4		3,221		2,580
	Construction & land			1			121			95			1		2,615		2,615
	Consumer			1			93			89			-		-		-
	Other			1			91			84			2		87		84
	Total			24		$	7,992		$	5,570			30	$	10,631	$	8,410
			For the year ended December 31, 2012
						Pre-modification			Post-modification
						outstanding			outstanding
			Number of			recorded			recorded
	($ in thousands)		contracts			investment			investment
	Commercial
	Manufacturing			9		$	6,708		$	5,423
	Finance and insurance			4			1,047			796
	Health care			1			296			288
	Real estate services			1			367			345
	Construction			12			4,734			4,040
	Other			11			2,074			1,963
				38			15,226			12,855
	Real estate - mortgage
	Residential & commercial owner-occupied			4			3,538			2,653
	Residential & commercial investor			1			3,305			3,305
				5			6,843			5,958
	Construction & land			10			8,331			7,469
	Consumer			6			1,504			1,466
	Total			59		$	31,904		$	27,748
Schedule Of Troubled Debt Restructurings That Subsequently Defaulted
			At December 31,
			2014					2013
			Number of		Recorded			Number of		Recorded
	Troubled debt restructurings that subsequently defaulted ($ in thousands)		contracts		investment			contracts		investment
	Commercial
	Construction		-		$	-		1		$	19
			-			-		1			19
	Real estate - mortgage
	Residential & commercial owner-occupied		-			-		1			737
	Other		1			84		-			-
	Total		1		$	84		2		$	756
Schedule Of Nonaccrual Loans
			At December 31,
	(in thousands)		2014			2013
	Commercial
	Manufacturing		$	66		$	79
	Finance and insurance			50			63
	Real estate services			212			-
	Construction			312			201
	Wholesale and retail trade			2,491			206
	Other			186			781
	Total commercial			3,317			1,330
	Real estate - mortgage
	Residential & commercial owner-occupied			2,091			5,020
	Residential & commercial investor			1,325			5,484
	Total real estate - mortgage			3,416			10,504
	Construction & land			135			1,986
	Consumer			2,126			101
	Total nonaccrual loans		$	8,994		$	13,921
Schedule Of Aging Of The Company's Loan Portfolio
			At December 31, 2014
																		Recorded
																		investment
																		in loans
			30 - 59			60 - 89												90 days or more
			Days past			Days past			90+ Days			Total past						past due and
	(in thousands)		due			due			past due			due		Current		Total loans		accruing
	Commercial
	Manufacturing		$	45		$	9		$	-		$	54	$	126,064	$	126,118	$	-
	Finance and insurance			-			-			-			-		81,047		81,047		-
	Health care			193			-			-			193		91,618		91,811		-
	Real estate services			-			-			-			-		112,388		112,388		-
	Construction			-			-			122			122		56,373		56,495		-
	Wholesale and retail trade			247			-			2,095			2,342		69,953		72,295		161
	Other			-			-			9			9		437,465		437,474		-
				485			9			2,226			2,720		974,908		977,628		161
	Real estate - mortgage
	Residential & commercial owner-occupied			-			-			473			473		421,935		422,408		-
	Residential & commercial investor			235			-			-			235		567,771		568,006		-
	Other			-			-			-			-		180		180		-
				235			-			473			708		989,886		990,594		-
	Construction & land			-			-			104			104		182,765		182,869		-
	Consumer			176			253			1,954			2,383		205,538		207,921		-
	Other			-			-			-			-		47,904		47,904		-
	Total loans held for investment		$	896		$	262		$	4,757		$	5,915	$	2,401,001	$	2,406,916	$	161
	Unearned net loan fees																-1,341
	Net loans held for investment															$	2,405,575
			At December 31, 2013
																		Recorded
																		investment
																		in loans
			30 - 59			60 - 89												90 days or more
			Days past			Days past			90+ Days			Total past						past due and
	(in thousands)		due			due			past due			due		Current		Total loans		accruing
	Commercial
	Manufacturing		$	-		$	-		$	-		$	-	$	105,696	$	105,696	$	-
	Finance and insurance			-			-			-			-		77,106		77,106		-
	Health care			259			-			-			259		99,906		100,165		-
	Real estate services			24			-			-			24		100,258		100,282		-
	Construction			-			-			19			19		53,292		53,311		19
	Wholesale and retail trade			-			-			100			100		71,004		71,104		-
	Other			727			324			-			1,051		316,815		317,866		-
				1,010			324			119			1,453		824,077		825,530		19
	Real estate - mortgage
	Residential & commercial owner-occupied			-			-			913			913		452,066		452,979		-
	Residential & commercial investor			-			-			-			-		448,742		448,742		-
	Other			-			-			-			-		-		-		-
				-			-			913			913		900,808		901,721		-
	Construction & land			816			-			1,951			2,767		125,903		128,670		-
	Consumer			-			2			-			2		181,065		181,067		-
	Other			-			-			-			-		49,394		49,394		-
	Total loans held for investment		$	1,826		$	326		$	2,983		$	5,135	$	2,081,247	$	2,086,382	$	19
	Unearned net loan fees																-2,023
	Net loans held for investment															$	2,084,359
Schedule Of Loans And Leases Receivable, Related Parties
	(in thousands)		2014			2013
	Balance - beginning of year		$	29,766		$	8,343
	New loan and advances			19,390			27,667
	Principal paydowns and payoffs			-23,634			-6,244
	Balance - end of year		$	25,522		$	29,766

Premises_And_Equipment_Tables

Premises And Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Premises And Equipment
Schedule Of Premises And Equipment
	(in thousands)	2014		2013
	Land	$	230	$	230
	Buildings		230		230
	Leasehold improvements		10,931		10,342
	Furniture, fixtures, and equipment		33,812		30,937
	Premises and equipment, gross		45,203		41,739
	Accumulated depreciation		-37,953		-35,705
	Premises and equipment, net	$	7,250	$	6,034

Intangible_Assets_Tables

Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Intangible Assets
Schedule of Finite-Lived Intangible Assets
		Customer
		contracts, lists
	(in thousands)	and relationships
	At December 31, 2012	$	3,573
	Disposals and other adjustments		-113
	Amortization		-662
	At December 31, 2013		2,798
	Acquired relationships		325
	Amortization		-597
	At December 31, 2014	$	2,526
Schedule Of Expected Amortization Expense
	(in thousands)
	2015	$	600
	2016		600
	2017		600
	2018		206
	2019		201
	Total	$	2,207

Deposits_Tables

Deposits (Tables)	12 Months Ended
	Dec. 31, 2014
Deposits
Schedule Of Certificates Of Deposit Portfolio
		At December 31,
	(in thousands)	2014		2013
	Less than $100	$	27,202	$	30,972
	$100 and more		183,805		214,345
		$	211,007	$	245,317
Schedule Of Interest Expense Allocated To Certificates Of Deposit
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Less than $100	$	125	$	158	$	220
	$100 and more		892		1,154		1,625
		$	1,017	$	1,312	$	1,845
Schedule Of Certificates Of Deposit, By Contractual Maturity
	(in thousands)	Amount
	Remaining maturity:
	Three months or less	$	75,863
	Over three months through six months		44,993
	Over six months through 12 months		48,985
	Over 12 months		13,964
	Total	$	183,805

Borrowed_Funds_Tables

Borrowed Funds (Tables)	12 Months Ended
	Dec. 31, 2014
Borrowed Funds
Schedule Of Securities Sold Under Agreements to Repurchase
		At December 31,
	(in thousands)	2014		2013
	Securities sold under agreements to repurchase (principally mortgage-backed securities with an estimated fair value of $54,652 and $162,781 in 2014 and 2013, respectively	$	49,976	$	138,494

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Long-Term Debt
Schedule Of Long-term Debt Instruments
		At December 31,
	(in thousands)	2014		2013		Interest rate	Maturity date	Earliest call date
	Junior subordinated debentures:
	CoBiz Statutory Trust I	$	20,619	$	20,619	3-month LIBOR + 2.95%	September 17, 2033	March 17, 2015
	CoBiz Capital Trust II		30,928		30,928	3-month LIBOR + 2.60%	July 23, 2034	January 23, 2015
	CoBiz Capital Trust III		20,619		20,619	3-month LIBOR + 1.45%	September 30, 2035	March 30, 2015
	Total junior subordinated debentures	$	72,166	$	72,166

Derivatives_Tables

Derivatives (Tables)	12 Months Ended
	Dec. 31, 2014
Derivatives
Schedule Of Derivative Instruments In The Statements Of Financial Position
			Asset derivatives								Liability derivatives
					Fair value at December 31,								Fair value at December 31,
			Balance sheet								Balance sheet
	(in thousands)		classification		2014			2013			classification		2014			2013
	Derivatives designated as hedging instruments under ASC 815:
	Cash flow hedge		Other assets		$	437		$	184		Accrued interest and other liabilities		$	5,017		$	4,007
	Fair value hedge		Other assets			297			1,735		Accrued interest and other liabilities			988			-
	Derivatives not designated as hedging instruments under ASC 815:
	Interest rate swap		Other assets		$	4,103		$	6,422		Accrued interest and other liabilities		$	4,284		$	6,409
	Foreign exchange forward contracts		Other assets			54			-		Accrued interest and other liabilities			17			10
Schedule Of Fair Value Of Derivative Financial Instruments And Their Classification On Condensed Consolidated Balance Sheets
			At December 31, 2014
									Net amounts
									included in
			Gross						other assets'
			amounts of			Gross			in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		assets			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges		$	734		$	-		$	734		$	-487		$	-		$	247
	Derivatives not designated as hedges			4,157			-			4,157			-220			-			3,937
	Total		$	4,891		$	-		$	4,891		$	-707		$	-		$	4,184
			At December 31, 2014
			Gross						Net amounts
			amounts of			Gross			included in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		liabilities			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges(1)		$	-6,005		$	-		$	-6,005		$	487		$	5,518		$	-
	Derivatives not designated as hedges(1)			-4,301			-			-4,301			220			3,891			-190
	Securities sold under agreements to repurchase(2)			-49,976			-			-49,976			-			49,976			-
	Total		$	-60,282		$	-		$	-60,282		$	707		$	59,385		$	-190
			At December 31, 2013
									Net amounts
									included in
			Gross						other assets'
			amounts of			Gross			in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		assets			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges		$	1,919		$	-286		$	1,633		$	-		$	-		$	1,633
	Derivatives not designated as hedges			6,422			-366			6,056			-			-			6,056
	Total		$	8,341		$	-652		$	7,689		$	-		$	-		$	7,689
			At December 31, 2013
			Gross						Net amounts
			amounts of			Gross			included in the			Gross amounts not offset
			recognized			amounts			Consolidated			Financial						Net
	(in thousands)		liabilities			offset			Balance Sheets			Instruments			Collateral			Amount
	Derivatives designated as hedges(1)		$	-4,007		$	286		$	-3,721		$	-		$	3,721		$	-
	Derivatives not designated as hedges(1)			-6,419			366			-6,053			-			6,053			-
	Securities sold under agreements to repurchase(2)			-138,494			-			-138,494			-			138,494			-
	Total		$	-148,920		$	652		$	-148,268		$	-		$	148,268		$	-
		-1		Included in accrued interest and other liabilities
		-2		Separately stated in Consolidated Balance Sheets
Schedule Of Notional Amounts Of Outstanding Derivative Positions
	(in thousands)		Notional			Fixed rate		Termination date
	Hedged item - Junior subordinated debentures issued by:
	CoBiz Statutory Trust I		$	20,000		6.04	%	March 17, 2015
	CoBiz Capital Trust II		$	30,000		5.99	%	April 23, 2020
	CoBiz Capital Trust III		$	20,000		5.02	%	March 30, 2024
Summary Of Gains And Losses Recognized In OCI Reclassified From Accumulated OCT Into Earnings
			Cash flow hedge component of AOCI
	(in thousands)		2014			2013			2012
	Beginning of year balance		$	-2,370		$	-5,607		$	-5,275
	Net change			-470			3,237			-332
	End of year balance		$	-2,840		$	-2,370		$	-5,607

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes
Schedule Of Components Of Income Tax Expense (Benefit)
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Current tax provision (benefit):
	Federal tax	$	9,737	$	7,497	$	11,290
	State tax		-109		1,072		1,216
	Total current tax provision		9,628		8,569		12,506
	Deferred tax provision (benefit):
	Federal tax		3,357		3,974		178
	State tax		513		654		-21
	Net operating loss carryforward		1,649		154		595
	Total deferred tax provision		5,519		4,782		752
	Provision for income taxes	$	15,147	$	13,351	$	13,258
	Provision related to discontinued operations	$	-	$	86	$	171
Schedule Of Deferred Tax Assets And Liabilities
		At December 31,
	(in thousands)	2014		2013
	Deferred tax assets:
	Allowance for loan and credit losses	$	12,451	$	14,054
	Intangible assets		1,872		2,151
	Other real estate owned		3,329		3,296
	Deferred loan fees		472		415
	Other accrued liabilities		1,325		2,324
	Stock-based compensation		1,428		1,930
	Interest on nonaccrual loans		577		412
	Employee bonus		2,472		2,175
	State operating loss carryforward		633		1,758
	Other		136		1,657
	Total deferred tax assets	$	24,695	$	30,172
	Deferred tax liabilities:
	Deferred initial direct loan costs	$	-1,538	$	-1,183
	Prepaid assets		-431		-697
	FHLB stock dividends		-63		-113
	Investment securities and derivatives		-2,655		-1,673
	Total deferred tax liabilities	$	-4,687	$	-3,666
	Net deferred tax assets	$	20,008	$	26,506
Schedule Of Effective Income Tax Rate Reconciliation
		For the year ended December 31,
	(in thousands)	2014		2013		2012
	Computed at the statutory rate (35%)	$	15,454	$	14,276	$	13,126
	Increase (decrease) resulting from:
	State income taxes - net of federal income tax effect		1,336		1,373		1,177
	Tax exempt income		-2,838		-1,976		-1,475
	Other - net		1,195		-322		430
	Actual tax provision (benefit)	$	15,147	$	13,351	$	13,258
Summary Of Income Tax Examinations
	Jurisdiction	Tax year
	United States	2011
	Colorado	2010
	Arizona	2010

Shareholders_Equity_Tables

Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Shareholders' Equity
Schedule Of Stock Reserved For Future Issuance
		At December 31,
		2014		2013
	Exercise of outstanding stock options	819,755		1,292,077
	Exercise of outstanding stock warrants	895,968		895,968
	Future granting of option and stock awards	2,508,115		1,096,680
	Future stock purchases through ESPP	273,188		116,637
		4,497,026		3,401,362
Schedule Of Qualified Small Business Lending Dividend Rates
	Relative increase in QSBL to Baseline	Dividend Rate
	Less than 2.5%	5.0	%
	Between 2.5% and 5.0%	4.0	%
	Between 5.0% and 7.5%	3.0	%
	Between 7.5% and 10.0%	2.0	%
	10.0% or more	1.0	%

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) Reclassifications (Tables)	12 Months Ended
	Dec. 31, 2014
Accumulated Other Comprehensive Income (Loss) Reclassifications
Schedule of reclassifications out of accumulated comprehensive income
		Year ended December 31,
	AOCI component	2014		2013		2012		Affected line item in the Consolidated Statement of Income
	Unrealized (gain) loss on AFS securities	$	1,154	$	439	$	782	Net gain (loss) on securities, other assets and OREO
	Tax (expense) benefit		-439		-167		-297	Provision (benefit) for income taxes
			715		272		485
	Cash flow hedges on loans		905		90		-	Interest and fees on loans
	Cash flow hedges on debt		-2,215		-2,185		-2,061	Interest expense on subordinated debentures
	Unrealized (gain) loss on derivatives		-1,310		-2,095		-2,061
	Tax (expense) benefit		498		796		783	Provision (benefit) for income taxes
			-812		-1,299		-1,278
	Total reclassifications out of AOCI	$	-97	$	-1,027	$	-793

Earnings_per_Common_Share_Tabl

Earnings per Common Share (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings per Common Share
Schedule Of Weighted Average Shares Outstanding Used In Calculation Of Basic And Diluted Loss Per Share
			Year ended December 31,
	(in thousands, except share amounts)		2014		2013		2012
	Net income from continuing operations		$	29,007	$	27,438	$	24,246
	Net income from discontinued operations			-		173		324
	Net income			29,007		27,611		24,570
	Preferred stock dividends			-574		-944		-2,815
	Net income available to common shareholders			28,433		26,667		21,755
	Dividends and undistributed earnings allocated to participating securities			-434		-457		-335
	Earnings allocated to common shares (1)		$	27,999	$	26,210	$	21,420
	Weighted average common shares - issued			40,616,022		40,193,315		39,170,218
	Average unvested restricted share awards			-609,276		-724,821		-613,710
	Weighted average common shares outstanding - basic			40,006,746		39,468,494		38,556,508
	Effect of dilutive stock options and awards outstanding			205,847		160,862		45,878
	Weighted average common shares outstanding - diluted			40,212,593		39,629,356		38,602,386
	Weighted average antidilutive common shares outstanding (2)			676,248		1,530,263		2,785,855
	Earnings per common share are as follows:
	Basic - from continuing operations		$	0.70	$	0.66	$	0.54
	Diluted - from continuing operations		$	0.70	$	0.66	$	0.54
	Basic - from discontinued operations		$	0.00	$	0.00	$	0.01
	Diluted - from discontinued operations		$	0.00	$	0.00	$	0.01
	Basic		$	0.70	$	0.66	$	0.55
	Diluted		$	0.70	$	0.66	$	0.55
		-1		Earnings allocated to common shareholders for basic EPS under the two-class method may differ from earnings allocated for diluted EPS when use of the treasury method results in greater dilution than the two-class method.
	Antidilutive shares excluded from the diluted earnings per share computation

Employee_Benefit_And_Stock_Com1

Employee Benefit And Stock Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2014
Employee Benefit And Stock Compensation Plans
Schedule Of Stock Option Valuation Assumptions
		2014						2013						2012
				Range						Range						Range
		Weighted						Weighted						Weighted
		average		Low		High		average		Low		High		average		Low		High
	Risk-free interest rate	1.38	%	0.79	%	1.82	%	0.96	%	0.41	%	1.80	%	0.62	%	0.34	%	0.95	%
	Expected dividend yield	1.27	%	1.05	%	1.49	%	1.42	%	1.23	%	1.67	%	1.12	%	0.65	%	1.32	%
	Expected volatility	40.34	%	29.38	%	52.50	%	49.80	%	39.49	%	65.77	%	61.70	%	45.52	%	71.27	%
	Expected life (years)	3.9						4.1						4.0
Summary Of Changes In Stock Option Awards
		2014
				Weighted average
	Stock Option Awards	Shares		exercise price
	Outstanding - beginning of year	1,292,077		$	11.82
	Granted	92,917			11.35
	Exercised	-154,091			7.25
	Forfeited	-411,148			17.73
	Outstanding - end of year	819,755		$	9.66
	Exercisable - end of year	649,264		$	9.59
Summary Of Changes In Stock Awards
		2014
				Weighted average
				grant date
	Restricted Stock Awards	Shares		fair value
	Unvested - beginning of year	681,578		$	7.04
	Granted	319,466			11.33
	Vested	-343,162			7.24
	Forfeited	-22,284			8.22
	Unvested - end of year	635,598		$	9.05
	Total fair value of vested shares (in thousands)			$	3,874
Schedule Of Stock Options Outstanding By Exercise Price Range
		Options outstanding							Options exercisable
				Weighted			Weighted				Weighted
				average			average				average
		Number		exercise			remaining		Number		exercise
	Range of exercise price	outstanding		price			life (years)		exercisable		price
	$4.49  -  $6.62	176,433		$	6.22		2.0		168,601		$	6.21
	$6.68  -  $7.54	178,935			7.35		2.7		171,602			7.38
	$7.57  -  $11.00	166,261			9.43		5.4		64,685			9.39
	$11.03  -  $12.39	229,476			12.08		2.3		175,726			12.17
	$13.73  -  $20.75	68,650			16.95		0.3		68,650			16.95
		819,755		$	9.66		2.8		649,264		$	9.59
Schedule Of Employee Stock Purchase Plan Activity
		For the year ended December 31,
		2014		2013		2012
	Available ESPP shares - beginning of year	116,637		163,933		229,833
	Plan amendment increasing available shares	200,000		-		-
	Purchases	-43,449		-47,296		-65,900
	Available ESPP shares - end of year	273,188		116,637		163,933

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies
Schedule Of Lease Commitments
	Year ending December 31,
	(in thousands)	Amount
	2015	$	5,547
	2016		4,435
	2017		3,631
	2018		3,259
	2019		1,771
	Thereafter		1,896
	Total	$	20,539
Schedule Of Financial Instruments With Off-Balance Sheet Risk
		At December 31,
	(in thousands)	2014		2013
	Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers	$	793,208	$	659,592
	Commitments to originate consumer loans - personal lines of credit and equity lines	$	32,072	$	31,174
	Overdraft protection plans	$	15,322	$	15,359
	Letters of credit	$	37,851	$	46,130
	Unfunded commitments for unconsolidated investments	$	7,356	$	6,607
	Company guarantees	$	2,160	$	1,756

Regulatory_Matters_Tables

Regulatory Matters (Tables)	12 Months Ended
	Dec. 31, 2014
Regulatory Matters
Schedule Of Regulatory Capital Amounts And Ratios Of The Company And The Bank
	At December 31, 2014
	(in thousands)	Company			Bank
	Shareholders' equity	$	308,769		$	323,266
	Disallowed intangible assets		-2,526			-
	Unrealized gain on available for sale securities		-7,168			-7,168
	Unrealized loss on cash flow hedges		2,840			-230
	Subordinated debentures		70,000			-
	Other deductions		-8			-
	Tier 1 regulatory capital	$	371,907		$	315,868
	Allowance for loan losses	$	32,250		$	31,878
	Total risk-based regulatory capital	$	404,157		$	347,746
		Company									Bank
	At December 31, 2014	Risk-based						Leverage			Risk-based						Leverage
	(in thousands)	Tier 1			Total capital			Tier 1			Tier 1			Total capital			Tier 1
	Regulatory capital	$	371,907		$	404,157		$	371,907		$	315,868		$	347,746		$	315,868
	Well-capitalized requirement		154,767			257,946			149,380			152,987			254,978			147,834
	Regulatory capital - excess	$	217,140		$	146,211		$	222,527		$	162,881		$	92,768		$	168,034
	Capital ratios		14.4	%		15.7	%		12.4	%		12.4	%		13.6	%		10.7	%
	Minimum capital requirement		4.0	%		8.0	%		4.0	%		4.0	%		8.0	%		4.0	%
	Well-capitalized requirement (1)		6.0	%		10.0	%		5.0	%		6.0	%		10.0	%		5.0	%
	At December 31, 2013
	(in thousands)	Company			Bank
	Shareholders' equity	$	281,085		$	294,157
	Disallowed intangible assets		-2,798			-
	Unrealized gain on available for sale securities		-5,100			-5,100
	Unrealized loss on cash flow hedges		2,370			46
	Subordinated debentures		70,000			-
	Other deductions		-8			-
	Tier 1 regulatory capital	$	345,549		$	289,103
	Allowance for loan losses	$	29,888		$	29,511
	Total risk-based regulatory capital	$	375,437		$	318,614
		Company									Bank
	At December 31, 2013	Risk-based						Leverage			Risk-based						Leverage
	(in thousands)	Tier 1			Total capital			Tier 1			Tier 1			Total capital			Tier 1
	Regulatory capital	$	345,549		$	375,437		$	345,549		$	289,103		$	318,614		$	289,103
	Well-capitalized requirement		142,997			238,329			139,043			141,232			235,387			137,537
	Regulatory capital - excess	$	202,552		$	137,108		$	206,506		$	147,871		$	83,227		$	151,566
	Capital ratios		14.5	%		15.7	%		12.4	%		12.3	%		13.5	%		10.5	%
	Minimum capital requirement		4.0	%		8.0	%		4.0	%		4.0	%		8.0	%		4.0	%
	Well-capitalized requirement (1)		6.0	%		10.0	%		5.0	%		6.0	%		10.0	%		5.0	%
	The ratios for the well-capitalized requirement are only applicable to the Bank.  However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company

Fair_Value_Measurements_Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Measurements
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
			Balance at		identical assets			inputs		inputs
	(in thousands)		December 31, 2014		(Level 1)			(Level 2)		(Level 3)
	Assets
	Available for sale securities:
	Mortgage-backed securities		$	283,504	$	-		$	283,504	$	-
	Trust preferred securities			59,655		21,737			31,164		6,754
	Corporate debt securities			101,210		-			101,210		-
	Municipal securities			15,446		-			15,446		-
	Total available for sale securities		$	459,815	$	21,737		$	431,324	$	6,754
	Derivatives:
	Cash flow hedge		$	437	$	-		$	437	$	-
	Fair value hedge			297		-			297		-
	Non-designated hedges			4,103		-			4,103		-
	Foreign exchange forward contracts			54		-			54		-
	Total derivative assets		$	4,891	$	-		$	4,891	$	-
	Liabilities
	Derivatives:
	Cash flow hedge		$	5,017	$	-		$	5,017	$	-
	Fair value hedge			988		-			988		-
	Non-designated hedges			4,284		-			4,284		-
	Foreign exchange forward contracts			17		-			17		-
	Total derivative liabilities		$	10,306	$	-		$	10,306	$	-
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
			Balance at		identical assets			inputs		inputs
	(in thousands)		December 31, 2013		(Level 1)			(Level 2)		(Level 3)
	Assets
	Available for sale securities:
	Mortgage-backed securities		$	333,211	$	-		$	333,211	$	-
	Trust preferred securities			82,324		46,252			30,036		6,036
	Corporate debt securities			110,982		-			110,982		-
	Municipal securities			8,616		-			8,616		-
	Total available for sale securities		$	535,133	$	46,252		$	482,845	$	6,036
	Derivatives:
	Cash flow hedge		$	184	$	-		$	184	$	-
	Fair value hedge			1,735		-			1,735		-
	Non-designated hedges			6,422		-			6,422		-
	Total derivative assets		$	8,341	$	-		$	8,341	$	-
	Liabilities
	Derivatives:
	Cash flow hedge		$	4,007	$	-		$	4,007	$	-
	Fair value hedge			6,409		-			6,409		-
	Non-designated hedges			10		-			10		-
	Total derivative liabilities		$	10,426	$	-		$	10,426	$	-
Financial Assets Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs
			For the year ended December 31,
	(in thousands)		2014		2013
	Beginning balance		$	6,036	$	980
	Transfers and purchases			706		5,119
	Net accretion			58		13
	Unrealized loss included in comprehensive income			-46		-76
	Ending balance		$	6,754	$	6,036
Schedule Of Financial Assets Measured At Fair Value On A Nonrecurring Basis
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
					identical assets			inputs		inputs
	(in thousands)		Total		(Level 1)			(Level 2)		(Level 3)
	Impaired loans, net of specific reserve:
	At December 31, 2014		$	15,734	$	-		$	-	$	15,734
	At December 31, 2013		$	22,187	$	-		$	-	$	22,187
Schedule Of Nonfinancial Assets Measured At Fair Value On A Nonrecurring Basis
					Fair value measurements using:
					Quoted prices in			Significant other		Significant
					active markets for			observable		unobservable
					identical assets			inputs		inputs		Year to date
	(in thousands)		Total		(Level 1)			(Level 2)		(Level 3)		gain (loss)
	OREO:
	At December 31, 2014		$	6,132	$	-		$	-	$	6,132	$	1,459
	At December 31, 2013		$	5,371	$	-		$	-	$	5,371	$	-708
Summary Of Other Real Estate Owned Transactions
			At December 31,
	(in thousands)		2014		2013
	OREO recorded at fair value		$	6,132	$	5,371
	Estimated selling costs			-313		-274
	OREO		$	5,819	$	5,097
Reconciliation Of Other Real Estate Owned Fair Value Measurement
	(in thousands)		2014		2013
	Beginning OREO balance		$	5,097	$	10,577
	Additions			4,992		449
	Sales			-5,305		-5,221
	Net loss on sale and valuation adjustments			1,035		-708
	Ending OREO balance		$	5,819	$	5,097
Fair Value Measurements, Recurring And Nonrecurring, Valuation Techniques
			Fair Value						Weighted
	Category		(in thousands)		Valuation Technique		Unobservable Input		Average	Range
	Trust preferred securities		$	6,754	Market approach		Discount to carrying value using broker quotes or observable prices on similar securities		14%	0% to 18%
	Impaired loans
	Commercial		$	1,150	Market approach		Management discount for asset type		41%	77% to 6%
	Real estate - mortgage			9,486	Income approach		Capitalization and/or discount rate		9%	9% to 10%
	Real estate - mortgage			2,407	Sales comparison	(1)	Sales comparison adjustments		4%	-9% to 14%
	Construction & land			679	Sales comparison	(1)	Sales comparison adjustments		3%	-24% to 5%
	Consumer			2,012	Sales comparison	(1)	Sales comparison adjustments		7%	5% to 14%
	Total		$	15,734
	OREO
	Commercial		$	455	Property appraisals		Management discount for property type and recent market volatility		19%	0% to 30%
	Land acquisition & development			5,677	Property appraisals		Management discount for property type and recent market volatility		19%	17% to 50%
	Total		$	6,132
		-1		The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals.  The majority of the appraisals utilize a single valuation approach or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving identical or comparable properties are used to determine fair value.  Appraisals may include an ‘as is’ sales comparison approach and an ‘upon completion’ valuation approach.  Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data.  Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values.  Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal.  Positive adjustments disclosed in this table represent increases to the sales comparison and negative adjustment represent decreases.
Schedule Of Estimated Fair Value Of Other Financial Instruments
			December 31, 2014					December 31, 2013
			Carrying		Estimated			Carrying		Estimated
	(in thousands)		value		fair value			value		fair value
	Financial assets:
	Cash and cash equivalents		$	91,565	$	91,565		$	76,028	$	76,028
	Investment securities available for sale			459,815		459,815			535,133		535,133
	Investment securities held to maturity			13,329		13,616			13,266		12,715
	Other investments			11,477		11,477			8,397		8,397
	Loans — net			2,372,810		2,371,756			2,047,309		2,045,447
	Accrued interest receivable			9,617		9,617			8,770		8,770
	Derivatives			4,891		4,891			8,341		8,341
	Financial liabilities:
	Deposits		$	2,492,291	$	2,492,340		$	2,279,037	$	2,279,996
	Securities sold under agreements to repurchase			49,976		49,991			138,494		138,312
	Short-term borrowings			112,469		112,469			-		-
	Accrued interest payable			813		813			679		679
	Junior subordinated debentures			72,166		72,166			72,166		72,166
	Derivatives			10,306		10,306			10,426		10,426

Segments_Tables

Segments (Tables)	12 Months Ended
	Dec. 31, 2014
Segments
Summary Of Operating And Selected Financial Information By Operating Segment
		For the year ended December 31, 2014
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	113,888	$	6	$	423	$	114,317
	Total interest expense		4,394		41		3,994		8,429
	Provision for loan losses		-3,346		-		-809		-4,155
	Noninterest income		9,940		21,052		1,083		32,075
	Noninterest expense		35,602		18,968		43,394		97,964
	Management fees and allocations		23,988		1,115		-25,103		-
	Provision (benefit) for income taxes		30,926		819		-16,598		15,147
	Net income (loss)	$	32,264	$	115	$	-3,372	$	29,007
	Depreciation and amortization		2,316		949		21		3,286
	Identifiable assets at December 31, 2014	$	3,025,107	$	14,979	$	22,080	$	3,062,166
		For the year ended December 31, 2013
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	105,719	$	11	$	397	$	106,127
	Total interest expense		5,195		61		5,170		10,426
	Provision for loan losses		-7,330		-		-1,474		-8,804
	Noninterest income		11,907		18,578		427		30,912
	Noninterest expense		35,265		18,224		41,139		94,628
	Management fees and allocations		22,313		959		-23,272		-
	Provision (benefit) for income taxes		30,049		211		-16,909		13,351
	Net income (loss) from continuing operations		32,134		-866		-3,830		27,438
	Income from discontinued operations, net of tax		-		173		-		173
	Net income (loss)	$	32,134	$	-693	$	-3,830	$	27,611
	Depreciation and amortization		2,564		1,074		32		3,670
	Identifiable assets at December 31, 2013	$	2,764,609	$	15,403	$	20,679	$	2,800,691
		For the year ended December 31, 2012
						Corporate
		Commercial		Fee-Based		Support and
	(in thousands)	Banking		Lines		Other		Consolidated
	Income Statement
	Total interest income	$	105,757	$	10	$	361	$	106,128
	Total interest expense		6,886		41		5,823		12,750
	Provision for loan losses		-3,546		-		-1,187		-4,733
	Noninterest income		12,646		17,716		197		30,559
	Noninterest expense		32,964		18,508		39,694		91,166
	Management fees and allocations		20,605		1,179		-21,784		-
	Provision (benefit) for income taxes		30,284		-331		-16,695		13,258
	Net income (loss) from continuing operations		31,210		-1,671		-5,293		24,246
	Income from discontinued operations, net of tax		-		324		-		324
	Net income (loss)	$	31,210	$	-1,347	$	-5,293	$	24,570
	Depreciation and amortization		2,649		1,321		34		4,004
	Identifiable assets at December 31, 2012	$	2,611,788	$	18,517	$	23,336	$	2,653,641

Condensed_Financial_Statements1

Condensed Financial Statements Of Parent Company (Tables)	12 Months Ended
	Dec. 31, 2014
Condensed Financial Statements Of Parent Company
Condensed Balance Sheets
	Condensed Balance Sheets	At December 31,
	(in thousands)	2014		2013
	Assets:
	Cash on deposit at subsidiary bank	$	24,495	$	24,742
	Investment in bank subsidiary		323,266		294,157
	Investment in non-bank subsidiaries		29,878		27,846
	Accounts receivable from bank subsidiary		498		172
	Accounts receivable from non-bank subsidiaries		1,218		8,893
	Other		17,291		16,539
	Total assets	$	396,646	$	372,349
	Liabilities and shareholders' equity:
	Liabilities:
	Accounts payable to bank subsidiary	$	6,718	$	8,237
	Accounts payable to non-bank subsidiaries		7,337		5,817
	Junior subordinated debentures		72,166		72,166
	Other liabilities		1,656		5,044
	Total liabilities		87,877		91,264
	Shareholders' equity		308,769		281,085
	Total liabilities and shareholders' equity	$	396,646	$	372,349
Condensed Statements Of Operations
	Condensed Statements of Income	For the years ended December 31,
	(in thousands)	2014		2013		2012
	Income:
	Management fees	$	4,397	$	4,457	$	3,861
	Dividends from bank subsidiary		8,116		8,000		-
	Dividends from non-bank subsidiaries		1,898		6,123		3,704
	Interest income		181		243		272
	Other income		1,102		445		342
	Total income		15,694		19,268		8,179
	Expenses:
	Salaries and employee benefits		4,408		4,255		4,715
	Interest expense		4,122		5,360		6,041
	Other expense		2,203		2,441		2,344
	Total expenses		10,733		12,056		13,100
	Loss before income taxes		4,961		7,212		-4,921
	Benefit for income taxes		-1,402		-2,748		-3,333
	Net loss before equity in undistributed
	earnings of subsidiaries		6,363		9,960		-1,588
	Equity in undistributed earnings of subsidiaries		22,644		17,651		26,158
	Net income	$	29,007	$	27,611	$	24,570
Condensed Statements Of Cash Flows
	Condensed Statements of Cash Flows	For the years ended December 31,
	(in thousands)	2014		2013		2012
	Cash flows from operating activities:
	Net income	$	29,007	$	27,611	$	24,570
	Equity in undistributed earnings of subsidiaries		-22,644		-17,651		-26,158
	Stock-based compensation		584		487		335
	Change in other assets and liabilities		2,205		8,195		1,340
	Net cash provided by operating activities		9,152		18,642		87
	Cash flows from investing activities:
	Net advances (to) from subsidiaries		-3,372		-878		548
	Other		-31		-18		-25
	Net cash provided by (used in) investing activities		-3,403		-896		523
	Cash flows from financing activities:
	Proceeds from issuance of common stock, net		1,570		1,960		12,582
	Taxes paid in net settlement of restricted stock		-1,045		-297		-
	Redemption of subordinated notes payable		-		-20,984		-
	Dividends paid on common stock		-6,076		-4,820		-2,747
	Dividends paid on preferred stock		-574		-1,465		-2,868
	Other		129		5		-
	Net cash provided by (used in) financing activities		-5,996		-25,601		6,967
	Net increase (decrease) in cash and cash equivalents		-247		-7,855		7,577
	Cash and cash equivalents - beginning of year		24,742		32,597		25,020
	Cash and cash equivalents - end of year	$	24,495	$	24,742	$	32,597

Supplemental_Financial_Data_Ta

Supplemental Financial Data (Tables)	12 Months Ended
	Dec. 31, 2014
Supplemental Financial Data
Schedule Of Other Income And Other Expense
	Other noninterest income	Year ended December 31,
	(in thousands)	2014		2013		2012
	Loan Fees	$	1,751	$	1,950	$	1,325
	Other customer service fees		2,170		1,620		1,415
	Bank-owned life insurance earnings		1,594		1,295		1,286
	Private equity investment income		-56		897		2,240
	Interest rate swap fees		-106		1,201		1,490
	Other income		72		56		184
	Total	$	5,425	$	7,019	$	7,940
	Other noninterest expense	Year ended December 31,
	(in thousands)	2014		2013		2012
	Marketing and business development	$	3,090	$	2,810	$	2,425
	Service contracts		4,027		3,569		2,295
	Professional fees		2,475		2,337		1,991
	Office supplies and delivery		1,550		1,541		1,559
	Charitable donations		714		993		826
	Other expense		2,868		1,826		3,470
	Total	$	14,724	$	13,076	$	12,566

Selected_Quarterly_Financial_D1

Selected Quarterly Financial Data (Tables)	12 Months Ended
	Dec. 31, 2014
Selected Quarterly Financial Data
Schedule Of Quarterly Financial Information
			2014								2013
	(in thousands)		Q4		Q3		Q2		Q1		Q4		Q3		Q2		Q1
	Interest income		$	29,611	$	29,205	$	28,510	$	26,991	$	26,954	$	26,961	$	26,160	$	26,052
	Interest expense			2,043		2,143		2,157		2,086		2,178		2,586		2,795		2,867
	Net interest income			27,568		27,062		26,353		24,905		24,776		24,375		23,365		23,185
	Income before income taxes			10,522		12,206		13,099		8,327		10,984		9,874		11,261		8,670
	Net income from continuing operations			6,982		7,891		8,617		5,517		7,275		7,025		7,262		5,876
	Income from discontinued operations, net of tax			-		-		-		-		-		-		-		173
	Net income			6,982		7,891		8,617		5,517		7,275		7,025		7,262		6,049
	Basic earnings per share(1)		$	0.17	$	0.19	$	0.21	$	0.13	$	0.18	$	0.17	$	0.18	$	0.14
	Diluted earnings per share(1)		$	0.17	$	0.19	$	0.21	$	0.13	$	0.18	$	0.17	$	0.18	$	0.14
		-1		Due to rounding, the sum of the quarterly earnings per share amounts may not equal earnings per share for the year as disclosed elsewhere in this report.

Nature_Of_Operations_and_Signi3

Nature Of Operations and Significant Accounting Policies - Organization - (Details)	3 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2014
	product	location
Organization
Business lines exited	2
Denver, Colorado
Organization
Number of branches		9
Boulder, Colorado
Organization
Number of branches		1
Vail, Colorado
Organization
Number of branches		1
Colorado Springs, Colorado
Organization
Number of branches		1
Fort Collins, Colorado
Organization
Number of branches		1
Phoenix, Arizona
Organization
Number of branches		6

Nature_Of_Operations_and_Signi4

Nature Of Operations and Significant Accounting Policies - Schedule of Cash Flow, Supplemental Disclosures - (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Supplemental disclosure of certain cash and cash equivalents
Interest	$8,295,000	$10,409,000	$12,823,000
Income taxes	11,061,000	11,197,000	4,975,000
Loans transferred to held for sale	7,087,000	8,044,000	6,201,000
Loans transferred to OREO and repossessed assets	2,660,000	449,000	421,000
Financed sales of OREO and loans held for sale		2,000,000	249,000
Deferred gain on sale of wealth transfer business			285,000
Cash and Cash Equivalents
Supplemental disclosure of certain cash and cash equivalents
Regulatory reserve requirement, balance	$13,400,000	$0

Nature_Of_Operations_and_Signi5

Nature Of Operations and Significant Accounting Policies - Other Disclosures (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Restricted cash
Restricted cash	$0	$0
Investments
Trading Securities	0
Minimum
Intangible Assets
Finite-lived intangible asset, useful life	10 years
Premises and Equipment
Useful life	3 years
Maximum
Intangible Assets
Finite-lived intangible asset, useful life	15 years
Premises and Equipment
Useful life	5 years
The Funds
Other Assets
Income (loss) from the Funds	($100,000)	$900,000	$2,200,000

Nature_Of_Operations_and_Signi6

Nature Of Operations and Significant Accounting Policies - Repossessed Assets and OREO (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Repossessed Assets
Repossessed assets	$0	$0
Other Real Estate Owned (OREO)
Beginning balance	8,674,000	8,055,000	7,668,000
Additions	398,000	2,185,000	1,872,000
Deductions due to sales	-312,000	-1,566,000	-1,485,000
Ending balance	$8,760,000	$8,674,000	$8,055,000

Discontinued_Operations_Narrat

Discontinued Operations (Narrative) (Details) (Wealth Transfer, USD $)	Dec. 31, 2012
In Millions, unless otherwise specified
Discontinued Operations
Carrying value of discontinued operations	$0.20
Contingent consideration	0.3
Maximum
Discontinued Operations
Contingent consideration	$0.60

Discontinued_Operations_Schedu

Discontinued Operations (Schedule Of Discontinued Operations) (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Discontinued Operations
Noninterest income		$333	$6,448
Noninterest income		74	5,953
Income (loss) before income taxes		259	495
Provision for income taxes		86	171
Net income from discontinued operations	$173	$173	$324

Investments_Reconciliation_Fro

Investments (Reconciliation From Amortized Cost To Fair Value Of Investment Securities) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Available for sale securities (AFS):
Amortized cost	$448,253	$526,908
Gross unrealized gains	12,645	11,813
Gross unrealized losses	1,083	3,588
Fair value	459,815	535,133
Held to maturity securities (HTM):
Amortized cost	13,329	13,266
Gross unrealized gains	298	6
Gross unrealized losses	11	557
Fair value	13,616	12,715
Mortgage-backed securities
Available for sale securities (AFS):
Amortized cost	275,855	326,555
Gross unrealized gains	8,052	7,467
Gross unrealized losses	403	811
Fair value	283,504	333,211
Held to maturity securities (HTM):
Amortized cost	140	175
Gross unrealized gains	4	6
Fair value	144	181
Trust preferred securities
Available for sale securities (AFS):
Amortized cost	57,974	82,768
Gross unrealized gains	2,127	1,250
Gross unrealized losses	446	1,694
Fair value	59,655	82,324
Held to maturity securities (HTM):
Amortized cost	13,189	13,091
Gross unrealized gains	294
Gross unrealized losses	11	557
Fair value	13,472	12,534
Corporate debt securities
Available for sale securities (AFS):
Amortized cost	99,249	108,862
Gross unrealized gains	2,186	3,088
Gross unrealized losses	225	968
Fair value	101,210	110,982
Municipal securities
Available for sale securities (AFS):
Amortized cost	15,175	8,723
Gross unrealized gains	280	8
Gross unrealized losses	9	115
Fair value	$15,446	$8,616

Investments_Schedule_Of_Procee

Investments (Schedule Of Proceeds and Gains (Losses) From Securities Sold Or Called) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Investments
Proceeds	$11,590		$9,598
Gains	1,242	552	1,651
Losses	($88)	($113)	($572)

Investments_Schedule_Of_Amorti

Investments (Schedule Of Amortized Cost And Estimated Fair Value Of Investment Securities By Contractual Maturities) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Available-for-sale, Amortized cost
Available for sale securities, Amortized cost, Due in one year or less	$24,240
Available for sale securities, Amortized cost, Due after one year through five years	61,244
Available for sale securities, Amortized cost, Due after five years through ten years	28,378
Available for sale securities, Amortized cost, Due after ten years	58,536
Available for sale securities, Amortized cost, Mortgage-backed securities	275,855
Available for sale securities, Amortized cost, Amortized cost	448,253
Available-for-sale, Fair value
Available for sale securities, Estimated fair value, Due in one year or less	24,458
Available for sale securities, Estimated fair value, Due after one year through five years	62,834
Available for sale securities, Estimated fair value, Due after five years through ten years	28,778
Available for sale securities, Estimated fair value, Due after ten years	60,241
Available for sale securities, Estimated fair value, Mortgage-backed securities	283,504
Fair value	459,815	535,133
Held-to-maturity, Amortized cost
Held to maturity securities, Amortized cost, Due after ten years	13,189
Held to maturity securities, Amortized cost, Mortgage-backed securities	140
Held-to-maturity Securities, Total	13,329	13,266
Held-to-maturity, Fair value
Held to maturity securities, Estimated fair value, Due after ten years	13,472
Held to maturity securities, Estimated fair value, Mortgage-backed securities	144
Fair value	$13,616	$12,715

Investments_Narrative_Details

Investments (Narrative) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	security	security
Investments
Investment securities pledged to secure public deposits	$171.10	$138.80
Public deposits	$122.30	$106.40
Securities in unrealized loss position	24	44

Investments_Schedule_Of_Securi

Investments (Schedule Of Securities Related To Unrecognized OTTI) (Details) (USD $)	12 Months Ended			24 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2014
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	$33,503	$130,839		$33,503
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	37,539	6,873		37,539
Available for sale securities in continuous unrealized loss position, Fair Value	71,042	137,712		71,042
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	186	3,463
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	897	125
Available for sale securities in continuous unrealized loss position, Unrealized loss	1,083	3,588
Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	845	12,534		845
Held-to-maturity Securities, Continuous Unrealized Loss Position, Fair Value, Total	845	12,534		845
Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss	11	557
Held-to-maturity Securities, Continuous Unrealized Loss Position, Aggregate Loss, Total	11	557
Credit component of OTTI recognized in earnings			300
Mortgage-backed securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	9,699	52,509		9,699
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	26,470			26,470
Available for sale securities in continuous unrealized loss position, Fair Value	36,169	52,509		36,169
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	12	811
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	391
Available for sale securities in continuous unrealized loss position, Unrealized loss	403	811
Trust preferred securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	17,175	49,934		17,175
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	6,145	1,903		6,145
Available for sale securities in continuous unrealized loss position, Fair Value	23,320	51,837		23,320
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	48	1,599
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	398	95
Available for sale securities in continuous unrealized loss position, Unrealized loss	446	1,694
Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value	845	12,534		845
Held-to-maturity Securities, Continuous Unrealized Loss Position, Fair Value, Total	845	12,534		845
Held-to-maturity Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Loss	11	557
Held-to-maturity Securities, Continuous Unrealized Loss Position, Aggregate Loss, Total	11	557
Corporate debt securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	5,856	20,609		5,856
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	4,924	4,970		4,924
Available for sale securities in continuous unrealized loss position, Fair Value	10,780	25,579		10,780
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	117	938
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	108	30
Available for sale securities in continuous unrealized loss position, Unrealized loss	225	968
Municipal securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	773	7,787		773
Available for sale securities in continuous unrealized loss position, Fair Value	773	7,787		773
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	9	115
Available for sale securities in continuous unrealized loss position, Unrealized loss	9	115
Debt securities
Securities in Continuous Unrealized Loss Positions
Credit component of OTTI recognized in earnings				$0

Investments_Schedule_Of_Other_

Investments (Schedule Of Other Investments) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Investments
Bank stocks - at cost	$9,305	$6,225
Investment in statutory trusts - equity method	2,172	2,172
Total	$11,477	$8,397

Loans_Schedule_Of_Loan_Portfol

Loans (Schedule Of Loan Portfolio Segments) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Loan portfolio segments
Total loans held for investment	$2,406,916	$2,086,382
Allowance for loan losses	-32,765	-37,050	-46,866
Unearned net loan fees	-1,341	-2,023
Total net loans	2,372,810	2,047,309
Commercial
Loan portfolio segments
Total loans held for investment	977,628	825,530
Allowance for loan losses	-14,614	-14,103	-13,448
Real estate - mortgage
Loan portfolio segments
Total loans held for investment	990,594	901,721
Allowance for loan losses	-12,463	-14,919	-17,832
Construction and land
Loan portfolio segments
Total loans held for investment	182,869	128,670
Allowance for loan losses	-2,316	-3,346	-9,893
Consumer
Loan portfolio segments
Total loans held for investment	207,921	181,067
Allowance for loan losses	-2,329	-2,471	-3,061
Other
Loan portfolio segments
Total loans held for investment	47,904	49,394
Allowance for loan losses	($488)	($479)	($451)

Loans_Acquired_loans_and_recla

Loans (Acquired loans and reclassifications) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
	contract	contract
Loan portfolio segments
Number of loans purchased during the period	9	90
Loans purchased during the period, amount	$58.30	$30.60
Overdraft demand deposits reclassified from deposits to loans	0.9	0.4
Commercial
Loan portfolio segments
Loans purchased during the period, amount	46.6	4.7
Real estate - mortgage
Loan portfolio segments
Loans purchased during the period, amount	11.7	3.3
Construction and land
Loan portfolio segments
Loans purchased during the period, amount		9.6
Other
Loan portfolio segments
Loans purchased during the period, amount		$13

Loans_Schedule_Of_Major_Portfo

Loans (Schedule Of Major Portfolio Segment and Non-Classified and Classified Loan Class) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Loan portfolio segments
Total loans held for investment	$2,406,916	$2,086,382
Unearned net loan fees	-1,341	-2,023
Total loans	2,405,575	2,084,359
Non-classified
Loan portfolio segments
Total loans held for investment	2,369,976	2,039,906
Classified
Loan portfolio segments
Total loans held for investment	36,940	46,476
Commercial
Loan portfolio segments
Total loans held for investment	977,628	825,530
Commercial | Non-classified
Loan portfolio segments
Total loans held for investment	961,888	810,565
Commercial | Classified
Loan portfolio segments
Total loans held for investment	15,740	14,965
Commercial | Manufacturing
Loan portfolio segments
Total loans held for investment	126,118	105,696
Commercial | Manufacturing | Non-classified
Loan portfolio segments
Total loans held for investment	121,617	101,114
Commercial | Manufacturing | Classified
Loan portfolio segments
Total loans held for investment	4,501	4,582
Commercial | Finance and insurance
Loan portfolio segments
Total loans held for investment	81,047	77,106
Commercial | Finance and insurance | Non-classified
Loan portfolio segments
Total loans held for investment	80,948	76,589
Commercial | Finance and insurance | Classified
Loan portfolio segments
Total loans held for investment	99	517
Commercial | Health care
Loan portfolio segments
Total loans held for investment	91,811	100,165
Commercial | Health care | Non-classified
Loan portfolio segments
Total loans held for investment	91,631	99,526
Commercial | Health care | Classified
Loan portfolio segments
Total loans held for investment	180	639
Commercial | Real estate services
Loan portfolio segments
Total loans held for investment	112,388	100,282
Commercial | Real estate services | Non-classified
Loan portfolio segments
Total loans held for investment	110,031	98,691
Commercial | Real estate services | Classified
Loan portfolio segments
Total loans held for investment	2,357	1,591
Commercial | Construction
Loan portfolio segments
Total loans held for investment	56,495	53,311
Commercial | Construction | Non-classified
Loan portfolio segments
Total loans held for investment	53,513	51,616
Commercial | Construction | Classified
Loan portfolio segments
Total loans held for investment	2,982	1,695
Commercial | Wholesale and retail trade
Loan portfolio segments
Total loans held for investment	72,295	71,104
Commercial | Wholesale and retail trade | Non-classified
Loan portfolio segments
Total loans held for investment	68,811	69,167
Commercial | Wholesale and retail trade | Classified
Loan portfolio segments
Total loans held for investment	3,484	1,937
Commercial | Commercial - Other
Loan portfolio segments
Total loans held for investment	437,474	317,866
Commercial | Commercial - Other | Non-classified
Loan portfolio segments
Total loans held for investment	435,337	313,862
Commercial | Commercial - Other | Classified
Loan portfolio segments
Total loans held for investment	2,137	4,004
Real estate - mortgage
Loan portfolio segments
Total loans held for investment	990,594	901,721
Real estate - mortgage | Residential and commercial investor
Loan portfolio segments
Total loans held for investment	568,006	448,742
Real estate - mortgage | Residential and commercial owner-occupied
Loan portfolio segments
Total loans held for investment	422,408	452,979
Real estate - mortgage | Real estate - mortgage - Other
Loan portfolio segments
Total loans held for investment	180
Real estate - mortgage | Non-classified
Loan portfolio segments
Total loans held for investment	973,496	877,665
Real estate - mortgage | Non-classified | Residential and commercial investor
Loan portfolio segments
Total loans held for investment	563,657	441,186
Real estate - mortgage | Non-classified | Residential and commercial owner-occupied
Loan portfolio segments
Total loans held for investment	409,659	436,479
Real estate - mortgage | Non-classified | Real estate - mortgage - Other
Loan portfolio segments
Total loans held for investment	180
Real estate - mortgage | Classified
Loan portfolio segments
Total loans held for investment	17,098	24,056
Real estate - mortgage | Classified | Residential and commercial investor
Loan portfolio segments
Total loans held for investment	4,349	7,556
Real estate - mortgage | Classified | Residential and commercial owner-occupied
Loan portfolio segments
Total loans held for investment	12,749	16,500
Construction and land
Loan portfolio segments
Total loans held for investment	182,869	128,670
Construction and land | Non-classified
Loan portfolio segments
Total loans held for investment	181,641	122,637
Construction and land | Classified
Loan portfolio segments
Total loans held for investment	1,228	6,033
Consumer
Loan portfolio segments
Total loans held for investment	207,921	181,067
Consumer | Non-classified
Loan portfolio segments
Total loans held for investment	205,131	179,645
Consumer | Classified
Loan portfolio segments
Total loans held for investment	2,790	1,422
Other
Loan portfolio segments
Total loans held for investment	47,904	49,394
Other | Non-classified
Loan portfolio segments
Total loans held for investment	47,820	49,394
Other | Classified
Loan portfolio segments
Total loans held for investment	$84

Loans_Schedule_Of_Allowance_Fo

Loans (Schedule Of Allowance For Loan Losses) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for loan losses
Allowance for loan losses, beginning of period	$37,050	$46,866
Provision	-4,155	-8,804	-4,733
Charge-offs	-2,517	-4,591
Recoveries	2,387	3,579
Allowance for loan losses, end of period	32,765	37,050	46,866
Commercial
Allowance for loan losses
Allowance for loan losses, beginning of period	14,103	13,448
Provision	2,094	233
Charge-offs	-1,956	-613
Recoveries	373	1,035
Allowance for loan losses, end of period	14,614	14,103
Real estate - mortgage
Allowance for loan losses
Allowance for loan losses, beginning of period	14,919	17,832
Provision	-2,839	-957
Charge-offs	-52	-3,055
Recoveries	435	1,099
Allowance for loan losses, end of period	12,463	14,919
Construction and land
Allowance for loan losses
Allowance for loan losses, beginning of period	3,346	9,893
Provision	-2,499	-7,150
Charge-offs	-50	-796
Recoveries	1,519	1,399
Allowance for loan losses, end of period	2,316	3,346
Consumer
Allowance for loan losses
Allowance for loan losses, beginning of period	2,471	3,061
Provision	257	-513
Charge-offs	-453	-122
Recoveries	54	45
Allowance for loan losses, end of period	2,329	2,471
Other
Allowance for loan losses
Allowance for loan losses, beginning of period	479	451
Provision	9	32
Charge-offs	-6	-5
Recoveries	6	1
Allowance for loan losses, end of period	488	479
Unallocated
Allowance for loan losses
Allowance for loan losses, beginning of period	1,732	2,181
Provision	-1,177	-449
Allowance for loan losses, end of period	$555	$1,732

Loans_Schedule_Of_Allowance_Fo1

Loans (Schedule Of Allowance For Loan Losses On The Basis Of Impairment Method) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	$44,812	$54,216
Allowance for loan losses, Individually evaluated for impairment	4,147	5,617
Loans held for investment, Collectively evaluated for impairment	2,360,763	2,030,143
Allowance for loan losses, Collectively evaluated for impairment	28,618	31,433
Commercial
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	20,415	17,454
Allowance for loan losses, Individually evaluated for impairment	3,441	2,140
Loans held for investment, Collectively evaluated for impairment	957,284	806,999
Allowance for loan losses, Collectively evaluated for impairment	11,173	11,963
Real estate - mortgage
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	17,803	25,501
Allowance for loan losses, Individually evaluated for impairment	281	2,371
Loans held for investment, Collectively evaluated for impairment	971,916	875,363
Allowance for loan losses, Collectively evaluated for impairment	12,182	12,548
Construction and land
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	4,004	10,454
Allowance for loan losses, Individually evaluated for impairment	280	932
Loans held for investment, Collectively evaluated for impairment	177,860	117,498
Allowance for loan losses, Collectively evaluated for impairment	2,036	2,414
Consumer
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	2,506	807
Allowance for loan losses, Individually evaluated for impairment	139	174
Loans held for investment, Collectively evaluated for impairment	205,449	180,249
Allowance for loan losses, Collectively evaluated for impairment	2,190	2,297
Other
Financing Receivable, Allowance for Credit Losses [Line Items]
Loans held for investment, Individually evaluated for impairment	84
Allowance for loan losses, Individually evaluated for impairment	6
Loans held for investment, Collectively evaluated for impairment	48,254	50,034
Allowance for loan losses, Collectively evaluated for impairment	482	479
Unallocated
Financing Receivable, Allowance for Credit Losses [Line Items]
Allowance for loan losses, Collectively evaluated for impairment	$555	$1,732

Loans_Schedule_Of_Impaired_Loa

Loans (Schedule Of Impaired Loans) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Impaired receivables with and without related allowance
Unpaid principal balance	$37,530,000	$46,145,000
Recorded investment on impaired loans	36,269,000	43,623,000
Recorded investment with a related allowance	29,884,000	33,193,000
Recorded investment with no related allowance	6,385,000	10,430,000
Related allowance	4,147,000	5,617,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	35,117,000	50,877,000	55,607,000
Interest income recognized	1,796,000	2,100,000	1,817,000
Interest income that would have been recorded had nonaccrual loans performed	300,000	600,000	700,000
Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	21,629,000	17,533,000
Recorded investment on impaired loans	20,415,000	17,454,000
Recorded investment with a related allowance	19,913,000	16,948,000
Recorded investment with no related allowance	502,000	506,000
Related allowance	3,441,000	2,140,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	16,583,000	19,098,000	18,290,000
Interest income recognized	1,113,000	1,103,000	816,000
Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	9,273,000	17,526,000
Recorded investment on impaired loans	9,260,000	16,485,000
Recorded investment with a related allowance	6,068,000	10,881,000
Recorded investment with no related allowance	3,192,000	5,604,000
Related allowance	281,000	2,371,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	11,164,000	21,553,000	20,298,000
Interest income recognized	423,000	437,000	603,000
Construction and land
Impaired receivables with and without related allowance
Unpaid principal balance	4,038,000	10,279,000
Recorded investment on impaired loans	4,004,000	8,877,000
Recorded investment with a related allowance	3,325,000	4,557,000
Recorded investment with no related allowance	679,000	4,320,000
Related allowance	280,000	932,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	5,957,000	9,042,000	16,047,000
Interest income recognized	166,000	499,000	395,000
Consumer
Impaired receivables with and without related allowance
Unpaid principal balance	2,506,000	807,000
Recorded investment on impaired loans	2,506,000	807,000
Recorded investment with a related allowance	494,000	807,000
Recorded investment with no related allowance	2,012,000
Related allowance	139,000	174,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	1,362,000	1,184,000	972,000
Interest income recognized	93,000	61,000	3,000
Other
Impaired receivables with and without related allowance
Unpaid principal balance	84,000
Recorded investment on impaired loans	84,000
Recorded investment with a related allowance	84,000
Related allowance	6,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	51,000
Interest income recognized	1,000
Manufacturing | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	5,169,000	4,887,000
Recorded investment on impaired loans	4,887,000	4,859,000
Recorded investment with a related allowance	4,833,000	4,797,000
Recorded investment with no related allowance	54,000	62,000
Related allowance	431,000	479,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	4,244,000	5,027,000	4,732,000
Interest income recognized	299,000	331,000	309,000
Finance and insurance | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	99,000	517,000
Recorded investment on impaired loans	99,000	517,000
Recorded investment with a related allowance	99,000	517,000
Related allowance	53,000	106,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	307,000	671,000	817,000
Interest income recognized	13,000	30,000	42,000
Health care | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	140,000	236,000
Recorded investment on impaired loans	140,000	236,000
Recorded investment with a related allowance	140,000	236,000
Related allowance	9,000	23,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	205,000	263,000	25,000
Interest income recognized	13,000	14,000	2,000
Real estate services | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	8,469,000	7,473,000
Recorded investment on impaired loans	8,469,000	7,473,000
Recorded investment with a related allowance	8,469,000	7,473,000
Related allowance	782,000	505,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	6,416,000	8,256,000	7,097,000
Interest income recognized	281,000	326,000	252,000
Construction | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	2,050,000	1,708,000
Recorded investment on impaired loans	2,050,000	1,708,000
Recorded investment with a related allowance	1,961,000	1,613,000
Recorded investment with no related allowance	89,000	95,000
Related allowance	296,000	222,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	1,604,000	2,625,000	2,380,000
Interest income recognized	158,000	251,000	107,000
Wholesale and retail trade | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	3,713,000	294,000
Recorded investment on impaired loans	3,091,000	248,000
Recorded investment with a related allowance	2,741,000	97,000
Recorded investment with no related allowance	350,000	151,000
Related allowance	1,611,000	59,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	1,303,000	370,000	631,000
Interest income recognized	184,000	17,000	15,000
Commercial - Other | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	1,989,000	2,418,000
Recorded investment on impaired loans	1,679,000	2,413,000
Recorded investment with a related allowance	1,670,000	2,215,000
Recorded investment with no related allowance	9,000	198,000
Related allowance	259,000	746,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	2,504,000	1,886,000	2,608,000
Interest income recognized	165,000	134,000	89,000
Residential and commercial owner-occupied | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	3,063,000	6,468,000
Recorded investment on impaired loans	3,050,000	5,967,000
Recorded investment with a related allowance	1,183,000	2,524,000
Recorded investment with no related allowance	1,867,000	3,443,000
Related allowance	117,000	709,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	4,102,000	8,915,000	9,914,000
Interest income recognized	176,000	162,000	44,000
Residential and commercial investor | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	6,210,000	11,058,000
Recorded investment on impaired loans	6,210,000	10,518,000
Recorded investment with a related allowance	4,885,000	8,357,000
Recorded investment with no related allowance	1,325,000	2,161,000
Related allowance	164,000	1,662,000
Impaired Loans: Average recorded investment and interest income
Average recorded investment	7,062,000	12,638,000	10,384,000
Interest income recognized	$247,000	$275,000	$559,000

Loans_Schedule_Of_Transactions

Loans (Schedule Of Transactions Related To Troubled Debt Restructurings) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Troubled debt restructurings
Beginning balance	$41,693
New restructurings	13,059
Paydowns	-23,697
Charge-offs	-865
Ending balance	30,190
Performing
Troubled debt restructurings
Beginning balance	29,683
New restructurings	12,183
Change in accrual status	-3,222
Paydowns	-11,369
Ending balance	27,275
Nonperforming
Troubled debt restructurings
Beginning balance	12,010
New restructurings	876
Change in accrual status	3,222
Paydowns	-12,328
Charge-offs	-865
Ending balance	$2,915

Loans_Schedule_Of_Troubled_Deb

Loans (Schedule Of Troubled Debt Restructurings) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
	contract	contract	contract
Troubled debt restructurings
Number of contracts	24	30	59
Pre-modification outstanding recorded investment	$7,992,000	$10,631,000	$31,904,000
Post-modification oustanding recorded investment	5,570,000	8,410,000	27,748,000
Charge-offs	400,000	400,000
Commercial
Troubled debt restructurings
Number of contracts	20	23
Pre-modification outstanding recorded investment	7,658,000	4,708,000
Post-modification oustanding recorded investment	5,274,000	3,131,000
Construction and land
Troubled debt restructurings
Number of contracts	1	1	10
Pre-modification outstanding recorded investment	121,000	2,615,000	8,331,000
Post-modification oustanding recorded investment	95,000	2,615,000	7,469,000
Consumer
Troubled debt restructurings
Number of contracts	1		6
Pre-modification outstanding recorded investment	93,000		1,504,000
Post-modification oustanding recorded investment	89,000		1,466,000
Other
Troubled debt restructurings
Number of contracts	1	2
Pre-modification outstanding recorded investment	91,000	87,000
Post-modification oustanding recorded investment	84,000	84,000
Manufacturing
Troubled debt restructurings
Number of contracts	3	4
Pre-modification outstanding recorded investment	1,611,000	791,000
Post-modification oustanding recorded investment	1,318,000	723,000
Manufacturing | Commercial
Troubled debt restructurings
Number of contracts			9
Pre-modification outstanding recorded investment			6,708,000
Post-modification oustanding recorded investment			5,423,000
Finance and insurance | Commercial
Troubled debt restructurings
Number of contracts			4
Pre-modification outstanding recorded investment			1,047,000
Post-modification oustanding recorded investment			796,000
Health care | Commercial
Troubled debt restructurings
Number of contracts			1
Pre-modification outstanding recorded investment			296,000
Post-modification oustanding recorded investment			288,000
Real estate services | Commercial
Troubled debt restructurings
Number of contracts	4	1	1
Pre-modification outstanding recorded investment	1,171,000	30,000	367,000
Post-modification oustanding recorded investment	1,024,000	55,000	345,000
Construction | Commercial
Troubled debt restructurings
Number of contracts	5	4	12
Pre-modification outstanding recorded investment	2,784,000	198,000	4,734,000
Post-modification oustanding recorded investment	1,478,000	153,000	4,040,000
Wholesale and retail trade | Commercial
Troubled debt restructurings
Number of contracts	3	4
Pre-modification outstanding recorded investment	1,297,000	1,413,000
Post-modification oustanding recorded investment	886,000	146,000
Commercial - Other | Commercial
Troubled debt restructurings
Number of contracts	5	10	11
Pre-modification outstanding recorded investment	795,000	2,276,000	2,074,000
Post-modification oustanding recorded investment	568,000	2,054,000	1,963,000
Residential and commercial owner-occupied
Troubled debt restructurings
Number of contracts	1	4
Pre-modification outstanding recorded investment	29,000	3,221,000
Post-modification oustanding recorded investment	28,000	2,580,000
Residential and commercial owner-occupied | Real estate - mortgage
Troubled debt restructurings
Number of contracts			4
Pre-modification outstanding recorded investment			3,538,000
Post-modification oustanding recorded investment			2,653,000
Residential and commercial investor | Real estate - mortgage
Troubled debt restructurings
Number of contracts			1
Pre-modification outstanding recorded investment			3,305,000
Post-modification oustanding recorded investment			$3,305,000

Loans_Schedule_Of_Troubled_Deb1

Loans (Schedule Of Troubled Debt Restructurings That Subsequently Defaulted) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
	contract	contract
Troubled debt restructurings that subsequently defaulted
Number of contracts	1	2
Recorded investment	$84,000	$756,000
Outstanding commitments on restructured loans	2,400,000	1,900,000
Commercial
Troubled debt restructurings that subsequently defaulted
Number of contracts		1
Recorded investment		19,000
Other
Troubled debt restructurings that subsequently defaulted
Number of contracts	1
Recorded investment	84,000
Construction | Commercial
Troubled debt restructurings that subsequently defaulted
Number of contracts		1
Recorded investment		19,000
Residential and commercial owner-occupied | Real estate - mortgage
Troubled debt restructurings that subsequently defaulted
Number of contracts		1
Recorded investment		$737,000

Loans_Schedule_Of_Nonaccrual_L

Loans (Schedule Of Nonaccrual Loans) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	$8,994	$13,921
Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	3,317	1,330
Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	3,416	10,504
Construction and land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	135	1,986
Consumer
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	2,126	101
Manufacturing | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	66	79
Finance and insurance | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	50	63
Real estate services | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	212
Construction | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	312	201
Wholesale and retail trade | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	2,491	206
Commercial - Other | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	186	781
Residential and commercial owner-occupied | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	2,091	5,020
Residential and commercial investor | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total nonaccrual loans	$1,325	$5,484

Loans_Schedule_Of_Aging_Of_The

Loans (Schedule Of Aging Of The Company's Loan Portfolio) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	$896	$1,826
60 - 89 Days past due	262	326
90+ Days past due	4,757	2,983
Total past due	5,915	5,135
Current	2,401,001	2,081,247
Total loans, excluding fees and costs	2,406,916	2,086,382
Unearned net loan fees	-1,341	-2,023
Total loans	2,405,575	2,084,359
Recorded investment in loans 90 days or more past due and accruing	161	19
Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	485	1,010
60 - 89 Days past due	9	324
90+ Days past due	2,226	119
Total past due	2,720	1,453
Current	974,908	824,077
Total loans, excluding fees and costs	977,628	825,530
Recorded investment in loans 90 days or more past due and accruing	161	19
Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	235
90+ Days past due	473	913
Total past due	708	913
Current	989,886	900,808
Total loans, excluding fees and costs	990,594	901,721
Construction and land
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due		816
90+ Days past due	104	1,951
Total past due	104	2,767
Current	182,765	125,903
Total loans, excluding fees and costs	182,869	128,670
Consumer
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	176
60 - 89 Days past due	253	2
90+ Days past due	1,954
Total past due	2,383	2
Current	205,538	181,065
Total loans, excluding fees and costs	207,921	181,067
Other
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	47,904	49,394
Total loans, excluding fees and costs	47,904	49,394
Manufacturing | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	45
60 - 89 Days past due	9
Total past due	54
Current	126,064	105,696
Total loans, excluding fees and costs	126,118	105,696
Finance and insurance | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	81,047	77,106
Total loans, excluding fees and costs	81,047	77,106
Health care | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	193	259
Total past due	193	259
Current	91,618	99,906
Total loans, excluding fees and costs	91,811	100,165
Real estate services | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due		24
Total past due		24
Current	112,388	100,258
Total loans, excluding fees and costs	112,388	100,282
Construction | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ Days past due	122	19
Total past due	122	19
Current	56,373	53,292
Total loans, excluding fees and costs	56,495	53,311
Recorded investment in loans 90 days or more past due and accruing		19
Wholesale and retail trade | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	247
90+ Days past due	2,095	100
Total past due	2,342	100
Current	69,953	71,004
Total loans, excluding fees and costs	72,295	71,104
Recorded investment in loans 90 days or more past due and accruing	161
Commercial - Other | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due		727
60 - 89 Days past due		324
90+ Days past due	9
Total past due	9	1,051
Current	437,465	316,815
Total loans, excluding fees and costs	437,474	317,866
Residential and commercial owner-occupied | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
90+ Days past due	473	913
Total past due	473	913
Current	421,935	452,066
Total loans, excluding fees and costs	422,408	452,979
Residential and commercial investor | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
30 - 59 Days past due	235
Total past due	235
Current	567,771	448,742
Total loans, excluding fees and costs	568,006	448,742
Real estate - mortgage - Other | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	180
Total loans, excluding fees and costs	$180

Loans_Schedule_Of_Loans_And_Le

Loans (Schedule Of Loans And Leases Receivable, Related Parties) (Details) (Officers and Directors, USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Officers and Directors
Related party loans
Balance - beginning of year	$29,766	$8,343
New loan and advances	19,390	27,667
Principal paydowns and payoffs	-23,634	-6,244
Balance - end of year	$25,522	$29,766

Premises_And_Equipment_Schedul

Premises And Equipment (Schedule Of Premises And Equipment) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Premises and equipment
Premises and equipment, gross	$45,203	$41,739
Accumulated depreciation	-37,953	-35,705
Premises and equipment, net	7,250	6,034
Land
Premises and equipment
Premises and equipment, gross	230	230
Building
Premises and equipment
Premises and equipment, gross	230	230
Leasehold improvements
Premises and equipment
Premises and equipment, gross	10,931	10,342
Furniture, fixtures, and equipment
Premises and equipment
Premises and equipment, gross	$33,812	$30,937

Premises_And_Equipment_Narrati

Premises And Equipment (Narrative) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Premises And Equipment
Depreciation expense	$2.70	$3	$3.20

Intangible_Assets_Schedule_of_

Intangible Assets (Schedule of Finite-Lived Intangible Assets) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Intangible assets and related accumulated amortization
Amortization	($597)	($662)	($724)
Intangible assets, ending balance	2,207
Customer contracts, lists and relationships
Intangible assets and related accumulated amortization
Intangible assets, beginning balance	2,798	3,573
Acquired relationships	325
Disposals		-113
Amortization	-597	-662
Intangible assets, ending balance	$2,526	$2,798

Intangible_Assets_Narrative_De

Intangible Assets (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Acquired Finite-Lived Intangible Assets [Line Items]
Cash consideration	$200,000
Acquired finite-lived intangible asset, useful life	10 years
Contingent consideration	100,000
Amortization	597,000	662,000	724,000
Customer contracts, lists and relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Amortization	597,000	662,000
Acquired relationships	$325,000

Recovered_Sheet1

Intangible Assets (Schedule Of Expected Amortization Expense) (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Intangible Assets
2015	$600
2016	600
2017	600
2018	206
2019	201
Finite-Lived Intangible Assets, Net, Total	$2,207

Deposits_Schedule_Of_Certifica

Deposits (Schedule Of Certificates Of Deposit Portfolio) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deposits
Related Party Deposit Liabilities	$99,500,000	$84,900,000
Less than $100,000	27,202,000	30,972,000
$100,000 and more	183,805,000	214,345,000
Certificates of Deposit	$211,007,000	$245,317,000

Deposits_Schedule_Of_Interest_

Deposits (Schedule Of Interest Expense Allocated To Certificates Of Deposit) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Deposits
Less than $100,000	$125	$158	$220
$100,000 and more	892	1,154	1,625
Interest Expense, Certificates of Deposit	$1,017	$1,312	$1,845

Deposits_Schedule_Of_Certifica1

Deposits (Schedule Of Certificates Of Deposit, By Contractual Maturity) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Contractual Maturities, Time Deposits, $100,000 or More [Abstract]
Three months or less	$75,863
Over three months through six months	44,993
Over six months through 12 months	48,985
Over 12 months	13,964
Total	183,805	214,345
Remaining maturity
Three months or less	75,863
Over three months through six months	44,993
Over six months through 12 months	48,985
Over 12 months	13,964
Total	$183,805	$214,345

Borrowed_Funds_Schedule_Of_Sec

Borrowed Funds (Schedule Of Securities Sold Under Agreements to Repurchase) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Borrowed Funds
Securities Sold Under Agreements to Repurchase.	$49,976	$138,494
Fair value of securities sold under agreements to repurchase	$54,652	$162,781

Borrowed_Funds_Narrative_Detai

Borrowed Funds (Narrative) (Details) (USD $)	12 Months Ended		3 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Jun. 30, 2014
Securities sold under agreements to repurchase and other short-term debt disclosures
Advances from Federal Home Loan Banks	$112.50	$0
FHLB advances, average outstanding balance during the period	104.2	33.2
Loans collateralized under FHLB advancement agreement	804.7	800.4
Lending value of loans pledged as collateral for FHLB line of credit	521.4	473.9
Securities Sold under Agreements to Repurchase
Securities sold under agreements to repurchase and other short-term debt disclosures
Short-term debt, average outstanding amount	83.5	154.5
Short-term debt, maximum amount outstanding at any month end	115.3	178.7
Short-term debt, weighted average interest rate	0.08%	0.22%
Revolving Line of Credit (LOC)
Securities sold under agreements to repurchase and other short-term debt disclosures
Maximum borrowing capacity			20
Commitment fee, percentage			0.25%
Amount outstanding	0
Revolving Line of Credit (LOC) | 1-month LIBOR
Securities sold under agreements to repurchase and other short-term debt disclosures
Interest rate terms, spread over reference rate			2.25%
Federal Fund Purchase Lines
Securities sold under agreements to repurchase and other short-term debt disclosures
Short-term debt, average outstanding amount	9.3	10.2
Maximum borrowing capacity	$175
Number of banks providing line of credit	7

LongTerm_Debt_Schedule_Of_Long

Long-Term Debt (Schedule Of Long-term Debt Instruments) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
CoBiz Statutory Trust I | 3-month LIBOR
Subordinated debentures and notes payable
Interest rate terms, spread over reference rate	2.95%
CoBiz Capital Trust II | 3-month LIBOR
Subordinated debentures and notes payable
Interest rate terms, spread over reference rate	2.60%
CoBiz Capital Trust III | 3-month LIBOR
Subordinated debentures and notes payable
Interest rate terms, spread over reference rate	1.45%
Junior subordinated debentures
Subordinated debentures and notes payable
Junior subordinated debentures	$72,166	$72,166
Junior subordinated debentures | CoBiz Statutory Trust I
Subordinated debentures and notes payable
Junior subordinated debentures	20,619	20,619
Maturity date	17-Sep-33
Earliest call date	17-Mar-15
Junior subordinated debentures | CoBiz Capital Trust II
Subordinated debentures and notes payable
Junior subordinated debentures	30,928	30,928
Maturity date	23-Jul-34
Earliest call date	23-Jan-15
Junior subordinated debentures | CoBiz Capital Trust III
Subordinated debentures and notes payable
Junior subordinated debentures	$20,619	$20,619
Maturity date	30-Sep-35
Earliest call date	30-Mar-15

LongTerm_Debt_Narrative_Part_I

Long-Term Debt (Narrative, Part I) (Details) (USD $)	1 Months Ended	12 Months Ended	1 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2003	Dec. 31, 2014	31-May-04	Aug. 31, 2005
CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust	$0.60
CoBiz Capital Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust			0.9
CoBiz Capital Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Minority interest held in statutory trust				0.6
Trust preferred securities | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value	20
Trust preferred securities, settlement date		17-Sep-33
Proceeds from sale of securities and minority interest	20.6
Trust preferred securities | CoBiz Capital Trust II
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value			30
Trust preferred securities, settlement date		23-Jul-34
Proceeds from sale of securities and minority interest			30.9
Trust preferred securities | CoBiz Capital Trust III
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Trust preferred securities, value				20
Trust preferred securities, settlement date		30-Sep-35
Proceeds from sale of securities and minority interest				$20.60
Minimum | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Period of notice required for redemption		30 days
Maximum | CoBiz Statutory Trust I
Financial Instruments Subject to Mandatory Redemption by Settlement Terms [Line Items]
Period of notice required for redemption		60 days

LongTerm_Debt_Narrative_Part_I1

Long-Term Debt (Narrative, Part II) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Long-Term Debt
Trust preferred securities included in Tier 1 capital	$70,000,000	$70,000,000
Trust preferred securities as a percentage of Total Tier 1 elements, maximum	25.00%
Total consolidated assets allowed for inclusion of trust preferred securities in regulatory capital	$15,000,000,000

Derivatives_Narrative_Details

Derivatives (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flow, Fair value, and non-designated hedges
Fair value of derivatives in a net liability position	$10,000,000
Collateral already posted	15,900,000
Cash flow hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness	0	0	0
Interest Income
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months	800,000
Interest Expense
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months	-1,900,000
Derivatives designated as hedging instruments | Interest rate swap | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Number of interest-rate swaps	5
Notional amount of derivative instrument	75,000,000
Derivative remaining maturities	4 years
Derivatives designated as hedging instruments | Interest rate swap | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Number of interest-rate swaps	5
Notional amount of derivative instrument	31,600,000
Derivatives designated as hedging instruments | Interest rate swap | Noninterest Expense | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness	200,000	100,000
Derivatives designated as hedging instruments | Interest rate swap | Minimum | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Weighted-average fixed rate (as a percent)	1.41%
Derivatives designated as hedging instruments | Interest rate swap | Maximum | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Derivative remaining maturities	3 years
Derivatives not designated as hedging instruments
Cash flow, Fair value, and non-designated hedges
Number of interest-rate swaps	108
Notional amount of derivative instrument	263,800,000
Derivatives not designated as hedging instruments | Interest rate swap | Other Income
Cash flow, Fair value, and non-designated hedges
Gains (losses) on derivatives not designated as hedged instruments	200,000	400,000
Derivatives not designated as hedging instruments | Foreign exchange forward contracts
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument	$7,300,000

Derivatives_Schedule_Of_Deriva

Derivatives (Schedule Of Derivatives Instruments In The Statements Of Financial Position) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Other assets | Cash flow hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	$437	$184
Other assets | Fair value hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	297	1,735
Accrued interest and other liabilities | Cash flow hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	5,017	4,007
Accrued interest and other liabilities | Fair value hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	988
Interest rate swap | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	4,103	6,422
Interest rate swap | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	4,284	6,409
Foreign exchange forward contracts | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	54
Foreign exchange forward contracts | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	$17	$10

Derivatives_Schedule_Of_Fair_V

Derivatives (Schedule Of Fair Value Of Derivative Financial Instruments And Their Classification On Condensed Consolidated Balance Sheets) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Derivative assets, net
Gross amounts of recognized assets	$4,891	$8,341
Gross amounts offset		-652
Net amounts included in 'other' assets in the condensed consolidated balance sheets	4,891	7,689
Financial instruments	-707
Net Amount	4,184	7,689
Securities sold under agreements to repurchase
Gross amounts of recognized liabilities	-49,976	-138,494
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	-49,976	-138,494
Collateral	49,976	138,494
Total offsetting derivative liabilities and securities sold under agreements to repurchase
Gross amounts of recognized liabilities	-60,282	-148,920
Gross amounts offset		652
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	-60,282	-148,268
Financial Instruments	707
Collateral	59,385	148,268
Net Amount	-190
Derivatives designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	734	1,919
Gross amounts offset		-286
Net amounts included in 'other' assets in the condensed consolidated balance sheets	734	1,633
Financial instruments	-487
Net Amount	247	1,633
Derivative liabilities, net
Gross amounts of recognized liabilities	-6,005	-4,007
Gross amounts offset		286
Net amounts included in 'accrued interest and other liabilities' in the condensed consolidated balance sheets	-6,005	-3,721
Financial instruments	487
Collateral	5,518
Securities sold under agreements to repurchase
Collateral		3,721
Derivatives not designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	4,157	6,422
Gross amounts offset		-366
Net amounts included in 'other' assets in the condensed consolidated balance sheets	4,157	6,056
Financial instruments	-220
Net Amount	3,937	6,056
Derivative liabilities, net
Gross amounts of recognized liabilities	-4,301	-6,419
Gross amounts offset		366
Net amounts included in 'accrued interest and other liabilities' in the condensed consolidated balance sheets	-4,301	-6,053
Financial instruments	220
Collateral	3,891
Net Amount	-190
Securities sold under agreements to repurchase
Collateral		$6,053

Derivatives_Schedule_Of_Notion

Derivatives (Schedule Of Notional Amounts Of Outstanding Derivative Positions) (Details) (USD $)	1 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2014	Dec. 31, 2014
CoBiz Statutory Trust I
Derivative [Line Items]
Notional amount of derivative instrument	$20,000	$20,000
Fixed rate	4.99%	6.04%
Termination date	17-Mar-22	17-Mar-15
CoBiz Capital Trust II
Derivative [Line Items]
Notional amount of derivative instrument		30,000
Fixed rate		5.99%
Termination date		23-Apr-20
CoBiz Capital Trust III
Derivative [Line Items]
Notional amount of derivative instrument		$20,000
Fixed rate		5.02%
Termination date		30-Mar-24

Derivatives_Schedule_Of_Accumu

Derivatives (Schedule Of Accumulated Other Comprehensive Income (Loss)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Derivatives
Accumulated other comprehensive income (loss), Derivatives designated as hedging instruments, beginning balance	($2,370)	($5,607)	($5,275)
Net change	-470	3,237	-332
Accumulated other comprehensive income (loss), Derivatives designated as hedging instruments, ending balance	($2,840)	($2,370)	($5,607)

Income_Taxes_Schedule_Of_Compo

Income Taxes (Schedule Of Components Of Income Tax Expense (Benefit)) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current tax provision (benefit):
Federal tax	$9,737	$7,497	$11,290
State tax	-109	1,072	1,216
Total current tax provision	9,628	8,569	12,506
Deferred tax provision (benefit)
Federal tax	3,357	3,974	178
State tax	513	654	-21
Net operating loss carrforward	1,649	154	595
Total deferred tax provision	5,519	4,782	752
Provision for income taxes	15,147	13,351	13,258
Provision related to discontinued operations		86	171
CoBiz Financial Inc.
Deferred tax provision (benefit)
Provision for income taxes	($1,402)	($2,748)	($3,333)

Income_Taxes_Narrative_Details

Income Taxes (Narrative) (Details) (Colorado, State and Local Jurisdiction, USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014
Operating loss carryforwards
Operating Loss Carryforwards	21
Minimum
Operating loss carryforwards
Operating Loss Carryforwards, Expiration Date	1-Jan-25
Maximum
Operating loss carryforwards
Operating Loss Carryforwards, Expiration Date	31-Dec-27

Income_Taxes_Schedule_Of_Defer

Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Income Taxes
Allowance for loan and credit losses	$12,451	$14,054
Intangible assets	1,872	2,151
Valuation adjustments on OREO	3,329	3,296
Deferred loan fees	472	415
Other accrued liabilities	1,325	2,324
Stock-based compensation	1,428	1,930
Interest on nonaccrual loans	577	412
Employee bonus	2,472	2,175
State operating loss carryforward	633	1,758
Other	136	1,657
Total deferred tax assets	24,695	30,172
Deferred initial direct loan costs	-1,538	-1,183
Prepaid assets	-431	-697
FHLB stock dividends	-63	-113
Investment securities and derivatives	-2,655	-1,673
Total deferred tax liabilities	-4,687	-3,666
Net deferred tax assets	$20,008	$26,506

Income_Taxes_Schedule_Of_Effec

Income Taxes (Schedule Of Effective Income Tax Rate Reconciliation) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconciliation of income tax expense at statutory rate to actual income tax expense
Statutory rate (as a percent)	35.00%	35.00%	35.00%
Computed at the statutory rate (35%)	$15,454	$14,276	$13,126
State income taxes - net of federal income tax effect	1,336	1,373	1,177
Tax exempt income	-2,838	-1,976	-1,475
Other - net	1,195	-322	430
Provision for income taxes	15,147	13,351	13,258
Unrecognized tax benefits
Unrecognized tax benefits	$0	$0

Income_Taxes_Summary_Of_Income

Income Taxes (Summary Of Income Tax Examinations) (Details)	12 Months Ended
	Dec. 31, 2014
United States
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2011
Colorado
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2010
Arizona
Income tax examinations by jurisdiction
Earliest tax year subject to examination	2010

Shareholders_Equity_Schedule_O

Shareholders' Equity (Schedule Of Stock Reserved For Future Issuance) (Details)	Dec. 31, 2014	Dec. 31, 2013
Common Stock
Common shares reserved for future issuance	4,497,026	3,401,362
Exercise of outstanding stock options
Common Stock
Common shares reserved for future issuance	819,755	1,292,077
Future granting of option and stock awards
Common Stock
Common shares reserved for future issuance	2,508,115	1,096,680
Future stock purchases through ESPP
Common Stock
Common shares reserved for future issuance	273,188	116,637
Tarp Warrant
Common Stock
Common shares reserved for future issuance	895,968	895,968

Shareholders_Equity_Narrative_

Shareholders' Equity (Narrative) (Details) (USD $)	12 Months Ended	0 Months Ended	12 Months Ended
	Dec. 31, 2012	Sep. 08, 2011	Dec. 31, 2014	Dec. 31, 2013
Preferred stock
Shares sold, aggregate purchase price	$11,830,000
Preferred stock, par value per share			$0.01	$0.01
Preferred stock, liquidation value per share	$1,000		$1,000	$1,000
Small Business Lending Fund (SBLF)
Shareholders' Equity Disclosures
SBLF Fund Pool		30,000,000,000
Total assets threshold for SBLF Loan qualification, maximum		10,000,000,000
Small Business Lending Fund (SBLF) | Series C Preferred Stock
Preferred stock
Shares sold, aggregate purchase price		57,400,000
Shares sold		57,366
Preferred stock, par value per share		$0.01
Preferred stock, liquidation value per share		$1,000
Redemption price per share			$1,000
Minimum redemption threshold, as a percent of original investment			25.00%
Original investment amount			$14,300,000
Tarp Warrant
Warrant
Warrant term (in years)			10 years
Number of shares issuable under warrant terms			895,968
Exercise price per share			$10.79

Shareholders_Equity_Dividends_

Shareholders' Equity (Dividends) (Details) (USD $)	12 Months Ended			1 Months Ended	15 Months Ended	16 Months Ended	36 Months Ended	24 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2011	Dec. 31, 2014	Dec. 31, 2012	Dec. 31, 2015	Sep. 30, 2013
Dividends
Dividends declared per share	$0.15	$0.12	$0.07
Dividends on preferred stock	$574,000	$944,000	$2,815,000
Dividend rate	1.00%	1.60%	4.90%
Series C Preferred Stock
Dividends
Dividends on preferred stock	600,000	900,000	2,900,000
Series C Preferred Stock | Less than 2.5%
Dividends
Dividend rate	5.00%
Series C Preferred Stock | Between 2.5% and 5.0%
Dividends
Dividend rate	4.00%
Series C Preferred Stock | Between 5.0% And 7.5%
Dividends
Dividend rate	3.00%
Series C Preferred Stock | Between 7.5% And 10.0%
Dividends
Dividend rate	2.00%
Series C Preferred Stock | 10.0% Or More
Dividends
Dividend rate	1.00%
Minimum | Between 2.5% and 5.0%
Other information
Relative increase in QSBL to baseline	2.50%
Minimum | Between 5.0% And 7.5%
Other information
Relative increase in QSBL to baseline	5.00%
Minimum | Between 7.5% And 10.0%
Other information
Relative increase in QSBL to baseline	7.50%
Minimum | 10.0% Or More
Other information
Relative increase in QSBL to baseline	10.00%
Maximum | Less than 2.5%
Other information
Relative increase in QSBL to baseline	2.50%
Maximum | Between 2.5% and 5.0%
Other information
Relative increase in QSBL to baseline	5.00%
Maximum | Between 5.0% And 7.5%
Other information
Relative increase in QSBL to baseline	7.50%
Maximum | Between 7.5% And 10.0%
Other information
Relative increase in QSBL to baseline	10.00%
Small Business Lending Fund (SBLF)
Other information
QSBL maximum loan limit	10,000,000
QSBL Maximum annual revenue threshold	$50,000,000
Small Business Lending Fund (SBLF) | Series C Preferred Stock
Dividends
Dividend rate				5.00%			1.00%
Other information
Fixed dividend rate period after tenth calendar quarter					4 years 6 months
QSBL maximum growth rate threshold for lowest dividend rate (as a percent)						10.00%
Dividend rate on preferred stock still outstanding after 2015	9.00%
Small Business Lending Fund (SBLF) | Minimum | Series C Preferred Stock
Dividends
Dividend rate					1.00%			1.00%
Small Business Lending Fund (SBLF) | Maximum | Series C Preferred Stock
Dividends
Dividend rate					9.00%			5.00%

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Income (Loss) Reclassifications (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reclassifications from AOCI
Net gain (loss) on securities, other assets and OREO									($2,618)	$683	$65
Interest and fees on loans									98,627	89,071	86,505
Interest expense on subordinated debentures									-4,122	-5,360	-6,041
(Income) loss before taxes	-10,522	-12,206	-13,099	-8,327	-10,984	-9,874	-11,261	-8,670	-44,154	-40,789	-37,504
Provision (benefit) for income taxes									15,147	13,351	13,258
Total reclassifications out of AOCI									28,433	26,667	21,755
Reclassification out of AOCI
Reclassifications from AOCI
Total reclassifications out of AOCI									-97	-1,027	-793
Reclassification out of AOCI | Unrealized (gain) loss on AFS securities
Reclassifications from AOCI
Net gain (loss) on securities, other assets and OREO									1,154	439	782
Provision (benefit) for income taxes									-439	-167	-297
Total reclassifications out of AOCI									715	272	485
Reclassification out of AOCI | Unrealized (gain) loss on derivatives | Interest rate swap
Reclassifications from AOCI
Interest and fees on loans									905	90
Interest expense on subordinated debentures									-2,215	-2,185	-2,061
(Income) loss before taxes									-1,310	-2,095	-2,061
Provision (benefit) for income taxes									498	796	783
Total reclassifications out of AOCI									($812)	($1,299)	($1,278)

Earnings_per_Common_Share_Sche

Earnings per Common Share (Schedule Of Weighted Average Shares Outstanding Used In Calculation Of Basic And Diluted Loss Per Share) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
NET INCOME FROM CONTINUING OPERATIONS	$6,982	$7,891	$8,617	$5,517	$7,275	$7,025	$7,262	$5,876	$29,007	$27,438	$24,246
Net income from discontinued operations								173		173	324
NET INCOME	6,982	7,891	8,617	5,517	7,275	7,025	7,262	6,049	29,007	27,611	24,570
Preferred stock dividends									-574	-944	-2,815
Net income available to common shareholders									28,433	26,667	21,755
Dividends and undistributed earnings allocated to participating securities									-434	-457	-335
Earnings allocated to common shareholders									27,999	26,210	21,420
Weighted average common shares - issued									40,616,022	40,193,315	39,170,218
Average unvested restricted share awards									-609,276	-724,821	-613,710
Weighted average common shares outstanding - basic									40,006,746	39,468,494	38,556,508
Effect of dilutive stock options and awards outstanding									205,847	160,862	45,878
Weighted average common shares outstanding - diluted									40,212,593	39,629,356	38,602,386
Weighted average antidilutive common shares outstanding									676,248	1,530,263	2,785,855
Basic - from continuing operations									$0.70	$0.66	$0.54
Diluted - from continuing operations									$0.70	$0.66	$0.54
Basic - from discontinued operation									$0	$0	$0.01
Diluted - from discontinued operations									$0	$0	$0.01
Basic	$0.17	$0.19	$0.21	$0.13	$0.18	$0.17	$0.18	$0.14	$0.70	$0.66	$0.55
Diluted	$0.17	$0.19	$0.21	$0.13	$0.18	$0.17	$0.18	$0.14	$0.70	$0.66	$0.55
CoBiz Financial Inc.
NET INCOME									$29,007	$27,611	$24,570

Employee_Benefit_And_Stock_Com2

Employee Benefit And Stock Compensation Plans (Narrative) (Details) (USD $)	12 Months Ended			0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	20-May-10	15-May-08	15-May-14	Dec. 31, 2005
Stock Options and Awards
Award expiration period	10 years
Share-based compensation expense	$3,100,000	$2,700,000	$1,900,000
Share-based compensation expense, related income tax benefit	1,200,000	1,000,000	700,000
Additional disclosures
Options vested or expected to vest	811,714
Options vested or expected to vest, weighted average exercise price	$9.65
Options vested or expected to vest, weighted-average remaining terms	2 years 9 months 18 days	2 years 9 months 18 days	2 years
Options vested or expected to vest and options exercisable, aggregate intrinsic value	3,100,000	3,100,000	2,600,000
Weighted average grant date fair value of options granted	$3.06	$3.10	$2.75
Total intrinsic value of options exercised	700,000	700,000	100,000
Weighted average grant date fair value, Granted	$11.33	$8.44	$5.64
Total fair value of vested shares	3,874,000	2,700,000	500,000
Total unrecognized compensation expense related to unvested share-based compensation arrangements granted under equity incentive plans	$4,000,000
Unrecognized compensation expense related to unvested share-based compensation arrangements, expected weighted average recognition period, years	1 year 9 months 18 days
2005 Plan
Stock Options and Awards
Shares authorized under plan				3,750,000	2,750,000	5,250,000	1,250,000
Award grant price as a percentage of the fair market value the underlying	85.00%
Number of shares available for grant	2,508,115
2005 Plan | Restricted Stock
Stock Options and Awards
Shares authorized under plan				2,000,000	500,000
Number of additional shares authorized under the plan				1,500,000	250,000

Employee_Benefit_And_Stock_Com3

Employee Benefit And Stock Compensation Plans (Schedule Of Stock Option Valuation Assumptions) (Details) (Options)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Fair value assumptions
Risk-free interest rate	1.38%	0.96%	0.62%
Expected dividend yield	1.27%	1.42%	1.12%
Expected volatility	40.34%	49.80%	61.70%
Expected life (years)	3 years 10 months 24 days	4 years 1 month 6 days	4 years
Minimum
Fair value assumptions
Risk-free interest rate	0.79%	0.41%	0.34%
Expected dividend yield	1.05%	1.23%	0.65%
Expected volatility	29.38%	39.49%	45.52%
Maximum
Fair value assumptions
Risk-free interest rate	1.82%	1.80%	0.95%
Expected dividend yield	1.49%	1.67%	1.32%
Expected volatility	52.50%	65.77%	71.27%

Employee_Benefit_And_Stock_Com4

Employee Benefit And Stock Compensation Plans (Summary Of Changes In Stock Option Awards) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Changes in shares under option awards
Shares, Outstanding - beginning of year	1,292,077
Shares, Granted	92,917
Shares, Exercised	-154,091
Shares, Forfeited	-411,148
Shares, Outstanding - end of year	819,755
Shares, Exercisable - end of year	649,264
Weighted average exercise price, Outstanding - beginning of year	$11.82
Weighted average exercise price, Granted	$11.35
Weighted average exercise price, Exercised	$7.25
Weighted average exercise price, Forfeited	$17.73
Weighted average exercise price, Outstanding - end of year	$9.66
Weighted average exercise price, Exercisable - end of year	$9.59

Employee_Benefit_And_Stock_Com5

Employee Benefit And Stock Compensation Plans (Summary Of Changes In Restricted Stock Awards) (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee Benefit And Stock Compensation Plans
Shares, Unvested - beginning of year	681,578
Shares, Granted	319,466
Shares, Vested	-343,162
Shares, Forfeited	-22,284
Shares, Unvested - end of year	635,598	681,578
Weighted average grant date fair value, Unvested - beginning of year	$7.04
Weighted average grant date fair value, Granted	$11.33	$8.44	$5.64
Weighted average grant date fair value, Vested	$7.24
Weighted average grant date fair value, Forfeited	$8.22
Weighted average grant date fair value, Unvested - end of year	$9.05	$7.04
Total fair value of vested shares	$3,874	$2,700	$500

Employee_Benefit_And_Stock_Com6

Employee Benefit And Stock Compensation Plans (Schedule Of Stock Options Outstanding By Exercise Price Range) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014
Stock options by exercise price ranges
Options outstanding, Number outstanding	819,755
Options outstanding, Weighted average exercise price	$9.66
Options outstanding, Weighted average remaining life (years)	2 years 9 months 18 days
Options exercisable, Number exercisable	649,264
Options exercisable, Weighted average exercise price	$9.59
$4.49 - $6.62
Stock options by exercise price ranges
Range of exercise price, low	$4.49
Range of exercise price, high	$6.62
Options outstanding, Number outstanding	176,433
Options outstanding, Weighted average exercise price	$6.22
Options outstanding, Weighted average remaining life (years)	2 years
Options exercisable, Number exercisable	168,601
Options exercisable, Weighted average exercise price	$6.21
$6.68 - $7.54
Stock options by exercise price ranges
Range of exercise price, low	$6.68
Range of exercise price, high	$7.54
Options outstanding, Number outstanding	178,935
Options outstanding, Weighted average exercise price	$7.35
Options outstanding, Weighted average remaining life (years)	2 years 8 months 12 days
Options exercisable, Number exercisable	171,602
Options exercisable, Weighted average exercise price	$7.38
$7.57 - $11.00
Stock options by exercise price ranges
Range of exercise price, low	$7.57
Range of exercise price, high	$11
Options outstanding, Number outstanding	166,261
Options outstanding, Weighted average exercise price	$9.43
Options outstanding, Weighted average remaining life (years)	5 years 4 months 24 days
Options exercisable, Number exercisable	64,685
Options exercisable, Weighted average exercise price	$9.39
$11.03 - $12.39
Stock options by exercise price ranges
Range of exercise price, low	$11.03
Range of exercise price, high	$12.39
Options outstanding, Number outstanding	229,476
Options outstanding, Weighted average exercise price	$12.08
Options outstanding, Weighted average remaining life (years)	2 years 3 months 18 days
Options exercisable, Number exercisable	175,726
Options exercisable, Weighted average exercise price	$12.17
$13.73 - $20.75
Stock options by exercise price ranges
Range of exercise price, low	$13.73
Range of exercise price, high	$20.75
Options outstanding, Number outstanding	68,650
Options outstanding, Weighted average exercise price	$16.95
Options outstanding, Weighted average remaining life (years)	3 months 18 days
Options exercisable, Number exercisable	68,650
Options exercisable, Weighted average exercise price	$16.95

Employee_Benefit_And_Stock_Com7

Employee Benefit And Stock Compensation Plans (Schedule Of Employee Stock Purchase Plan Activity) (Details) (ESPP, USD $)	1 Months Ended	12 Months Ended
	31-May-14	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
ESPP
Stock Options and Awards
Increase in shares authorized for issuance	200,000
Discretionary contribution maximum match, as a percent of employee deductions		50.00%
Matching contributions made to plan		$0	$0	$0
Available ESPP shares - beginning of year		116,637	163,933	229,833
Plan amendment increasing available shares		200,000
Purchases		-43,449	-47,296	-65,900
Available ESPP shares - end of year		273,188	116,637	163,933

Employee_Benefit_And_Stock_Com8

Employee Benefit And Stock Compensation Plans (Narrative II) (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Employee 401(k) Plan and Supplemental Executive Retirement Plan
Employer matching contribution, percent	4.50%	4.50%	3.00%
Employer contributions charged to expense	$1.50	$1.60	$1.10
Supplemental Employee Retirement Plan
Employee 401(k) Plan and Supplemental Executive Retirement Plan
Expected benefits under the SERP		$2.40

Commitments_and_Contingencies_1

Commitments and Contingencies (Narrative) (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Lease commitments
Rent expense	$5,100,000	$5,000,000	$5,300,000
Future minimum lease payments	20,539,000
Federal Reserve Bank stock, shares	78,573
Federal Reserve Bank stock, value	3,900,000
Federal Reserve Bank stock, par value	$50
Investment held as a percentage of total subscription amount due	50.00%
Percentage of investment that may be callable by the Federal Reserve	50.00%
Federal Reserve Bank stock, remaining membership subscription obligation	3,900,000
Director
Lease commitments
Rent expense	2,100,000	2,200,000	1,900,000
Future minimum lease payments	$2,900,000

Commitments_and_Contingencies_2

Commitments and Contingencies (Schedule Of Lease Commitments) (Details) (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Commitments and Contingencies
2015	$5,547
2016	4,435
2017	3,631
2018	3,259
2019	1,771
Thereafter	1,896
Future minimum lease payments, Total	$20,539

Commitments_and_Contingencies_3

Commitments and Contingencies (Schedule Of Financial Instruments With Off-Balance Sheet Risk) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Commitments to originate commercial or real estate construction loans and unused lines of credit granted to customers
Commitments
Financial Instruments With Off-Balance Sheet Risk	$793,208,000	$659,592,000
Commitments to originate consumer loans - personal lines of credit and equity lines
Commitments
Financial Instruments With Off-Balance Sheet Risk	32,072,000	31,174,000
Overdraft protection plans
Commitments
Financial Instruments With Off-Balance Sheet Risk	15,322,000	15,359,000
Letters of credit
Commitments
Financial Instruments With Off-Balance Sheet Risk	37,851,000	46,130,000
Unfunded commitments for unconsolidated investments
Commitments
Financial Instruments With Off-Balance Sheet Risk	7,356,000	6,607,000
Company guarantees
Commitments
Financial Instruments With Off-Balance Sheet Risk	2,160,000	1,756,000
Commitments For Unconsolidated Investments
Commitments
Financial Instruments With Off-Balance Sheet Risk	12,500,000
Unfunded commitments	$7,400,000

Regulatory_Matters_Reconciliat

Regulatory Matters (Reconciliation Of Regulatory Capital) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Regulatory matters
Shareholders' equity	$308,769	$281,085
Disallowed intangible assets	-2,526	-2,798
Unrealized gain on available for sale securities	-7,168	-5,100
Unrealized loss on cash flow hedges	2,840	2,370	5,607	5,275
Subordinated debentures	70,000	70,000
Other deductions	-8	-8
Tier I regulatory capital	371,907	345,549
Allowance for loan losses	32,250	29,888
Total risk-based regulatory capital	404,157	375,437
Bank
Regulatory matters
Shareholders' equity	323,266	294,157
Unrealized gain on available for sale securities	-7,168	-5,100
Unrealized loss on cash flow hedges	-230	46
Tier I regulatory capital	315,868	289,103
Allowance for loan losses	31,878	29,511
Total risk-based regulatory capital	$347,746	$318,614

Regulatory_Matters_Schedule_Of

Regulatory Matters (Schedule Of Regulatory Capital Amounts And Ratios Of The Company And The Bank) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Regulatory matters
Tier I, Risk-based, Regulatory capital	$371,907	$345,549
Tier I, Risk-based, Well-capitalized requirement	154,767	142,997
Tier I, Risk-based, Regulatory capital - excess	217,140	202,552
Tier I, Risk-based, Capital ratios	14.40%	14.50%
Tier I, Risk-based, Minimum capital requirement	4.00%	4.00%
Tier I, Risk-based, Well capitalized requirement	6.00%	6.00%
Total capital, Risk-based, Regulatory capital	404,157	375,437
Total capital, Risk-based, Well-capitalized requirement	257,946	238,329
Total capital, Risk-based, Regulatory capital - excess	146,211	137,108
Total capital, Risk-based, Capital ratios	15.70%	15.70%
Total capital, Risk-based, Minimum capital requirement	8.00%	8.00%
Total capital, Risk-based, Well capitalized requirement	10.00%	10.00%
Tier I, Leverage, Regulatory capital	371,907	345,549
Tier I, Leverage, Well-capitalized requirement	149,380	139,043
Tier I, Leverage, Regulatory capital - excess	222,527	206,506
Tier I, Leverage, Capital ratios	12.40%	12.40%
Tier I, Leverage, Minimum capital requirement	4.00%	4.00%
Tier I, Leverage, Well capitalized requirement	5.00%	5.00%
Bank
Regulatory matters
Tier I, Risk-based, Regulatory capital	315,868	289,103
Tier I, Risk-based, Well-capitalized requirement	152,987	141,232
Tier I, Risk-based, Regulatory capital - excess	162,881	147,871
Tier I, Risk-based, Capital ratios	12.40%	12.30%
Tier I, Risk-based, Minimum capital requirement	4.00%	4.00%
Tier I, Risk-based, Well capitalized requirement	6.00%	6.00%
Total capital, Risk-based, Regulatory capital	347,746	318,614
Total capital, Risk-based, Well-capitalized requirement	254,978	235,387
Total capital, Risk-based, Regulatory capital - excess	92,768	83,227
Total capital, Risk-based, Capital ratios	13.60%	13.50%
Total capital, Risk-based, Minimum capital requirement	8.00%	8.00%
Total capital, Risk-based, Well capitalized requirement	10.00%	10.00%
Tier I, Leverage, Regulatory capital	315,868	289,103
Tier I, Leverage, Well-capitalized requirement	147,834	137,537
Tier I, Leverage, Regulatory capital - excess	$168,034	$151,566
Tier I, Leverage, Capital ratios	10.70%	10.50%
Tier I, Leverage, Minimum capital requirement	4.00%	4.00%
Tier I, Leverage, Well capitalized requirement	5.00%	5.00%

Fair_Value_Measurements_Narrat

Fair Value Measurements (Narrative) (Details) (USD $)	12 Months Ended			3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2014
Fair value, narrative disclosures
Provision for loan and credit losses	($4,155,000)	($8,804,000)	($4,768,000)
TPS
Fair value, narrative disclosures
Number of securities transferred to Level 3	3
Transfers from Level 2 to Level 3				700,000
Impaired Loans
Fair value, narrative disclosures
Provision for loan and credit losses	400,000	100,000
Net charge-offs	$100,000	$1,000,000

Fair_Value_Measurements_Financ

Fair Value Measurements (Financial Assets And Liabilities Measured At Fair Value On Recurring Basis) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets and liabilities measured at fair value
Investment securities available for sale	$459,815	$535,133
Total derivative assets	4,891	8,341
Total derivative liabilities	10,306	10,426
Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities	988
Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	21,737	46,252
Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	431,324	482,845
Total derivative assets	4,891	8,341
Total derivative liabilities	10,306	10,426
Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative liabilities	988
Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	6,754	6,036
Mortgage-backed securities
Assets and liabilities measured at fair value
Investment securities available for sale	283,504	333,211
Mortgage-backed securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	283,504	333,211
Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	59,655	82,324
Trust preferred securities | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	21,737	46,252
Trust preferred securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	31,164	30,036
Trust preferred securities | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	6,754	6,036
Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	101,210	110,982
Corporate debt securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	101,210	110,982
Municipal securities
Assets and liabilities measured at fair value
Investment securities available for sale	15,446	8,616
Municipal securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	15,446	8,616
Foreign exchange forward contracts
Assets and liabilities measured at fair value
Total derivative assets	54
Total derivative liabilities	17	10
Foreign exchange forward contracts | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	54
Total derivative liabilities	17	10
Derivatives designated as hedging instruments | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets	437	184
Total derivative liabilities	5,017	4,007
Derivatives designated as hedging instruments | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	297	1,735
Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets	437	184
Total derivative liabilities	5,017	4,007
Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets	297	1,735
Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	4,103	6,422
Total derivative liabilities	4,284	6,409
Derivatives not designated as hedging instruments | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	4,103	6,422
Total derivative liabilities	$4,284	$6,409

Fair_Value_Measurements_Financ1

Fair Value Measurements (Financial Assets Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Reconciliation of Level 3 inputs
Beginning balance	$6,036	$980
Transfers and purchases	706	5,119
Net accretion (amortization)	58	13
Unrealized loss included in comprehensive income	-46	-76
Ending balance	$6,754	$6,036

Fair_Value_Measurements_Schedu

Fair Value Measurements (Schedule Of Financial Assets Measured At Fair Value On A Nonrecurring Basis - Impaired Loans) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	$15,734
OREO	6,132	5,371
Year to date gain (loss)	1,459	-708
Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
OREO	6,132	5,371
Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	15,734	22,187
Impaired Loans | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	15,734	22,187
OREO
Assets and liabilities measured at fair value
OREO	$6,132

Fair_Value_Measurements_Schedu1

Fair Value Measurements (Schedule Of Reconciliation Of The Fair Value Measurement Of Other Real Estate Owned) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value Measurements
OREO recorded at fair value	$6,132	$5,371
Estimated selling costs	-313	-274
OREO	$5,819	$5,097	$10,577

Fair_Value_Measurements_Summar

Fair Value Measurements (Summary Of Other Real Estate Owned Transactions) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair Value Measurements
Beginning balance	$5,097	$10,577
Additions	4,992	449
Sales	-5,305	-5,221
Net loss on sale and valuation adjustments	1,035	-708
Ending balance	$5,819	$5,097

Fair_Value_Measurements_Schedu2

Fair Value Measurements (Schedule Of Valuation Process used to determine Level 3) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Fair value valuation processes
Investment securities available for sale	$459,815	$535,133
Impaired loans	15,734
OREO recorded at fair value	6,132	5,371
Impaired Loans
Fair value valuation processes
Impaired loans	15,734	22,187
OREO
Fair value valuation processes
OREO recorded at fair value	6,132
Market approach | Trust preferred securities
Fair value valuation processes
Investment securities available for sale	6,754
Valuation Technique	Market approach
Unobservable Input	Discount to carrying value using broker quotes or observable prices on similar securities
Market approach | Weighted Average | Trust preferred securities
Fair value valuation processes
Discount rate	14.00%
Market approach | Minimum | Trust preferred securities
Fair value valuation processes
Discount rate	0.00%
Market approach | Maximum | Trust preferred securities
Fair value valuation processes
Discount rate	18.00%
Commercial | Market approach | Impaired Loans
Fair value valuation processes
Impaired loans	1,150
Valuation Technique	Market approach
Unobservable Input	Management discount for asset type
Commercial | Market approach | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	41.00%
Commercial | Market approach | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	77.00%
Commercial | Market approach | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	6.00%
Commercial | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	455
Valuation Technique	Property appraisals
Unobservable Input	Management discount for property type and recent market volatility
Commercial | Property appraisals | Weighted Average | OREO
Fair value valuation processes
Discount rate	19.00%
Commercial | Property appraisals | Minimum | OREO
Fair value valuation processes
Discount rate	0.00%
Commercial | Property appraisals | Maximum | OREO
Fair value valuation processes
Discount rate	30.00%
Real estate - mortgage | Income approach | Impaired Loans
Fair value valuation processes
Impaired loans	9,486
Valuation Technique	Income approach
Unobservable Input	Capitalization and/or discount rate
Real estate - mortgage | Income approach | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	9.00%
Real estate - mortgage | Income approach | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	9.00%
Real estate - mortgage | Income approach | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	10.00%
Real estate - mortgage | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	2,407
Valuation Technique	Sales comparison
Unobservable Input	Sales comparison adjustments
Real estate - mortgage | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	4.00%
Real estate - mortgage | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	-9.00%
Real estate - mortgage | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	14.00%
Construction and land | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	679
Valuation Technique	Sales comparison
Unobservable Input	Sales comparison adjustments
Construction and land | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	3.00%
Construction and land | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	-24.00%
Construction and land | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	5.00%
Consumer | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	2,012
Valuation Technique	Sales comparison
Unobservable Input	Sales comparison adjustments
Consumer | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	7.00%
Consumer | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	5.00%
Consumer | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	14.00%
Land acquisition and development | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$5,677
Valuation Technique	Property appraisals
Unobservable Input	Management discount for property type and recent market volatility
Land acquisition and development | Property appraisals | Weighted Average | OREO
Fair value valuation processes
Discount rate	19.00%
Land acquisition and development | Property appraisals | Minimum | OREO
Fair value valuation processes
Discount rate	17.00%
Land acquisition and development | Property appraisals | Maximum | OREO
Fair value valuation processes
Discount rate	50.00%

Fair_Value_Measurements_Schedu3

Fair Value Measurements (Schedule Of Estimated Fair Value Of Other Financial Instruments) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	$91,565	$76,028	$65,893	$59,210
Investment securities available for sale	459,815	535,133
Investment securities held to maturity	13,329	13,266
Other investments	11,477	8,397
Loans - net	2,372,810	2,047,309
Accrued interest receivable	9,617	8,770
Derivatives assets	4,891	8,341
Deposits.	2,492,291	2,279,037
Securities sold under agreements to repurchase	49,976	138,494
Short-term borrowings	112,469
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	10,306	10,426
Carrying Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	91,565	76,028
Investment securities available for sale	459,815	535,133
Investment securities held to maturity	13,329	13,266
Other investments	11,477	8,397
Loans - net	2,372,810	2,047,309
Accrued interest receivable	9,617	8,770
Derivatives assets	4,891	8,341
Deposits.	2,492,291	2,279,037
Securities sold under agreements to repurchase	49,976	138,494
Short-term borrowings	112,469
Accrued interest payable	813	679
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	10,306	10,426
Total Fair Value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and cash equivalents	91,565	76,028
Investment securities available for sale	459,815	535,133
Investment securities held to maturity	13,616	12,715
Other investments	11,477	8,397
Loans - net	2,371,756	2,045,447
Accrued interest receivable	9,617	8,770
Derivatives assets	4,891	8,341
Deposits.	2,492,340	2,279,996
Securities sold under agreements to repurchase	49,991	138,312
Short-term borrowings	112,469
Accrued interest payable	813	679
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	$10,306	$10,426

Segments_Summary_Of_Operating_

Segments (Summary Of Operating And Selected Financial Information By Operating Segment) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total interest income	$29,611	$29,205	$28,510	$26,991	$26,954	$26,961	$26,160	$26,052	$114,317	$106,127	$106,128
Total interest expense	2,043	2,143	2,157	2,086	2,178	2,586	2,795	2,867	8,429	10,426	12,750
Provision for loan losses									-4,155	-8,804	-4,733
Noninterest income									32,075	30,912	30,559
Noninterest expense									97,964	94,628	91,166
Provision (benefit) for income taxes									15,147	13,351	13,258
NET INCOME FROM CONTINUING OPERATIONS	6,982	7,891	8,617	5,517	7,275	7,025	7,262	5,876	29,007	27,438	24,246
Income (loss) from discontinued operations								173		173	324
Net income	6,982	7,891	8,617	5,517	7,275	7,025	7,262	6,049	29,007	27,611	24,570
Depreciation and amortization									3,286	3,670	4,004
Identifiable assets	3,062,166				2,800,691				3,062,166	2,800,691	2,653,641
Commercial Banking
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total interest income									113,888	105,719	105,757
Total interest expense									4,394	5,195	6,886
Provision for loan losses									-3,346	-7,330	-3,546
Noninterest income									9,940	11,907	12,646
Noninterest expense									35,602	35,265	32,964
Management fees and allocations									23,988	22,313	20,605
Provision (benefit) for income taxes									30,926	30,049	30,284
NET INCOME FROM CONTINUING OPERATIONS										32,134	31,210
Net income									32,264	32,134	31,210
Depreciation and amortization									2,316	2,564	2,649
Identifiable assets	3,025,107				2,764,609				3,025,107	2,764,609	2,611,788
Fee-Based Lines
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total interest income									6	11	10
Total interest expense									41	61	41
Noninterest income									21,052	18,578	17,716
Noninterest expense									18,968	18,224	18,508
Management fees and allocations									1,115	959	1,179
Provision (benefit) for income taxes									819	211	-331
NET INCOME FROM CONTINUING OPERATIONS										-866	-1,671
Income (loss) from discontinued operations										173	324
Net income									115	-693	-1,347
Depreciation and amortization									949	1,074	1,321
Identifiable assets	14,979				15,403				14,979	15,403	18,517
Corporate Support and Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total interest income									423	397	361
Total interest expense									3,994	5,170	5,823
Provision for loan losses									-809	-1,474	-1,187
Noninterest income									1,083	427	197
Noninterest expense									43,394	41,139	39,694
Management fees and allocations									-25,103	-23,272	-21,784
Provision (benefit) for income taxes									-16,598	-16,909	-16,695
NET INCOME FROM CONTINUING OPERATIONS										-3,830	-5,293
Net income									-3,372	-3,830	-5,293
Depreciation and amortization									21	32	34
Identifiable assets	22,080				20,679				22,080	20,679	23,336
CoBiz Financial Inc.
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Total interest expense									4,122	5,360	6,041
Provision (benefit) for income taxes									-1,402	-2,748	-3,333
Net income									29,007	27,611	24,570
Identifiable assets	$396,646				$372,349				$396,646	$372,349

Condensed_Financial_Statements2

Condensed Financial Statements Of Parent Company (Condensed Balance Sheets) (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Condensed Financial Statements of Parent Company
Cash on deposit at subsidiary bank	$54,629	$53,359
Other	19,910	27,585
TOTAL ASSETS	3,062,166	2,800,691	2,653,641
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	2,753,397	2,519,606
Shareholders' equity	308,769	281,085
TOTAL LIABILITIES AND EQUITY	3,062,166	2,800,691
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Cash on deposit at subsidiary bank	24,495	24,742
Investments in bank subsidiary	323,266	294,157
Investment in non-bank subsidiaries	29,878	27,846
Accounts receivable from bank subsidiary	498	172
Accounts receivable from non-bank subsidiaries	1,218	8,893
Other	17,291	16,539
TOTAL ASSETS	396,646	372,349
Accounts payable to bank subsidiaries	6,718	8,237
Accounts payable to non-bank subsidiaries	7,337	5,817
Junior subordinated debentures	72,166	72,166
Other liabilities	1,656	5,044
TOTAL LIABILITIES	87,877	91,264
Shareholders' equity	308,769	281,085
TOTAL LIABILITIES AND EQUITY	$396,646	$372,349

Condensed_Financial_Statements3

Condensed Financial Statements Of Parent Company (Condensed Statements Of Operations) (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements of Parent Company
Other income									$5,425	$7,019	$7,940
Salaries and employee benefits									69,089	64,540	59,935
Interest expense	2,043	2,143	2,157	2,086	2,178	2,586	2,795	2,867	8,429	10,426	12,750
Other									14,724	13,076	12,566
Other expense									14,724	13,076	12,566
INCOME BEFORE INCOME TAXES	10,522	12,206	13,099	8,327	10,984	9,874	11,261	8,670	44,154	40,789	37,504
Provision for income taxes									15,147	13,351	13,258
NET INCOME	6,982	7,891	8,617	5,517	7,275	7,025	7,262	6,049	29,007	27,611	24,570
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Management fees									4,397	4,457	3,861
Dividends from bank subsidiary									8,116	8,000
Dividends from non-bank subsidiaries									1,898	6,123	3,704
Interest income									181	243	272
Other income									1,102	445	342
Total income									15,694	19,268	8,179
Salaries and employee benefits									4,408	4,255	4,715
Interest expense									4,122	5,360	6,041
Other									2,203	2,441	2,344
Other expense									2,203	2,441	2,344
Total expenses									10,733	12,056	13,100
INCOME BEFORE INCOME TAXES									4,961	7,212	-4,921
Provision for income taxes									-1,402	-2,748	-3,333
Net income (loss) before equity in undistributed earnings of subsidiaries									6,363	9,960	-1,588
Equity in undistributed earnings (loss) of subsidiaries									22,644	17,651	26,158
NET INCOME									$29,007	$27,611	$24,570

Condensed_Financial_Statements4

Condensed Financial Statements Of Parent Company (Condensed Statements Of Cash Flows) (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Condensed Financial Statements of Parent Company
Net income	$29,007	$27,611	$24,570
Stock-based compensation	3,141	2,742	1,965
Net cash provided by operating activities	27,271	26,751	31,512
Other	-1,976	24	39
Net cash used in investing activities	-243,370	-151,654	-222,537
Proceeds from issuance of common stock, net	1,570	1,960	12,582
Taxes paid in net settlement of restricted stock	-1,045	-297
Redemption of notes payable		-20,984
Dividends paid on common stock	-6,076	-4,820	-2,747
Dividends paid on preferred stock	-574	-1,465	-2,868
Net cash provided by financing activities	231,636	135,038	197,708
NET INCREASE IN CASH AND CASH EQUIVALENTS	15,537	10,135	6,683
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	76,028	65,893	59,210
CASH AND CASH EQUIVALENTS, END OF PERIOD	91,565	76,028	65,893
CoBiz Financial Inc.
Condensed Financial Statements of Parent Company
Net income	29,007	27,611	24,570
Equity in undistributed earnings of subsidiaries	-22,644	-17,651	-26,158
Stock-based compensation	584	487	335
Change in other assets and liabilities	2,205	8,195	1,340
Net cash provided by operating activities	9,152	18,642	87
Net advances (to) from subsidiaries	-3,372	-878	548
Other	-31	-18	-25
Net cash used in investing activities	-3,403	-896	523
Proceeds from issuance of common stock, net	1,570	1,960	12,582
Taxes paid in net settlement of restricted stock	-1,045	-297
Redemption of notes payable		-20,984
Dividends paid on common stock	-6,076	-4,820	-2,747
Dividends paid on preferred stock	-574	-1,465	-2,868
Other	129	5
Net cash provided by financing activities	-5,996	-25,601	6,967
NET INCREASE IN CASH AND CASH EQUIVALENTS	-247	-7,855	7,577
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	24,742	32,597	25,020
CASH AND CASH EQUIVALENTS, END OF PERIOD	$24,495	$24,742	$32,597

Supplemental_Financial_Data_De

Supplemental Financial Data (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Supplemental Financial Data
Loan Fees	$1,751	$1,950	$1,325
Other customer service fees	2,170	1,620	1,415
Bank-owned life insurance	1,594	1,295	1,286
Private equity investment income	-56	897	2,240
Interest rate swap fees	-106	1,201	1,490
Other income	72	56	184
Other noninterest income	5,425	7,019	7,940
Marketing and business development	3,090	2,810	2,425
Service contracts	4,027	3,569	2,295
Professional fees	2,475	2,337	1,991
Office supplies and delivery	1,550	1,541	1,559
Charitable donations	714	993	826
Other expense	2,868	1,826	3,470
Other noninterest expense	$14,724	$13,076	$12,566

Selected_Quarterly_Financial_D2

Selected Quarterly Financial Data (Details) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Selected Quarterly Financial Data
Interest income	$29,611	$29,205	$28,510	$26,991	$26,954	$26,961	$26,160	$26,052	$114,317	$106,127	$106,128
Interest expense	2,043	2,143	2,157	2,086	2,178	2,586	2,795	2,867	8,429	10,426	12,750
Net interest income	27,568	27,062	26,353	24,905	24,776	24,375	23,365	23,185	105,888	95,701	93,378
Income before income taxes	10,522	12,206	13,099	8,327	10,984	9,874	11,261	8,670	44,154	40,789	37,504
Net income (loss) from continuing operations	6,982	7,891	8,617	5,517	7,275	7,025	7,262	5,876	29,007	27,438	24,246
Income (loss) from discontinued operations								173		173	324
Net income	$6,982	$7,891	$8,617	$5,517	$7,275	$7,025	$7,262	$6,049	$29,007	$27,611	$24,570
Basic	$0.17	$0.19	$0.21	$0.13	$0.18	$0.17	$0.18	$0.14	$0.70	$0.66	$0.55
Diluted	$0.17	$0.19	$0.21	$0.13	$0.18	$0.17	$0.18	$0.14	$0.70	$0.66	$0.55